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ABSTRACT 
Kaposi’s sarcoma-associated herpesvirus (KSHV) is the aetiologic agent of Kaposi’s 
sarcoma (KS), a malignancy characterised by spindle-shaped tumour cells with an endothelial 
phenotype that line primitive vascular structures. This thesis examines the concept that KSHV 
infection of primary endothelial cells alters their migration, supporting development of the 
extensive aberrant angiogenesis seen in KS.  
Primary human umbilical vein endothelial cells were infected with KSHV and their 
migration examined at time points between one and ten days post-inoculation. Infected cells 
transmigrated preferentially across porous filters compared to untreated or non-infected cells, and 
wounds in inoculated monolayers closed more rapidly compared to untreated cultures. Several 
cellular properties which might regulate cell migration rates were altered by KSHV inoculation. 
The virus modulated the laminin profile of the sub-endothelial matrix by reducing laminin-P1 
deposition but increasing that of the laminin-4 chain. No effect on deposition of either 
fibronectin or collagen IV was found. An increase in cell-surface expression of the laminin-
binding integrin-6 subunit was also detected with infection. Furthermore, KSHV infection 
partitioned actin stress fibres to the cell cortex and reduced the size and number of focal 
adhesions per cell. These results support a pro-migratory, pro-angiogenic effect of KSHV on 
endothelial cells that might be targeted to treat KS. 
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PI3K Phosphatidylinositol 3-kinase 
PIPK Phosphatidylinositol phosphate kinase- 
PIX PAK-interacting exchange factor 
PKB Protein kinase B 
PKL Paxillin kinase linker 
PlGF Placenta-derived growth factor 
PMA Phorbal myristate acetate 
PROX-1 Prospero homeobox protein-1 
PtdIns Phosphatidylinositol 
PtdIns(4,5)P2 Phosphatidylinositol 4,5 bisphosphate 
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RGD Arginine-Glycine-Aspartate 
RNA Ribonucleic acid 
RRV Rhesus monkey Rhadinovirus 
RTA Lytic switch and transcription activator protein 
SH2 Src homology-2 
SH3 Src homology-3 
SHIP-2 SH2-containing inositol 5-phosphatase-2 
SHP-2 SH2-containing phosphatase-2 
SHPS-1 SHP-2 substrate-1 
siRNA Small interfering RNA 
Src Src-family kinases 
Syn-4 Syndecan-4 
Synd Syndesmos 
Synt Syntenin 
TGFb Transforming growth factor beta 
Th T-helper 
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uPAR Urokinase plasminogen activator receptor 
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UV-KSHV-
EC 
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V KSHV-infected HUVEC 
VASP Vasodilator-stimulated phosphoprotein 
VCAM-1 Vascular cell adhesion molecule-1 
VEGF Vascular endothelial growth factor 
VEGFR Vascular endothelial growth factor receptor 
vFLIP Viral FLICE inhibitory protein 
vGPCR Viral G protein-coupled receptor 
WASP Wiscott-Aldrich Syndrome Protein 
WAVE Wiscott-Aldrich family verprolin homologous protein 
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Throughout this thesis, which involves the inoculation of HUVEC with KSHV, the cell types 
generated are defined in the figures by the following abbreviations (see also section 2.2): 
Untreated (UT-EC) or (UT): Control cells inoculated with blank culture medium  
KSHV-inoculted (KSHV-EC): Cells inoculated with infectious KSHV  
UV-irradiated KSHV-inoculated (UV-KSHV-EC): Cells inoculated with KSHV that had 
been inactivated by UV irradiation 
KSHV-infected (V): Cells wthin the KSHV-inoculated culture that on the basis of their 
positivity for GFP expression were concluded infected with KSHV at the timepoint of study 
Non-infected (NI): Cells within the KSHV-inoculated culture that on the basis of their 
negativity for GFP expression were concluded not infected with KSHV at the timepoint of 
study   
Uninfected: Any cell from either an untreated or KSHV-inoculated culture that did not 
appear infected at the timepoint of study.  
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1.1 KAPOSI’S SARCOMA-ASSOCIATED HERPESVIRUS (KSHV) 
1.1.1 Classification 
Kaposi’s sarcoma-associated herpesvirus (KSHV) was first identified in 1994 by the method 
of representational difference analysis (Chang et al., 1994) (section 1.2.4). The virus has a 
double-stranded deoxyribonucleic acid (dsDNA) genome and was classified by phylogenetic 
sequence-based analysis to be a herpesvirus. It was the eighth and most recent human herpesvirus 
discovered; hence its alternative assignation HHV8 (human herpesvirus eight) (Chang et al., 
1994).  
Mammalian herpesviruses, together with avian and reptilian herpesviruses, are grouped in the 
taxonomic family, ‘Herpesviridae’ of the order ‘Herpesvirales’. This family is further subdivided 
into subfamilies of Alpha (), Beta () and Gammaherpesvirinae () (reviewed by Davison et al., 
2009) according to biological properties including: host range, replication cycle and cell tropism 
(reviewed by Wen and Damania, 2010)  
Of the human herpesviruses, KSHV is most closely related to HHV4, which is commonly 
referred to as the Epstein-Barr virus (EBV). Both KSHV and EBV are gammaherpesviruses 
although the genome of KSHV shows greater homology to those of the  prototype rhadinovirus, 
Herpesvirus Saimiri  (HVS) (Russo et al., 1996), and Rhesus monkey Rhadinovirus (RRV) 
(Alexander et al., 2000). Subsequently, KSHV has been assigned to the 2 or Rhadinovirus genus 
whilst EBV is classified in the genera 1 or Lymphocryptovirus (reviewed by Davison et al., 
2009) (Figure 1.1).  
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Figure 1.1: Phylogenetic dendrogram of the taxonomic family Herpesviridae.  
The dendrogram was calculated based on the sequences of the herpesvirus major basic 
capsid proteins (section 1.1.2) The relationships between 21 herpesviruses across the three 
subfamilies (,  and ) are shown. The location of KSHV within the 2 subgroup is 
highlighted (red box) showing its close phylogenetic relationship to the Rhesus rhadinovirus 
and Herpesvirus saimiri. Modified from Trus et al (2001). 
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1.1.2 Structure of the KSHV virion   
KSHV virions share the three-layered architecture distinct to herpesviruses (McGeoch et al., 
2006; Said et al., 1997; Trus et al., 2001; Wu et al., 2000). This is evident from negative stain 
electron microscopy and electron cryomicroscopy with image reconstruction. The three structural 
layers that surround the dsDNA core include: (1) an innermost icosahedral capsid built of four 
principal protein subunits including: major capsid protein, triplex -subunit, triplex -subunit and 
the small basic capsid protein (the triplexes are 2 heterotrimers); (2) a middle protein-rich 
tegument; (3) an outer glycoprotein-impregnated lipid envelope. The glycoproteins that decorate 
the outer envelope are thought to mediate KSHV entry by acting as ligands to specific receptor 
proteins on the host cell (section 1.1.7) (Figure 1.2). 
 
Figure 1.2: The three-layered architecture of herpesvirus virions.  
Numbers indicate the three main structural layers that surround the dsDNA core.  
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In contrast to the capsid, the composition and architecture of the tegument layer is less well 
defined and appears to include both viral and host cell proteins (Bechtel et al., 2005b; Zhu et al., 
2005). Messenger RNAs (mRNAs) have also been detected (Bechtel et al., 2005a). It is suggested 
that the tegument proteins, when they are released into the cell during virus entry, coordinate 
fundamental processes of the virus lifecycle that are necessary for de novo infection to establish, 
such as: translocation of the viral capsid to the nucleus, modulation of the cell cycle, viral gene 
activation and host gene inactivation (Bechtel et al., 2005a; Bechtel et al., 2005b; Zhu et al., 
2005).  
1.1.3 The KSHV genome 
The dsDNA genomes of herpesviruses range in size from 124 to 295kbp (reviewed by 
McGeoch et al., 2006). The KSHV genome (Figure 1.3) is approximately 170kbp (Rezaee et al., 
2006). When packaged within the capsid, the DNA is linear. Unpaired, complementary 
nucleotides are found at each terminus and support episome formation upon circularisation of the 
genome during infection (section 1.1.4). Genes involved in virion replication or structure are 
conserved among members of the Herpesviridae and are organised into seven genomic blocks 
located predominantly within the central region. The order of arrangement of these genes is the 
same across viruses of the same subfamily but differs between subfamilies. Despite this gene 
conservation, herpesviruses from within the same genera do not necessarily use homologous 
genes for the same processes in their lifecycle.  
The non-core genes are mostly situated toward the termini. It is thought that many new gene 
functions have arisen through mechanisms of gene duplication and lateral transfer from either the 
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host cell or other viruses. Many of those thought to have been acquired from the host might aid 
survival of the virus in the host cell through immunomodulatory and anti-apoptotic functions 
(reviewed by McGeoch et al., 2006).   
The central protein-coding region of the KSHV genome is 140.5kbp and encodes eighty-six 
genes of which at least twenty-two have predicted immunomodulatory functions (see Rezaee et 
al., 2006). Sixty-six KSHV genes show homology to those of HVS and are designated open 
reading frames (ORFs) 4 to 75 accordingly. Those unique to KSHV are notated with the letter 
‘K’ to distinguish them from HVS homologues (Russo et al., 1996). 
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Figure 1.3: The KSHV genome.  
The dsDNA KSHV genome totals approximately 170kbp and consists of a central unique 
region (U) flanked at each end by a sequence of direct repeats (TR) that mediate 
circularisation of the linear genome into the viral episome. The sequence shown is of U 
followed by a single copy of TR (widened bar). Coloured arrows indicate protein coding 
regions with phylogenetic relationships as defined by the key. Narrow white bars indicate 
introns. Gene nomenclature is given below the bar and the names of the encoded proteins 
are stated above. Taken from Rezaee (2006). 
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1.1.4 The KSHV lifecycle 
In order to survive, viruses need to replicate and assemble new progeny. They are absolutely 
dependent upon their host cell and subvert its molecular machinery to support processes of DNA 
replication, transcription and translation.  
Herpesviruses demonstrate two alternative reproductive programs namely episomal latency 
and lytic replication. Latency is a period of dormancy during which viral gene expression is 
heavily restricted and new viral particles are not assembled. The genome is maintained as a 
circular episome and is propagated between daughter cells at low copy number. By contrast lytic 
replication describes an active phase of new virion production during which the majority of viral 
genes are expressed according to a temporally regulated cascade. The ‘immediate early genes’ 
are expressed first followed by the ‘delayed early genes’ and finally the ‘late genes’. Such orderly 
changes in gene expression ensure that host anti-viral immune responses are subverted for 
maintenance of the infected cell and viral DNA is replicated to attain a high copy number before 
the structural proteins, required for new virion assembly, are synthesized (reviewed by Ganem, 
2007)  
KSHV infection, both in vivo and in vitro is typically latent. The study of the lytic cycle 
typically requires chemical-induced reactivation or ectopic expression of the KSHV lytic switch 
and transcription activator protein (RTA/K50) (Ganem, 2007).  
1.1.5 Incidence and transmission of KSHV infection 
KSHV infection occurs worldwide; however, prevalence varies between populations and even 
within regions as reported for Italy (Whitby et al., 1998) and Africa (Mbulaiteye et al., 2005). 
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Countries within Asia, Northern America and Northern Europe have low overall prevalence. 
Mediterranean, Middle Eastern and Caribbean countries have intermediate prevalence and high 
prevalence is seen in Africa and parts of the Amazon basin (reviewed by Dukers and Rezza, 
2003; Mbulaiteye et al., 2004).  
Phylogenetic studies have defined a number of KSHV subtypes: A, B, C, D, E and N. 
Sequence variation between subtypes is below 3% and resides almost exclusively in ORF K1; 
thus the subtype categorization is based primarily upon K1 sequence. Geographical differences in 
subtype prevalence are reported, suggesting that subtypes may have originated via different 
selective pressures operating alongside different human populations. For example subtypes B, D, 
E and N have been associated with people of African, Old Asian and Polynesian, Amerindian and 
South African populations respectively. Population associations have not been described for 
subtypes A and C but both are found in Northern Europe, the Americas and Asia (reviewed by 
Dukers and Rezza, 2003; Schulz, 2006). 
Relationships between rates of KSHV infection and demographic factors including gender or 
age vary. Therefore, it appears that the principal modes of transmission differ with geographical 
region. While this may be due to variability in assays it suggests that social, economic and 
environmental conditions are important determinants (see Mbulaiteye et al., 2005). In non-
endemic countries such as Northern Europe and North America, seroprevalence is generally 
higher among men than women and may in part reflect a disproportionately high incidence of 
infection found among the male homosexual community in these regions. Indeed the increased 
occurrence in male homosexuals implies that facets of male homosexual practice potentiate 
transmission. A lack of infection during childhood in low prevalence regions is further supportive 
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of a sexual route of transmission. Conversely, however, in Africa, where disease is endemic, 
seropositivity is equal among men and women and increases during childhood, reaching 40-70% 
by adulthood (Corey et al., 2002); hence non-sexual modes of KSHV infection are also possible. 
Close contact, a lack of hygienic practices such as regular bathing and washing of hands, and 
overcrowding might aid transmission in these populations (Mbulaiteye et al., 2004; Mbulaiteye et 
al., 2003).  
KSHV replication is thought to occur primarily at the oropharynx and saliva is typically the 
only mucosal secretion positive for KSHV DNA in seropositive persons. Studies investigating 
KSHV shedding in genital secretions concluded a low and inconsistent presence and there is 
limited evidence to suggest that replication of the virus occurs at genital sites (see Corey et al., 
2002; Koelle et al., 1997; Pauk et al., 2000) hence saliva is likely to mediate most of KSHV 
transmission in both the homosexual (Blackbourn et al., 1998; Koelle et al., 1997; Pauk et al., 
2000; Vieira et al., 1997) and non-homosexual setting (Dedicoat et al., 2004; Mbulaiteye et al., 
2004). Such is consistent with the common practices of oral-genital sex and deep kissing 
performed by homosexual men and also with childhood behaviors and parent-child interactions 
such as the use of saliva to clean children’s faces (see Dedicoat et al., 2004; Dukers and Rezza, 
2003; Mbulaiteye et al., 2004; Mbulaiteye et al., 2003; Pauk et al., 2000). Nonetheless, if salivary 
contact is the major route of transmission, it is somewhat surprising that KSHV prevalence and 
incidence of associated disease is not higher and that KSHV is not transferred efficiently within 
heterosexual relationships.  
Blood is unlikely to mediate much of KSHV transmission, particularly in low prevalence 
areas, since the isolation of KSHV DNA from peripheral blood mononuclear cells (PBMC) is 
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minimal among either healthy (Blackbourn et al., 1997) or seropositive individuals without 
KSHV-related disease (Cannon et al., 2003). Furthermore, KSHV infection occurs at similar rates 
in human immunodeficiency virus (HIV)-positive individuals acquiring HIV parenterally and 
HIV-negative blood donors (Kedes et al., 1996) and in contrast to viral infections including: 
HIV-1, hepatitis B and hepatitis C, which spread readily among intravenous drug users, efficient 
transmission does not occur for KSHV (Renwick et al., 2002).  
1.1.6 Cell types infected by KSHV 
In vitro and in vivo studies have demonstrated that KSHV has a broad cellular tropism in its 
natural human host. This work implies that KSHV entry receptors must have a fairly ubiquitous 
expression. In vivo, KSHV DNA and transcripts have been identified in human B cells, 
monocytes, macrophages, keratinocytes, and endothelial cells and in vitro, infection of 
endothelial, epithelial and fibroblast cell lineages has been successful. In addition, infection of a 
number of animal cells has been reported (see Akula et al., 2003). 
1.1.7 The mechanism of KSHV infection   
The paradigm for herpesvirus infection implicates steps of: (1) adsorption and binding to the 
host cell; (2) fusion of the viral envelope with the host cell membrane (plasma membrane or 
intracellular endosomal membrane); (3) release of the capsid to the cytosol; (4) translocation of 
the capsid to the nuclear envelope; (5) delivery of the genome into the nucleus (Akula et al., 
2003; Kaleeba and Berger, 2006a).  
Many microorganisms bind to their host cell through interaction of their surface proteins with 
host cell proteoglycans. As demonstrated for a number of alpha, beta and gammaherpesviruses, 
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as well as other types of virus such as: HIV-1, vaccinia virus, sindbis virus, adeno-associated 
virus, foot and mouth disease virus and respiratory syncytial virus, KSHV exploits heparan 
sulfate-like moieties for adsorption (see Akula et al., 2001b). The role of heparan in KSHV-
binding appears specific but dispensable since soluble heparin (100g/ml) inhibited, but did not 
completely abolish the binding and uptake of the virus and caused displacement of KSHV when 
added to virus-cell mixtures. In contrast, pre-treating KSHV with either chondroitin sulfates A or 
C (1000g/ml) failed to reduce either step or to induce displacement of pre-adsorbed virus. 
Treatment with heparinases I and III also afforded 65% reduction in infection (Akula et al., 
2001b).  
Overall, KSHV is expected to exploit additional host cell surface molecules besides heparan 
for adsorption to the host cell. It is suggested that interactions with heparan sulfate provide the 
initial ligand-receptor interactions during the adsorption phase, serving to concentrate KSHV at 
the host cell and facilitate its binding to other cell-surface receptors that act as adsorption or entry 
receptors and/or signal transducers during the infection process (Akula et al., 2001b).  
Studies have indicated that KSHV-glycoprotein B (gB/ORF8) (Akula et al., 2001a) and K8.1 
(Wang et al., 2001) mediate binding of KSHV to heparan-sulfate moieties. The encoding of two 
or more glycoproteins for heparan binding appears typical among herpesviruses and reflects the 
importance of heparan sulfate moieties as host-cell receptors. gB has counterparts in other 
herpesvirus (for example Herpes simplex virus (HSV)-1; HSV-2; Human cytomegalovirus 
(HCMV); HHV-7 (see Wang et al., 2001) which also function in heparan sulfate binding. In 
contrast K8.1 is unique to KSHV but is a positional homologue of the EBV and Murine 
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gammaherpesvirus 68 (MHV-68) envelope glycoproteins gp350/220 and gp150 respectively, 
which have roles in virus infectivity (see Wang et al., 2001).  
Electron microscopy images of the early events following KSHV entry into microvascular 
endothelial cells indicate that KSHV enters endothelial cells by fusion of the virion envelope with 
the plasma membrane (Dezube et al., 2002), although the same study also identified virions 
enclosed within vacuoles which is suggestive of endocytic uptake. Consistently, entry to human 
fibroblasts involved pH-dependent, clathrin-mediated endocytosis (Akula et al., 2003) but entry 
to 293L cells, while pH acidification dependent, proved clathrin and caveolae independent (Inoue 
et al., 2003). Overall, the mechanism of KSHV entry might be cell-type specific (Kaleeba and 
Berger, 2006a). Equally, direct and endocytic mechanisms might participate depending upon 
virus titre. The mechanism by which virions are routed into the cell might further dictate whether 
either latency or productive infection occurs (Dezube et al., 2002).  
The host cell receptors critical for entry are not well established and might differ according to 
cell type. In vitro studies have identified a number of candidate molecules including the Arg-Gly-
Asp (RGD)-binding integrins 31 (Akula et al., 2002) and v3 (Garrigues et al., 2008)  
Dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN) 
(Rappocciolo et al., 2006), and the 12-transmembrane light chain of the human 
cysteine/glutamate exchange transporter system, xCT (Kaleeba and Berger, 2006b). Interestingly, 
KSHV gB contains an RGD motif at its amino terminus, which is highly conserved among 
KSHV strains (Meng et al., 1999) and is a likely mediator of the interaction of KSHV with 
integrin receptors (Akula et al., 2002). The cognate KSHV ligands for xCT and DC-SIGN are not 
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known but in support of a role for xCT, KSHV fusion correlates with xCT expression (Kaleeba 
and Berger, 2006b).    
1.1.8 Diseases associated with KSHV infection  
In 2009 the International Agency for Research on Cancer (IARC) assigned KSHV as the 
aetiologic agent for the endothelial neoplasm Kaposi’s sarcoma (KS) and for the rare, non-
Hodgkin B-cell lymphoma, Primary Effusion Lymphoma (PEL). Although not the formal 
causative agent for Multicentric Castleman’s Disease (MCD), KSHV infection is also associated 
with the plasmablastic form of this lymphoproliferative disease (Bouvard et al., 2009). Both B-
cell disorders are generally linked to an underlying state of immunodeficiency and primarily 
affect HIV-seropositive Aquired Immunodeficiency Syndrome (AIDS) patients.  
1.1.8.1 Primary Effusion Lymphoma (PEL) 
PEL (also referred to as body cavity lymphoma) is an aggressive, usually fatal, non-
Hodgkin’s lymphoma that is thought to arise by the clonal proliferation of post-germinal B-cells 
given the hypermutation of their immunoglobulins and the presence of late stage B-cell 
differentiation markers. The tumour typically localises to the body cavities including the pleural 
space or pericardium; however, lymphomas of solid mass in the lymph nodes, lungs or 
gastrointestinal tract are observed in some patients.  In approximately 80% of cases, co-infection 
of KSHV with EBV is seen (reviewed by Verma and Robertson, 2003).   
1.1.8.2 Multicentric Castleman’s Disease (MCD) 
KSHV is associated with approximately 50% of plasmablastic MCD cases in which KSHV 
DNA is detected in around 30% of B-cells in the mantle zones surrounding the germinal centres. 
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The alternative hyaline-vascular form of MCD is generally KSHV negative. MCD is an 
aggressive, systemic, non-malignant illness. Symptoms include sustained fever and sweats, 
weight loss, lymphadenopathy and splenomegaly. Lesions develop at multiple sites and are 
polyclonal. The lymphoproliferation incurred is attributed to hypersecretion of interleukin (IL)-6. 
In KSHV infected lesions, the KSHV homologue of IL-6, vIL-6, may also contribute. In contrast 
to PEL, co-infection with EBV has not been noted for MCD (reviewed by Verma and Robertson, 
2003) .  
The work contained in this thesis is with regard to the role of KSHV in KS pathogenesis.  
Therefore, the following section in this introduction provides an overview to KS and the 
identification of KSHV as the aetiologic agent for that disease.  
1.2 KAPOSI’S SARCOMA (KS)  
1.2.1 Histology of KS lesions 
KS was first described in 1872 by the Hungarian dermatologist, Moritz Kaposi as ‘idiopathic 
multiple pigmented sarcoma of the skin’. It was not until 1891 that the eponymous name, 
Kaposi’s sarcoma, was assigned (see Boshoff and Weiss, 1997). KS lesions are multifocal and 
typically cutaneous, although in more aggressive disease they also affect the viscera. The lesions 
have a distinct raised and purplish appearance (reviewed by Restrepo and Ocazionez, 2011) 
(Figure 1.4).  
The lesions originate as flat maculae (patch stage) and progress through a plaque to nodular 
stage (Ensoli et al., 2001) increasing in granularity and cell type by the infiltration of 
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inflammatory cells, including: dendritic cells, macrophages, plasma cells and lymphocytes and 
the extravasation of erythrocytes (reviewed by Ensoli et al., 2001; Mesri et al., 2010; Pantanowitz 
et al., 2009; Restrepo and Ocazionez, 2011). An abnormal, primitive vasculature of slit-like 
vessels is formed by the proliferation of activated endothelial cells and as the tumour progresses 
the stroma surrounding the vascular spaces becomes increasingly filled with cells of spindle 
morphology which represent the main proliferative component (see Ensoli et al., 2001; Restrepo 
and Ocazionez, 2011). These spindle cells have an endothelial phenotype and feature latent 
KSHV infection; only 2-5% of cells are lytically infected (Moses et al., 1999; Orenstein et al., 
1997; Staskus et al., 1997; Zhong et al., 1996) (Figure 1.4). The proliferation of these tumour 
cells is believed to contribute to the aberrant neoangiogenesis and neolymphangiogenesis (see 
Colman and Blackbourn, 2008; Mesri et al., 2010) that is a hallmark of KS. Infiltrating B-cells 
and neovascular endothelial cells also harbour the virus (Antman and Chang, 2000).  
There is some debate concerning whether KS is a true sarcoma. This is in view of the 
simultaneous appearance of multiple lesions across the body, their polyclonality and an absence 
of chromosomal changes. Nonetheless, in advanced disease, clonality of spindle cells has been 
reported (Rabkin et al., 1995) and nuclear and chromosomal abnormalities typical of malignancy 
identified (Bedi et al., 1995; Dictor et al., 1991; Ensoli et al., 2001). 
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Figure 1.4: The macroscopic and cellular appearance of KS lesions.  
(A) Photograph of the chest of a patient with AIDS-related KS illustrating the multifocal, 
cutaneous nature of the lesions and their raised purplish appearance. (B) Haematoxylin 
(nucleus) and eosin (cytoplasm) stained section of a KS lung lesion viewed with a 25x 
objective lens illustrating an abundance of abnormal slit like vessels and extravasated 
erythrocytes (Blackbourn unpublished data). (C) Paraffin-embedded KS skin section dual 
stained for nuclear-expressed KSHV latency associated nuclear antigen-1 (LANA-1) and 
vascular endothelial growth factor C (VEGFC), which is expressed in the cytoplasm of 
KSHV-infected cells of KS lesions. The image illustrates the spindle-shape of KSHV-
infected endothelial cells and their localisation lining the aberrant vasculature. Adapted 
from Colman and Blackbourn (2008). 
 
1.2.2 The epidemiologic forms of KS  
To date four epidemiologically distinct forms of KS have been described (classic, endemic, 
epidemic and iatrogenic) that are histopathologically identical indicating a similar mechanism of 
development. KSHV is the aetiologic agent for all (reviewed by Mesri et al., 2010; Restrepo and 
Ocazionez, 2011) (section 1.2.4). 
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‘Classic’ also termed ‘sporadic’ KS was the form originally identified by Moritz Kaposi. It is 
a rare, slow growing, indolent disease observed primarily among elderly men, between 50 and 70 
years of age, who are of Mediterranean, Eastern European and Jewish descent (Boshoff et al., 
1995a; Oriel, 1997). Lesions are generally restricted to the skin of the lower limbs. Internal 
organs are rarely affected. Secondary malignancies, typically non-Hodgkin lymphomas, are also 
seen in up to 30% of patients (Escalon and Hagemeister, 2006)  
‘Endemic’ otherwise known as ‘African’ KS was first reported in the early 1900s among 
populations in subequatorial Africa, such as countries including: The Congo Republic, The 
Congo, Burundi, Uganda and Zambia. It is a chronic nodular disease that primarily affects the 
legs and feet (Ziegler, 1993). Interestingly, incidence is five times more common in males than 
females even though seropositivity for KSHV is high and similar in males and females in this 
population (Boshoff and Weiss, 1997). Endemic KS is the most prevalent cancer among men in 
this area, representing, up to 10% of malignancies in men (see Parkin, 2006). A highly fatal 
lymphadenopathic disease variant that affects the viscera is also seen in this region among 
children prior to adolescence: it accounts for up to 25% of childhood cancers (see Restrepo and 
Ocazionez, 2011).  
‘Iatrogenic’ or ‘transplant-associated’ KS describes disease arising in patients who are 
receiving immune suppression therapy or who have undergone solid-organ transplantation and 
are consequently receiving immunosuppressive drugs to prevent rejection of the donated organ 
by their body’s immune system (Penn, 1988, 1991). There is no apparent association between KS 
and congenital immune deficiency states. The withdrawal of immunosuppressive regimens can 
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lead to regression of this disease (Wen and Damania, 2010) suggesting that immune suppression 
is a key contributor to the establishment of KS in KSHV-infected individuals. 
The risk of KS increases 1000 to 5000 fold in subjects infected with HIV compared to the 
general population and 50% of HIV-infected individuals develop KS. In fact KS is the most 
common malignancy associated with AIDS and is therefore one of the recognised AIDS-defining 
diseases (reviewed by Parkin, 2006).  
The HIV/AIDS epidemic and coincident rise in cases of KS saw the description of the fourth 
form of KS as ‘Epidemic’ or ‘AIDS-related’ KS. It is clinically the most aggressive form of KS 
and affects populations globally; although, with the introduction of highly active anti-retroviral 
therapy (HAART), incidence in the western world has been much reduced (Sarwar et al., 2007). 
The limited availability of such therapy in developing countries means that KS continues to be a 
major clinical concern in those countries. In the western world, the disease is mainly seen among 
HIV-infected male homosexuals but also bisexual men and female sexual partners of bisexual 
men, while in Africa and developing countries it is common in heterosexual adults. The higher 
incidence of KS among homosexuals in the western world is consistent with the increased 
seroprevalence of KSHV in that population (section 1.1.5). 
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1.2.3 Risk factors for KS 
This section provides a summary of some of the additional risk factors that have been 
suggested for KS (see also Colman and Blackbourn, 2008; Dukers and Rezza, 2003). 
Environment: The incidence of KS is higher in rural regions and is increased among persons 
in agricultural occupations such as cereal cultivation (Cottoni et al., 1997). Associations with 
altitude and climate are not clearly defined and may differ between countries. Studies examining 
incidence rates of KS across Africa reported highest frequencies near to the equator and at 
altitudes over 2000ft where humidity was moderate to high (Cook-Mozaffari et al., 1998; Ziegler, 
1993). This was however in contrast to the geographic patterns noted in Italy where decreasing 
risk of Classic KS with increasing altitude was described (Ascoli et al., 2009; Geddes et al., 
1995). Red clay, limestone and volcanic soils have also been associated with the disease in both 
Africa (Cook-Mozaffari et al., 1998; Ziegler, 1993) and Italy (Ascoli et al., 2009) but the fact that 
KS occurs at low frequency in areas such as Ethiopia, which have volcanic soils, suggests 
additional cofactors modulate risk (Ziegler, 1993).  
Gender and genetics: There is a predilection of KS for men. Genetic polymorphisms also 
influence susceptibility to a number of viral infections. Tentative associations with allele 
genotypes of the Fc fragment of the IgG low affinity IIIa receptor (FCGR3A) (Brown et al., 
2005; Lehrnbecher et al., 2000), human leukocyte antigen (HLA) (Dorak et al., 2005; Gaya et al., 
2004; Masala et al., 2005) and IL-6 promoter (Foster et al., 2000) have been postulated but 
require further clarification. 
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HIV-1 Tat protein: HIV-1 infection increases tendency to develop epidemic KS ten-fold 
compared to HIV-2 infection in populations where KSHV seroprevalence is identical (Horenstein 
et al., 2008). These data suggest that a factor peculiar to HIV-1 potentiates KS progression in 
ways other than by immune suppression. In vitro studies have implicated a role for the HIV-1 
protein Tat that is released by acutely infected T-cells. Once extracellular, Tat induces the 
adhesion, growth, migration and invasive properties of normal and KS endothelial cells through 
binding of its RGD sequence to integrin receptors and its basic sequence to heparan sulphates. 
The latter supports angiogenesis through competitive liberation of basic fibroblast growth factor 
(bFGF). Tat also induces upregulated expression of cytokines, adhesion molecules and matrix 
metalloproteinases (MMPs) that have angiogenic and invasion promoting effects (reviewed by 
Ensoli et al., 2001).   
Immune suppression: Reduced immune control over KSHV leading to increased viral load 
might explain instances of epidemic and iatrogenic KS. Weakening of the immune system occurs 
with age, other neoplasms and concurrent infections; thus immune suppression might also trigger 
onset of Classic KS. In support, a Greecian study of Classic KS observed that CD4+ T-cell 
counts were significantly lower in cases compared to controls (Touloumi et al., 1999).  
Socioeconomic: Overcrowding in countries burdened by endemic KS is speculated to 
contribute to transmission of KSHV in these communities (Dukers and Rezza, 2003); moreover, 
KSHV seropositivity is associated with either surface water or a communal standpipe as the 
source for drinking water compared to a private supply (Mbulaiteye et al., 2005). However, 
whilst overcrowding is generally greater among families of low economic status and consistently 
KSHV seropositivity was associated with lower maternal education and income and low status 
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father’s occupation for a cohort of 600 Ugandan children (Mbulaiteye et al., 2005), other case 
control studies in Uganda have reported incidence to be higher among individuals with improved 
educational and professional level and increased earning capacity. It is speculated that wealthy 
land owners in developing countries might spend longer toiling the land and thus incur greater 
exposure to risk from possible cofactors such as soil or water and livestock (Ziegler et al., 2003; 
Ziegler et al., 1997).  
Co-infection: Co-infection of the host with other viruses or parasites might be important in 
various forms of KS. For example HHV6 and HHV7 have been noted to infect the monocyte 
population of KS lesions (Kempf et al., 1997) and HCMV infection is frequently observed in KS. 
Moreover, in vitro studies demonstrate that HCMV is capable of reactivating KSHV from latency 
into lytic replication (Vieira et al., 2001).  
A role for malaria infection was suggested from observations that incidence of KS was high 
in areas that were or had been endemic for malaria (see Geddes et al., 1995; Ruocco et al., 2011). 
It is hypothesised that parasites, such as malaria, might serve as cofactors for KS by inducing 
reactivation of the virus and/or enhancing susceptibility to infection by the virus. The 
downregulation of T helper (Th)-1 cellular responses and upregulation of Th-2 humoral 
responses might limit host cell control of KSHV infection (Lin et al., 2008). While two 
epidemiologic studies conducted in northern (Cottoni et al., 2006) and north-eastern Sardinia 
(Cottoni et al., 1997) did not find statistical association between Classic KS and malaria, 
evidence of a link between KSHV seroprevalence and malaria parasitaemia was reported among 
women in Uganda (Wakeham et al., 2011). Moreover, the finding that anti-mosquito strategies to 
eradicate malaria in Sardinia led to a reduction in KSHV seroprevalence (Ascoli ref Colunzzi, 
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2003) provided further support for malaria as a possible cofactor for KS. Other parasite infections 
that have been linked to KS include: Mansonella perstans, hookworm (Wakeham et al., 2011) 
and Stronglyoides stercoralis (Lin et al., 2008). Frequencies of infection with intestinal parasites 
including: Schistosoma mansouri, Giardia lamblia, Trichomonas hominis and Entamoeba 
histolytica were also higher in KS patients compared to other cancer patients but the differences 
were not statistically significant (Lin et al., 2008). Contrary to Wakeham et al (2011), Lin et al 
(2008) reported an inverse association between KS and hookworm; however, Lin et al (2008) did 
not control for HIV infection: HIV-infection might have caused a decrease in parasite egg 
production and subsequent detection in stools, thereby accounting for the inverse or insignificant 
association between KS and a number of the parasites studied.  
The distribution of promoter arthropods, which are blood sucking insects that cause irritating 
bites (Ascoli et al., 2009; Coluzzi et al., 2002), has also been found to correlate with the 
incidence of KS in Sardinia (Ascoli et al., 2009). Interestingly, as for parasites, the promoter 
arthropods were at their highest densities under environment conditions previously highlighted as 
potential risk factors for KS, for example areas with past malaria prevalence, limestone, acid 
volcanic soil, lower altitude and cereal cultivation. Thus, the non-uniform distribution of KS 
globally but also within small geographic regions might be explained by the geographic variation 
in parasite and insect distributions. Roles for these organisms as cofactors might help to explain 
some of the environmental links to KS (Ascoli et al., 2009). It is suggested that by piercing the 
skin and injecting their saliva, promoter arthropods stimulate KSHV reactivation, leading to 
increased transmission through shedding of the virus in human saliva. Their saliva also induces 
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itching and inflammatory responses in the host that might underlie KS development (Ascoli et al., 
2009).  
1.2.4 Identification of KSHV as the aetiologic agent for KS 
As already introduced, KSHV is the recognised aetiologic agent of KS. The hypothesis that 
KS was caused by a viral pathogen was first presented during the 1960s, in view of the 
geographic variation in incidence of KS. At the identification of herpesvirus-like particles in 
short term cultures of KS biopsies, a role for HCMV infection was initially proposed but HCMV 
DNA failed to be detected in samples of KS tumours and the hypothesis was quashed. The HIV 
pandemic in the 1980s with subsequent AIDS epidemics and a correlated rise in AIDS-related KS 
revived the search for viral causation. HIV was not a candidate since Classic KS predated 
epidemic KS and the incidence of epidemic KS differed considerably between different 
populations infected with HIV.  
In 1994, the genome sequences of a KS lesion and normal tissue for a single AIDS-KS patient 
were compared by method of representational difference analysis (Chang et al., 1994). This work 
identified two short DNA fragments (330bp and 631bp) with homology to herpesviral capsid and 
tegument components respectively that were present in the lesions but not normal tissue (Chang 
et al., 1994). The sequences were found to be for a novel herpesvirus, KSHV. 
A number of PCR based studies have since amplified Chang’s herpesviral capsid 233bp 
sequence in DNA isolated from non AIDS-KS biopsies (Boshoff et al., 1995b; Dupin et al., 1995; 
Moore and Chang, 1995; Schalling et al., 1995; Su et al., 1995), providing strong support for 
KSHV as the putative KS aetiologic agent for all forms of KS as opposed to a mere 
CHAPTER ONE: Introduction 
 
24 
 
contaminating opportunistic virus in the tumours of immunosuppressed AIDS patients. That 
sequences were amplified from lesions in different tissues (Schalling et al., 1995) but remain 
largely undetected in normal skin (Dupin et al., 1995; Moore and Chang, 1995; Schalling et al., 
1995) provides additional persuasion for KSHV as the causative factor and this conclusion is 
strengthened by converse observations for the quantification of HIV pro-viral DNA in AIDS 
patients where no difference between abundance of HIV-pro-viral DNA in tumour and unaffected 
tissues is reported (Dupin et al., 1995). KSHV sequences have also been detected in peripheral 
blood mononuclear cells (PBMC) of HIV positive KS patients (Boshoff et al., 1995b), 
specifically CD19+ B-cells (Ambroziak et al., 1995) and prospective studies among HIV positive 
populations that analysed KSHV infection of PBMCs concluded that infection precedes tumour 
development and is a predictor of risk (Moore et al., 1996).  
As described above (section 1.2.1), KSHV-infected spindle cells, are the main tumour cells of 
KS lesions. Moreover, their distribution lining the aberrant vascular spaces suggests a major role 
in the process of tumour angiogenesis that is a prominent hallmark of KS.  
The overall aim of this thesis was to further current understanding of how KSHV infection 
drives development of KS lesions. Since the infected spindle cells of KS lesions have an 
endothelial character, suggesting an endothelial cell origin, it was decided to focus specifically 
upon the impact of KSHV infection on endothelial cell functions. Moreover, as the migration of 
endothelial cells is a central process in angiogenesis (sections 1.3.2 and 1.3.3), the effect of 
KSHV infection on functions that might regulate the migration of endothelial cells was 
principally examined.  
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As relevant background for these studies, the following sections provide an overview to 
endothelial cells and their functions with a particular focus on their role in angiogenesis. 
Subsequently, the process of endothelial migration is described and factors that regulate 
endothelial cell migration discussed.  
1.3 ENDOTHELIAL CELLS 
Endothelial cells are simple squamous cells that arise from the splanchnopleuric mesoderm 
(reviewed by Sumpio et al., 2002). Monolayers of endothelial cells surrounded by a thin protein 
basement membrane form the innermost lining (tunica intima) of all structures within the 
circulatory system, including the heart and all blood and lymphatic vessels. In an adult this totals 
1-6x1013 cells forming an organ with mass of about 1kg (reviewed by Sumpio et al., 2002). 
Vascular capillaries which join arterioles and venules in the closed circulatory system, and 
lymphatic capillaries which drain to the larger collecting lymphatics, have only a tunica intima 
whereas the endothelia of arteries, arterioles, venules, veins and larger lymphatics are surrounded 
by a middle layer (tunica media) of smooth muscle and elastic tissue (elastin and collagen) and 
an outer layer (tunica adventitia) made from collagenous connective tissue. The tunica media is 
very thick at the site of the arteries to enable the vessels to withstand the high blood pressure as 
blood leaves the heart but this layer becomes thinner with distance from the heart.  
1.3.1 Overview of endothelial cell functions 
The endothelium has several roles within the circulatory system. It helps to reduce turbulence 
of blood flow, enabling fluid to be pumped further and acts as a selective permeability barrier to 
regulate the exchange of small and large molecules between the blood and the tissues. 
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Furthermore, via the action of secreted paracrine and endocrine mediators, and their regulated 
expression of certain surface receptors, endothelial cells influence both underlying smooth 
muscle cells and circulating cells, including platelets and leukocytes, to control blood pressure 
and processes of haemostasis, inflammation and immune responses.  
Regulation of vessel permeability: The extent of endothelial permeability varies between 
endothelia at different anatomical sites according to the organization and specialization of the 
endothelial cells. For example, the blood brain barrier (endothelium lining the brain 
microvasculature) is continuous and of low permeability due to a specialized system of tight 
junctions between the cells. This ensures that uptake of molecules into the brain is selective and 
the entrance of cells and pathogens from the blood into brain extracellular fluid is prevented. 
Small hydrophobic molecules can cross the blood brain barrier but nutrients, primarily glucose 
and amino acids, are specifically transported. The tight junctions establish polarity to the 
endothelium which aids in this selective uptake and similarly the regulated release of toxic waste 
products away from the brain (reviewed by Abbott et al., 2010; Garlanda and Dejana, 1997).  
In contrast, sinusoidal vessels are found at sites including the liver, lymphoid tissue, bone 
marrow, spleen and endocrine organs. The endothelium of sinusoids is discontinuous with large 
intercellular clefts and few tight junctions between cells; thereby allowing the free passage of 
small and medium-sized proteins and also the transmigration of leukocytes into the tissues. Pores 
in endothelial cells called fenestrae act as additional filters of fluids, solutes and particles in some 
vascular beds such as the liver sinusoids, the kidney and gastrointestinal tract (reviewed by Aird, 
2007).  
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Control of blood flow: Endothelial cells regulate vascular tone through the production and 
release of vasoconstrictors including endothelin and platelet activating factor (PAF) and 
vasodilators including: nitric oxide and prostacyclin. In the physiologic homeostatic state, the 
endothelium also helps to maintain blood flow by preventing platelet adhesion and activation and 
the generation of thromboses. Firstly, the endothelium presents a negatively charged surface that 
repels platelets from the vessel wall. Secondly, factors synthesised including nitric oxide and 
prostacyclin are inhibitory to platelet activation by stimulating an increase in intracellular levels 
of each of: cyclic guanosine monophosphate (cGMP) and cyclic adenosine monophosphate 
(cAMP); ecto-ADPase which catabolises extracellular AMP to guard against activation of the 
vessel wall; thrombomodulin and tissue factor inhibitor which inhibit the prothrombotic effects of 
-thrombin. Components of the endothelium-associated matrix also activate antithrombotic 
factors. For example, heparan sulfate and related glycosaminoglycans activate antithrombin III, 
and dermatan sulfate activates heparin cofactor II. Under conditions of injury, these protective 
mechanisms break down and the endothelium changes from an anti to prothrombotic surface. 
Endothelial cells become activated and express PAF and tissue factor, and platelets become 
exposed to sub-endothelial matrix proteins including: von Willebrand factor, fibrillar collagens, 
fibronectin and laminins to which they can bind, become activated and aggregate (reviewed by 
Cines et al., 1998; Jackson, 2011).  
Role in inflammation and immune responses: The adaptive immune response requires 
activation of antigen specific lymphocytes involving the binding of antigen presented by major 
histocompatability complex (MHC) molecules on the antigen presenting cell to the cognate T-cell 
receptor. Naïve T-cells primarily encounter antigen presented by antigen presenting cells in 
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secondary lymphoid tissue. Endothelial cells of high endothelial venules (HEV) at the sites of 
lymphoid tissue are adapted to facilitate continuous patrol of the tissue by lymphocytes. 
Approximately 25% of lymphocytes passing through HEV will bind and transmigrate into the 
lymphoid tissue (Girard and Springer, 1995). HEV support this recruitment through their 
constitutive expression of mucin ligands (glycosylation dependent call adhesion molecule 1 
(GlyCAM1), mucosal addressin cell adhesion molecule 1 (MAdCAM-1) and CD34) which bind 
to the transmembrane glycoprotein, L-selectin, that is expressed by most leukocytes and also 
through their presentation, possibly following transcytosis, of the chemokine CCL21. CCL21 
signals via its cognate receptor CCR7 on the leukocytes to mediate activation of leukocyte 
integrins, firm adhesion and cell spreading ahead of emigration from the vasculature into the 
lymphoid tissue (Carlsen et al., 2005; Forster et al., 2008; Girard and Springer, 1995). Under 
inflamed conditions, cytokines including tumour necrosis factor-alpha (TNF, IL-1 and 
interferon gamma (IFN induce upregulation of adhesion receptors, notably vascular cell 
adhesion molecule-1 (VCAM-1) and P and E-selectin, by vascular endothelium thereby 
establishing a surface for the recruitment of effector lymphocytes (Springer, 1995). Once 
tethered, the lymphocytes receive further chemokine and prostanoid (e.g. prostaglandin D2 
(PGD2)) signals that direct their stable adhesion and the process of diapedesis (Ahmed et al., 
2011). Passage across endothelium and receipt of a PGD2 signal also enhances the propensity of 
lymphocytes to exit the tissue entering the lymphatic system for return to the blood (Ahmed et 
al., 2011). Similar processes support the recruitment of neutrophils from the blood into inflamed 
tissue as part of the initial innate immune response (Tull et al., 2009).  
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Role in formation of the blood and lymphatic vasculature: Endothelial cells have central roles 
in the formation of new blood and lymphatic vessels in the processes of vasculogenesis, 
lymphatic vascular morphogenesis, angiogenesis and lymphangiogenesis. Vasculogenesis is the 
process of vascularisation of the embryo. It involves the fusion of blood islands (aggregates of 
endothelial precursor cells that have differentiated from mesodermal cells) into primary capillary 
plexi which then organise into the vascular network of arterioles, arteries, capillaries, venules and 
veins (see Adams and Alitalo, 2007; Lamalice et al., 2007). Subsequently, vascular smooth 
muscle cells associate with the arteries and veins while pericytes surround the capillaries. 
Lymphatic vascular morphogenesis is the formation of the early lymphatic vessels from the blood 
vasculature in the embryo. Lymphatic endothelial cells (LEC) sprout from the embryonic vein 
and assemble into lymph sacs that separate from the blood vascular system in a mechanism 
involving platelet aggregation and continue to sprout into the lymphatic primary plexus. In turn 
this plexus remodels into the collecting, pre-collecting and capillary vessels of the lymphatic 
system (see Adams and Alitalo, 2007; Albrecht and Christofori, 2011; Schulte-Merker et al., 
2011). Angiogenesis is the formation of new blood vessels from preexisting ones. During 
embryogenesis, angiogenesis and lymphangiogenesis extend the early vascular and lymphatic 
trees respectively. In adulthood, angiogenesis is important for wound healing and tissue 
regeneration (Lamalice et al., 2007). Angiogenesis and lymphangiogenesis also occur in 
tumourigenesis being fundamental for the continued growth and increased stage of the lesion. 
Lymphangiogenesis and the enlargement of the lymph vessels also facilitates metastasis 
(reviewed by Achen and Stacker, 2008; Alitalo, 2011; Karnezis et al., 2012; Weis and Cheresh, 
2011). In contrast to the tightly regulated processes of physiological vessel formation, wherein 
vessels mature to a specific type and then become quiescent, new vessels grow without stopping 
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during tumour angiogenesis. This results in a disorganised network of leaky, dilated, tortuous 
vessels in which flow is often slow and irregular (see Bergers and Benjamin, 2003).  
Since an extensive aberrant vasculature is a hallmark of KS lesions, the molecular 
mechanisms of tumour angiogenesis are overviewed in the following section. 
Lymphangiogenesis has been less well characterized than blood vascular angiogenesis but similar 
signaling pathways appear to be involved; therefore the following description is primarily in the 
context of blood vascular angiogenesis but the major differences between the triggers for the two 
processes are highlighted. 
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1.3.2 Mechanisms of tumour angiogenesis 
Sprouting angiogenesis (section 1.3.2.1), the growth of new vessels out of pre-existing ones, 
is the main mechanism of growth of the blood and lymphatic vasculature during embryogenesis 
and adulthood. It is also considered to be the predominant mechanism of tumour angiogenesis; 
however, recent evidence suggests roles for two further angiogenic processes that are seen in 
physiologic vasculogenesis, in tumour angiogenesis including: (1) the recruitment of endothelial 
progenitor cells and their assembly into new vessels; (2) intussusception angiogenesis, which is 
the splitting of pre-existing vessels into two daughter vessels. In addition, tumours may achieve 
sufficient neovascularisation to assist their growth through the co-option of existing vessels or the 
process of ‘vasculogenic mimicry’ wherein tumour cells dedifferentiate to an endothelial 
phenotype and assemble into tube-like structures (reviewed by Carmeliet and Jain, 2011; Hillen 
and Griffioen, 2007). It is becoming increasingly apparent that in addition to endothelial cells, 
mural cells called pericytes, which form direct and indirect interactions with capillary endothelial 
cells, have important roles throughout angiogenesis and vessel stabilistion (reviewed by Gerhardt 
and Betsholtz, 2003; Raza et al., 2010).  
Pericytes: Pericytes are elongated contractile cells that ensheath the capillary wall on the 
abluminal endothelial surface. The association between endothelial cells and pericytes is so close 
that they share a common basement membrane: both cells contribute to the synthesis of this 
matrix and attach to its proteins via integrin heterodimers (section 1.3.4). Where there are holes 
in the basement membrane, tight junctions, adherens junctions and gap junctions form between 
the two cell types to facilitate the transmission of contractile force between their actin 
cytoskeletons and the exchange of nutrients, metabolites, secondary messengers and ions; thereby 
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supporting cross regulation between the two cell types (reviewed by Gerhardt and Betsholtz, 
2003; Raza et al., 2010). 
Pericytes are phenotypically plastic with the potential to differentiate into other mesenchymal 
cell types including: smooth muscle cells, fibroblasts and osteoblasts (see Gerhardt and Betsholtz, 
2003). While a pan pericyte marker has not been defined, the most common markers include: 
desmin, -smooth muscle actin, regulator of G-protein signaling 5, PDGFR and chondroitin 
sulfate proteoglycan (see Raza et al., 2010). Dependent upon the capillary bed, pericytes are 
found either as individual cells or as a monolayer: the extent of coverage of the endothelial 
abluminal surface ranges between 10 and 50%. Generally pericyte coverage is higher at capillary 
branch sites while surfaces involved in gas or nutrient exchange are devoid of pericytes (see 
Gerhardt and Betsholtz, 2003). Pericytes appear to have a fundamental role in the central nervous 
system for the maintenance of the integrity and function of the blood brain barrier. This is 
reflected by a significantly higher pericyte coverage of brain compared to peripheral capillaries 
(reviewed by Winkler et al., 2011). Angiogenesis is driven by a panoply of pro-growth factors 
(vascular endothelial growth factors (VEGF); FGF, angiopoietins (ANG), epidermal growth 
factor (EGF), platelet derived growth factor (PDGF), transforming growth factor beta (TGF), 
placenta-derived growth factor (PlGF), TNF, interleukins, ephrins, soluble adhesion molecules, 
PAF and angiogenin) of which VEGFs and ANGs are of major importance (reviewed by 
Carmeliet and Jain, 2011; Conway et al., 2001).  
VEGFs: The mammalian VEGF family includes five members (VEGFA, B, C, D and PlGF) 
and their splice variants. VEGFs function as dimers and bind in an overlapping pattern to three 
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receptor tyrosine kinases (VEGFR1, 2 and 3). VEGFA, B and PlGF bind VEGFR1, VEGFA 
binds VEGFR2 and VEGFC and D bind VEGFR3. Proteolytic processing of VEGFC and D also 
facilitates their binding to VEGFR2 (reviewed by Olsson et al., 2006). Ligand binding leads to 
the homo or heterodimerisation of their receptors and subsequent receptor activation. Activity is 
also regulated by co-receptors such as heparin sulfate proteoglycan and neuropilins which bind to 
both VEGFs and VEGFRs (see Adams and Alitalo, 2007; Olsson et al., 2006). VEGFA signaling 
via VEGFR2 is particularly associated with angiogenesis while VEGFC and D which signal via 
VEGFR3 expressed on lymphatic endothelial cells (LEC) are the main stimulants of 
lymphangiogenesis (reviewed by Achen and Stacker, 2008; Olsson et al., 2006) although VEGFA 
through VEGFR2, also expressed by LEC, may contribute (see Achen and Stacker, 2008).  
ANGs: The human ANG family includes three members (ANG-1, 2 and 4) that bind 
competitively to the TIE-2 receptor. ANG-1 functions as a TIE-2 agonist and promotes 
endothelial quiescence and vessel stabilisation through the establishment of cell-cell junctions, 
pericyte coverage and basement membrane deposition. ANG-2 functions as a competitive ANG-1 
antagonist, promoting pericyte detachment and vascular permeability and favouring endothelial 
cell sprouting. ANG-4 has not been well characterized but is believed to act similarly to ANG-1 
(reviewed by Carmeliet and Jain, 2011). 
1.3.2.1 Sprouting angiogenesis 
Sprouting angiogenesis is a consecutive process (Figure 1.5) initiated when angiogenic 
stimulatory factors, in particular VEGF, induce an increase in the permeability of the endothelial 
cell layer and plasma proteins, such as fibrinogen and fibronectin, extravasate forming a matrix 
on which endothelium can migrate. It has been suggested that VEGF released by pericytes in 
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response to the paracrine action of NO secreted by activated endothelial cells is the principal 
source of VEGF in some tissue beds (Reynolds et al., 2000). ANG-2 subsequently released by 
activated endothelial cells functions as a competitive ANG-1 antagonist at the TIE-2 receptor; 
this promotes a loss of interactions between endothelial cells and surrounding pericytes and 
destablises the existing vasculature. Activated endothelial cells and pericytes secrete proteases 
such as MMPs that degrade the basement membrane and extracellular matrix locally releasing 
angiogenic factors and clearing a route for growth of the new endothelial sprout into the 
perivascular space (Carmeliet and Collen, 2000).  
In this process of sprouting, disintegration of the vasculature by non-selective sprouting along 
the vessel length is prevented by NOTCH-receptor-ligand pathways that establish one cell, 
termed the ‘tip cell,’ to lead the sprout and cause neighbouring cells to assume a subsidiary role 
as stalk cells. The tip cell continuously extends and retracts filopodia to sense the environment. 
Semaphorins and ephrins are key guidance molecules. The stalk cells elongate, proliferate and 
migrate behind the tip cell to extend the sprout. These regulating events of tip-cell selection are 
linked to the proangiogenic VEGF axis: VEGFA induces Delta-like ligand 4 (DLL4) expression 
by the tip cell and DLL4 binds to its cognate NOTCH receptor on the neigbouring cell. 
Activation of NOTCH suppresses the expression of VEGFR2 by the stalk cell and leads to 
upregulation of VEGFR1; thus stalk cells become less sensitive to the sprout promoting VEGFA 
stimulus and more responsive to PlGF. Ultimately, where adjacent sprouts and vessels meet and 
interact positively, continuous lumens establish allowing perfusion of the new vessel. The vessels 
become stabilized by the reformation of cell-cell junctions, coverage of the vessel by pericytes 
and the deposition of basement membrane (reviewed by Adams and Alitalo, 2007; Carmeliet and 
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Jain, 2011; Hillen and Griffioen, 2007; Weis and Cheresh, 2011). It is proposed that the secretion 
of PDGF-B by endothelial cells and the subsequent activation of PDGFR- on pericytes 
stimulates pericyte recruitment (reviewed by Gerhardt and Betsholtz, 2003). Factors including 
Ang1, sphingosine-1-phosphate and MMPs might also promote pericyte recruitment and the 
expression of tissue inhibitors of matrix metalloproteinases by both pericytes and endothelial 
cells contribute to vessel stabilistion (Raza et al., 2010). 
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Figure 1.5: The process of sprouting angiogenesis. 
Angiogenic factors (e.g. vascular endothelial growth factors (VEGF) and angiopoietins (ANG)) released by tumours cause a 
quiescent vessel (A) to become destabilized and a tip cell to form in a NOTCH-receptor-ligand pathway (B). Proteases secreted 
by activated endothelial cells (EC) degrade the basement membrane (BM) and extracellular matrix (ECM) locally releasing 
angiogenic factors and creating a path for the stalk cells to proliferate, elongate and migrate into the perivascular space guided 
by the tip cell which senses the environment through receptors on its filiopodial projections. A lumen forms in the sprouting 
vessel (C). Sprouts from adjacent vessels fuse allowing perfusion of the neovessel. The new vessel is stabilized by the 
formation of EC-EC junctions, coverage by pericytes and BM deposition by both EC and pericytes (D). Adapted from 
Carmeliet and Jain  (2011). 
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1.3.3 The mechanism of cell migration 
The migration of endothelial cells during angiogenesis is the product of three migratory 
mechanisms: chemotaxis (migration toward a gradient of soluble chemoattractants); 
haptotaxis (migration toward a gradient of immobilised ligands) and mechanotaxis (migration 
induced by mechanical forces experienced at the blood vessel inner face). Stimulants for these 
processes include: soluble growth factors, extracellular matrix (ECM) components and sheer 
stress, respectively. Endothelial cells sense these signals via receptors on their filopodial 
extensions and migrate in the direction coordinated by the sum of the received signals. A 
cycle of stepwise changes to the organisation of the cell’s actin cytoskeleton underlies the 
process.  
After a stimulus is detected by sensing filopodial projections, a lamelipodium is extended 
from the leading edge. Surface adhesion receptors called integrins (section 1.3.4) cluster 
beneath and mediate attachment of this extension to the underlying substratum, which in vivo 
is the ECM (section 1.4). Activation of the integrins promotes the assembly of protein 
complexes called focal adhesions (section 1.3.5) at these sites and the formation of actin 
stress-fibres. Subsequent contraction of the cell body achieves forward progression of the cell. 
This is followed by release of the rear of the cell and the cycle completes with the recycling of 
the adhesive and signalling molecules (reviewed by Gardel et al., 2010; Lamalice et al., 2007) 
(Figure 1.6). A host of cellular and extracellular proteins are thus important mediators of cell 
migration and their abundance, organisation and activation states are potential modifiers of 
cell motility. 
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Figure 1.6: The major steps in cell migration.  
In response to a motility stimulus (soluble chemoattractant (e.g. growth factor), 
immobilised ligand (e.g. extracellular matrix component) or sheer stress) cells extend a 
lamellipodium toward the stimulus. Focal adhesions link the cytoskeleton to the 
extracellular matrix and contraction of actin stress fibres pulls the cell body forward. The 
rear of the cell detaches and adhesive and signalling proteins are recycled. Adapted from 
Lamalice et al (2007).    
  
1.3.4 Integrins 
Integrins are a family of adhesion molecules that together with proteins including 
cadherins, immunoglobulin super family cell adhesion molecules, selectins and syndecans are 
critical mediators of cell-cell and cell-ECM interactions (Alberts et al., 2002). Integrins 
synergize with other cell surface receptors, such as G-protein coupled and kinase receptors, 
that respond to soluble chemokines or growth factors, to regulate the shape, polarity and 
motility and also the survival and proliferation of cells (see Hynes, 2002).  
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Integrins are heterodimeric proteins composed of non-covalently associated  and  
subunits both of which are highly glycosylated single-pass transmembrane proteins (90-
160kDa) (Anthis and Campbell, 2011; Hynes, 1992) (Figure 1.7). Eighteen  and eight  
subunits have been identified to date with further variants generated by differential splicing. 
These subunits are arranged into at least twenty-four  heterodimers (see Anthis and 
Campbell, 2011; Hynes, 2002) making the integrins a highly diverse family both structurally 
and functionally (Figure 1.8). Despite a similarity in primary structure (Springer and Wang, 
2004) the phenotypes of knockout mice indicate that each integrin subunit has a specific and 
non-redundant function (reviewed by Hynes, 2002).  
The different integrin heterodimers recognise distinct ligands, although there is some 
overlap (Figure 1.8), and relay signals bidirectionally across the membrane conveying 
information concerning the extracellular environment into the cell (termed ‘outside-in’ 
signalling) but also regulating integrin adhesiveness according to intracellular conditions 
(termed ‘inside-out’ signalling). Integrin cytoplasmic tails lack enzymatic or actin binding 
activity but support signalling as they present domains for the recruitment of complexes of 
enzymatic and adaptor proteins with signalling capacity. The -tails are the main platforms 
for these intracellular interactions while the -subunits are the principal determinants of 
extracellular ligand binding specificity (Anthis and Campbell, 2011).  
A given cell type presents a distinct array of integrins. The main endothelial integrins 
include: 11; 21; 31; 51; 61; v3 (Stupack and Cheresh, 2002). Overall, 
integrins have roles in a broad spectrum of biological processes including development, tissue 
repair, innate and adaptive immunity, haemostasis and angiogenesis; thus the deregulation of 
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integrins is implicated in many diseases such as autoimmune conditions, vascular disease and 
cancer (reviewed by Humphries, 2000; Hynes, 2002; Rathinam and Alahari, 2010).  
The binding of integrins to their ligands involves the shared coordination of a divalent 
cation, either calcium or magnesium, between the integrin and its ligand. Accordingly, a 
carboxylate residue, either an aspartate or glutamate residue, is key in the ligand binding site. 
The I domains, present in about half of  subunits, and the I-like domains of  subunits are 
important for ligand binding because they contain a metal ion dependent adhesion site that 
binds the critical cation: the ion becomes fully coordinated by interaction with the ligand. 
Herein magnesium and calcium can have opposite effects upon the binding of different 
integrins to their ligands (Mizejewski, 1999). In the presence of the  subunit I domain, the -
subunit I-like domain assumes an indirect role in ligand binding, regulating the activity of the 
I domain through contacts with the  subunit -propeller domain (see Humphries, 2000; 
Springer and Wang, 2004).   
Studies suggest two extremes of integrin activation state, an “active/on” state and 
“inactive/off” state, which lie in conformational equilibrium (Anthis and Campbell, 2011). 
Intracellular and extracellular conditions impinge upon this equilibrium and dictate where the 
balance lies. Many integrins appear to retain an adhesion competent state whilst others, such 
as the 2 integrins that regulate leukocyte extravasation from circulation and the major 
platelet integrin, IIb3, which directs haemostasis, are necessarily maintained in an inactive 
state until cells are appropriately activated (see Hynes, 2002). A bent, closed conformation is 
suggested for the inactive receptor: the structure is stabilized by extensive interactions 
between buried surfaces of the integrin head and tailpieces. In contrast, from an extended 
conformation, an open, active conformation that is capable of high affinity interaction with its 
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ligand can be accessed. This form is stabilised by ligand binding (reviewed by Anthis and 
Campbell, 2011; Hynes, 2002; Springer and Wang, 2004). 
With the exception of integrin 64, which connects to intermediate filaments, integrin 
cytoplasmic domains link via a plethora of sub-membrane adaptor proteins to the actin-based 
microfilament system of the cell’s cytoskeleton. The assembly of such protein complexes 
generally requires integrin clustering (see Hynes, 2002). The following section provides an 
overview to the focal protein assemblies that form at cell-substratum attachment sites. 
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Figure 1.7: Diagrammatic representation of a universal integrin receptor. 
Integrin receptors are heterodimers formed by the non-covalent association of one  and 
one  subunit. Both subunits are single pass transmembrane proteins with a long 
extracellular domain compared to cytoplasmic domain. On the extracellular side they bind 
to molecules of the extracellular matrix. On the intracellular side they recruit molecules of 
focal adhesions which provide a physical link to the actin cytoskeleton. The tertiary 
structures of both subunits are maintained through disulfide bridges (-S-S-) and non-
activated integrins contain divalent cation salt bridges that are extruded upon ligand binding 
(). Both subunits contribute to the ligand binding pocket (dotted red line). Both subunits 
are heavily glycosylated (*). Phosphorylation site (P). Adapted from Mizejewski (1999). 
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Figure 1.8: The integrin receptor family.  
Eight  subunits are known to assort with eighteen  subunits in the formation of 24 
different integrin heterodimers. Among these, expression of a subgroup is restricted to 
leukocytes (dotted box). Subunits with bold surrounds indicate those expressed by 
endothelial cells. The ligand binding specificities of the subunits expressed by endothelial 
cells are indicated: collagen (red star (*)); fibronectin (blue star (*)); laminin (green star 
(*)) and Arg-Glu-Asp (RGD) (grey shading). Adapted from Hynes (2002). 
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1.3.5 Focal adhesions 
The physical connection of the ECM to the ends of actin stress fibres means that the 
structures formed are adhesive and the cell is brought close to its substratum at these sites. 
The nascent complexes, which generally form beneath the lamellipodia of migrating cells, are 
small dot-like structures termed ‘focal complexes’. These complexes are usually immobile 
and short-lived, either dissembling or elongating into mature ‘focal adhesions’ within 
seconds. In contrast, focal adhesions can exist for tens of minutes before gradually 
disappearing or maturing further into stable fibrillar adhesions (reviewed by Gardel et al., 
2010; Geiger et al., 2001; Parsons et al., 2010; Wolfenson et al., 2009)  
Focal adhesion assembly is driven by tension forces that are either generated 
intracellularly by myosin-II driven contraction of the cytoskeleton or are provided by an 
extracellular applied force (Geiger et al., 2001). In this way, focal adhesion formation reflects 
the contractile state of the cell and also the pliability of the matrix (see Parsons et al., 2010; 
Wolfenson et al., 2009). By acting as anchorage sites for bundles of stress fibres, focal 
adhesions support the generation of traction forces within the cell and their transduction to the 
matrix, mediating cell adhesion, manipulation of matrix protein organisation and the forward 
movement of migrating cells (reviewed by Parsons et al., 2010; Wolfenson et al., 2009).   
Relaxation of the cytoskeleton generally leads to focal adhesion disassembly. In the cycle 
of events underlying cell migration, focal adhesions disassemble when they become localised 
to the rear of the cell. This allows forward movement of the rest of the cell (Figure 1.6) (see 
Ridley et al., 2003). The mechanism for disassembly is uncertain but suggested triggers 
include: down regulation of myosin II contractility by a high density of microtubules (Elbaum 
et al., 1999; Small et al., 2002), activity of the focal adhesion protease calpain (Bhatt et al., 
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2002) and microtubule-dependent endocytosis activated by the Focal Adhesion Kinase 
(FAK)-dynamin pathway (Burridge, 2005; Ezratty et al., 2005; Wolfenson et al., 2009).  
Current estimates suggest that over 125 different proteins function at focal adhesions (see 
Deakin and Turner, 2008) although not all are necessarily present simultaneously in all 
complexes. Integrins are the central components of most focal adhesions, binding to ECM 
molecules (mainly fibronectin, vitronectin and collagens) via their extracellular domain and 
plaque proteins via their cytoplasmic domain. However, other non-integrin membrane-bound 
protein and glycoprotein components are involved such as: syndecan-4 (Syn-4) (Echtermeyer 
et al., 1999; Okina et al., 2009); layilin (Lay) (Borowsky and Hynes, 1998; Wegener et al., 
2008); urokinase plasminogen activator receptor (uPAR) (Chapman and Wei, 2001; Wei et 
al., 1999), leukocyte common antigen receptor (LAR) (Serra-Pages et al., 1995) and SHP-2 
substrate-1 (SHPS-1) (Tsuda et al., 1998), as well as signalling lipids, for example 
phosphatidylinositol 4,5 bisphosphate (PtdIns (4,5)P2), which can regulate actin 
polymerisation (reviewed by Geiger et al., 2001)  
Most cytosolic focal adhesion proteins are multi-domain proteins and have several 
possible binding partners. Competition for binding is apparent among these partners; thus the 
specific combinations of proteins recruited provide regulation of focal adhesion functions. 
Many protein docking sites are generated by phosphorylations catalysed by tyrosine, and 
serine-threonine kinases that are recruited to the adhesions. For example, phosphotyrosines 
are sites for Src homology-2 (SH2)-domain-containing proteins. Proline rich sequences are 
similarly docking sites for SH3-domain-containing proteins (see Zamir and Geiger, 2001).  
Among the plethora of proteins there are some which connect the integrins directly to the 
actin cytoskeleton. These are the main structural scaffolds of the complexes. Other proteins 
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with adaptor or enzymatic functions associate only with the integrin tails; while others bind to 
the actin filaments. Additional adaptor proteins and enzymes bind to these integrin or actin 
binding proteins and function in completing multi-protein, intracellular connections between 
the ECM and the actin cytoskeleton and in signalling (Table 1.1 and Figure 1.9) (see Geiger 
et al., 2001; Zamir and Geiger, 2001).   
FAK is recognised to be a principal regulator of focal adhesion dynamics through its 
actions as both a kinase and a scaffold protein (see Mitra et al., 2005). Studies suggest that it 
has important roles in the assembly but also the disassembly of focal adhesions as 
phosphorylation of FAK was associated with focal adhesion formation (Parsons, 2003) but 
equally focal adhesion formation was increased in FAK-null fibroblasts (Ilic et al., 1995).  
FAK becomes localised at forming adhesions through the binding of its focal adhesion 
targeting (FAT) domain to paxillin and talin at the sites of integrin clusters. Subsequent 
autophosphorylation of FAK at Tyr397 creates a binding site for Src kinase and a dual-
activated FAK-Src signalling complex is formed. Src phosphorylation of additional 
phosphotyrosines on FAK maximises its catalytic (Tyr576 and Tyr577) and adaptor (Tyr861 
and Tyr925) activity: pTyr861 potentiates SH3-domain mediated binding of p130Cas to the 
C-terminal proline rich region and pTyr925 recruits Growth factor receptor-bound protein 
(Grb)-2 via its SH2-domain. These interactions lead to the respective activation of the Rho-
family small guanosine triphosphate (GTP)-binding protein RacGTPase and the RasGTPase-
extracellular signal-regulated kinase-2 (ERK2)/mitogen-activated protein kinase (MAPK) 
cascade with impacts upon migration (reviewed by Frame et al., 2010; Mitra et al., 2005).  
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Other Rho-family GTPases: Cdc42, RhoG and RhoA also have roles in modulating the 
establishment of cell polarity and controlling migration; their regulators are likewise 
controlled by FAK (see Frame et al., 2010).  
Cdc42, RhoG and Rac regulate lamellipolia and filopodia formation at the leading edge. 
The polymerisation of the branched actin network of lamellipodia is mediated by the actin 
related protein (Arp)2/3 complex which is activated by the Wiskott-Aldrich Syndrome Family 
Proteins WAVE (Wiscott-Aldrich family Verprolin homologous protein) and WASP 
(Wiscott-Aldrich Syndrome Protein) that are Rac and Cdc42 effectors. WAVE and WASP 
proteins themselves also feedback to positively and negatively regulate Rac and Cdc42 
through binding to guanine nucleotide exchange factors (GEFs) and GTPase activating 
proteins (GAPs). Furthermore, FAK associates with Cdc42 activated-N-WASP to promote 
cell motility through retaining N-WASP in the cytosol (see Mitra et al., 2005). FAK also 
binds directly to Arp2/3 (Serrels et al., 2007). 
RhoA typically functions at the sides and rear of the cell. The mechanism of zonal Rho-
family GTPase activity within a polarised migrating cell is not fully defined. FAK has also 
been implicated in the regulation of RhoA through binding and phosphorylating 
p190RhoGEF (Tomar and Schlaepfer, 2009). Finally, gradients of phosphoinositides (PtdIns) 
are generated in cells that are migrating in response to chemoattractant and provide 
intracellular amplification of the shallow chemokine gradient across the cell. They also bind 
to and recruit certain focal adhesion proteins (e.g. -actinin, vinculin and talin). Several of the 
PtdIns kinases in this cascade interact with and are activated by FAK such as Type I PtdIns 
phosphate kinase- (PIPK), which converts PtdIns(4)P to PtdIns(4,5)P2 and PtdIns 3-kinase 
(PI3K), which converts PtdIns(4,5)P2 to PtdIns(3,4,5)P3 (see Mitra et al., 2005)   
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Figure 1.9: Diagrammatic representation of a focal adhesion.  
Focal adhesions are multi-protein complexes that assemble at sites of integrin (orange) 
activation and link the cytoplasmic actin cytoskeleton to the extracellular matrix (ECM). Bi-
directional signalling occurs enabling the cytoskeleton to exert force on the ECM but also 
the ECM to influence the cell’s contractility. Other non-integrin membrane bound proteins 
are also found (pink). On the inside of the cell there are: scaffolding proteins that link 
integrins to the cytoskeleton (brown); integrin binding (blue) and actin binding (green) 
adaptors and enzymes; as well as additional adaptors and enzymes (purple) [adaptors are 
indicated by darker shades, enzymes by light shades]. Refer to text and Table 1.1 for 
definition of acronymns. Adapted from Geiger (2001). 
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Table 1.1: Proteins present in focal adhesions and their functions. 
Protein function Examples 
Connect integrins directly to 
the actin cytoskeleton 
-actinin 
filamin 
talin 
tensin 
Integrin binding  
caveolin  
integrin-linked kinase (ILK) 
paxillin 
14-3-3 
Actin binding  
ezrin-radixin-moesin proteins (ERM) 
fimbrin 
nexilin 
parvin  
vasodilator-stimulated phosphoprotein (VASP) 
vinculin 
Adaptor proteins 
Crk-associated substrate (CAS) 
cysteine-rich protein (CRP) 
Grb-7 
PAK-interacting exchange factor (PIX) 
palladin (Pall) 
paxillin kinase linker (PKL) 
syndesmos (synd) 
syntenin (synt) 
vinexin 
zyxin 
Enzymes 
Abl kinase  
calpain II 
carboxy-terminal src kinase (Csk) 
focal adhesion kinase (FAK) 
p21-activated kinase (PAK) 
phosphatidyl inositol 3-kinase (PI3K) 
SH2-containing phosphatase-2 (SHP-2) 
SH2-containing inositol 5-phosphatase-2 (SHIP-2) 
Src-family kinases (Src) 
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1.4 THE EXTRACELLULAR MATRIX (ECM) 
Similar to a number of other tissues including epithelial, nerve, muscle and fat, the 
endothelium is interfaced on its subluminal side by a thin, highly organized dense meshwork 
of protein fibres called the basement membrane (see Kruegel and Miosge, 2010; Sund et al., 
2004). This protein matrix is deposited by endothelial and supporting cells and maintains 
separation of the endothelium from the more porous, fibrillar connective tissue beneath 
(Schwarzbauer, 1999). Together, basement membrane and connective tissue constitute the 
ECM.  
The ECM is a dynamic substance being continuously secreted and remoulded. The 
specific composition and organization of the ECM differs according to the tissue type, stage 
of development and location (see Kruegel and Miosge, 2010; Schwarzbauer, 1999; Sund et 
al., 2004).  
The ECM has a critical role in the assembly, stabilization and properties of the vasculature 
since endothelial cells bind to components of the ECM via their surface integrins and non-
integrin receptors and receive signals that regulate their proliferation (see Assoian and 
Schwartz, 2001; Meredith and Schwartz, 1997; Roovers and Assoian, 2000; Vinals and 
Pouyssegur, 1999), survival (Meredith and Schwartz, 1997) and migration (section 1.4.4) and 
which establish and maintain their organization into blood vessel structures (see Davis and 
Senger, 2005). 
During vascular morphogenesis endothelial cells from distant sites can organize into 
multicellular structures by the generation of contractile forces through the ECM (Davis and 
Senger, 2005). In sprouting angiogenesis, ECM fibres aligned by traction forces might 
provide the pathways for the follow-the-leader behavior of endothelial cells (see Vernon and 
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Sage, 1995). Overall it has been suggested that the role of the ECM in endothelial cell 
migration, proliferation and survival is equal to or greater than that of angiogenic growth 
factors. Furthermore, by immobilizing angiogenic growth factors, the ECM may assist in their 
actions (see Davis and Senger, 2005).   
Although the structures of interstitial connective tissue and the basement membrane differ, 
they comprise similar proteins. The major components of the endothelial basement membrane 
include laminins, collagen IV and fibronectin; additional accessory components include 
perlecan, nidogens, entactin, heparin sulphate proteoglycans and collagen XVIII. It is not 
clear whether endothelial cells in vivo can generate a complete functional basement 
membrane or whether this is dependent upon supporting cells such as pericytes to contribute 
accessory components such as nidogens (see Davis and Senger, 2005). The following 
paragraphs provide a description of each of the three major protein types present in 
endothelial basement membrane.  
1.4.1 Laminins  
Laminins are a family of large heterotrimeric proteins (500-900kDa) that appear to be the 
principal determinants of basement membrane assembly (Davis and Senger, 2005).  
Each laminin trimer is comprised of one , one , and one  chain assembled into a cross-
shape with two or three short arms and one long arm (Figure 1.10). Five , three  and three 
 chains have been identified and demonstrate some tissue specificity. Overall, when splice 
variants are also considered, sixteen different laminins have been identified. Individual chains 
contain several conserved domains (Figure 1.10). These have structural and functional 
importance. Furthermore, the specific patterns with which laminin molecules are deposited in 
the matrix can influence the matrix function (reviewed by Hamill et al., 2009).  
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Laminin trimers are assembled intracellularly and are then secreted. Sequences in the C-
terminus of the coiled-coil, alpha helical domains of each chain are implicated in the process 
of trimerisation. Initially, disulfide bonds form between the  and  chains, creating an acidic 
pocket that is subsequently stabilised by the interaction of a basic site on the  chain. 
Trimerisation, by the binding of the  chain also drives secretion (Nomizu et al., 1996). 
Laminin deposition and the formation of laminin matrices is regulated by cell surface 
receptors including: integrins, dystroglycan, 32/67kDa laminin receptor, 67kDa elastin-
laminin receptor, galactoside-binding lectin, galactosyltransferase, heparan sulphate 
proteoglycans, and Ig-related basal cell adhesion molecule (see Patarroyo et al., 2002).  
Several integrins have been found to interact with laminins including: 1, 21, 31, 
61, 64, v3 and 71. They demonstrate distinct and overlapping specificities 
(reviewed by (Patarroyo et al., 2002; Tzu and Marinkovich, 2008). Most of the characterised 
sites of integrin-laminin binding are within the G-domain and domain VI of the laminin  
chains but some interactions with laminin  and  chains have been described. Proteolysis of 
laminin ,  and  chains might also expose additional sites for integrin binding (reviewed by 
Patarroyo et al., 2002; Tzu and Marinkovich, 2008).  
The predominant laminins expressed in endothelial basement membranes are thought to 
include laminin-411, and laminin-511, but there is some additional contribution from laminin-
421 and laminin-521. During development laminin-411 appears to predominate over laminin-
511 in the vascular bed but in adult tissues there is a switch and laminin-511 becomes the 
more abundant. While laminin-511 is capable of self-polymerisation, laminin-411 lacks the 
necessary globular LN domain at the N terminus of its 4 chain. Subsequently, it may be 
unable to drive the assembly of the laminin matrix but might still establish connections with 
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other matrix constituents such as collagens, nidogens, and perlecan (reviewed by Davis and 
Senger, 2005).  
 
Figure 1.10: Diagrammatic representations of laminins 411 and 511.  
Laminins are heterotrimeric molecules in which the three chains (,  and ) are organised 
into a cross shape. 5, 3 and chains are known. Endothelial laminins are composed of 
assortments of 4, 5, 1, 2 and chains and include laminins 411, 511, 421 and 521. 
Each chain features a number of functionally important domains including LN, L4 and LF 
globular domains that are interspersed among laminin-type epidermal growth factor-like LE 
domains. An -helical domain follows the LE repeats. In the heterotrimer these stretches 
wind around each other forming a coil-coil. The -helical region of the -chain is interrupted 
by a stretch of amino acids called the -knob. Five globular LG domains follow the -helical 
domain of the -chain. Domains LG1-LG3 adopt a clover leaf shape. The LG4-LG5 domain 
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may be proteolytically cleaved from the 4 chain following secretion. The 4 chain also lacks 
the amino-terminal LN domain found in most other  chains, this may impact polymerisation. 
Binding sites for matrix molecules (proteoglycans, collagen IV, netrin and nidogen) and cell 
surface receptors (integrins and dystroglycan) are indicated. Adapted from Hamill et al 
(2009). 
 
1.4.2 Collagens 
Collagens are large macromolecules which in vertebrates serve as one of the major 
extracellular scaffolds, providing mechanical strength and organisation to the extracellular 
matrix. Twenty-eight different collagens have been identified to date (types I-XXVIII). Their 
basic building units are collagen -chains that self-assemble, according to the chains present, 
into several supramolecular structures including: fibrils, microfibrils, networks and 
transmembrane proteins. Other macromolecules such as laminins, perlecan, and proteoglycans 
attach to these scaffolds in the construction of the multimolecular ECM and cells adhere to the 
ECM by the binding of certain integrin (primarily of the 1 subgroup of integrins (11, 
21)) and non-integrin receptors (heparin sulphate proteoglycans, glycoprotein VI, mannose 
receptor family and discoidin domain receptors) to specific sites within collagen structures 
(reviewed by Khoshnoodi et al., 2006; Khoshnoodi et al., 2008; Leitinger and Hohenester, 
2007)  
The assembly of collagens first involves the homo or hetero-trimerisation of three type-
specific -chains which intertwine forming triple helical protomers. Following their secretion 
from the cell, these protomers oligomerise into the ‘encoded’ supramolecular structure. The 
constituent -chains of collagens have a common structure. They feature a central 
collagenous domain, characterised by triplet repeats of the residues Gly-X-Y, which is 
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flanked by non-collagenous domains at both the N and C termini. The excision or processing 
of these terminal domains is important for the assembly of some collagens (see Khoshnoodi et 
al., 2006).  
Collagen IV (Figure 1.11), a network collagen, is of particular interest to this study as it is 
an exclusive collagen of basement membrane where it influences the behaviours, such as 
adhesion, migration and differentiation, of many cell types including: endothelial cells, 
hepatocytes, keratinocytes, pancreatic cells, platelets and tumour cells (see Khoshnoodi et al., 
2008). Up to six -chains (1-6) have been identified in collagen IV networks from across 
different tissues and developmental stages. While seventy-six trimers are theoretically 
possible using these six chains, only three heterotrimers (112, 345, 556) are 
observed in vertebrate basement membranes illustrating the high degree of encoded 
specificity that exists in collagen trimer formation. Studies suggest that the C-terminal non-
collagenous regions of collagen IV -chains (~230 residues) control the chains incorporated 
into the triple helices through a three-dimensional domain swapping mechanism (reviewed by 
Khoshnoodi et al., 2006).  
The central collagenous domains of collagen IV -chains (~1400 residues) contain 
between 21 and 26 short non-collagenous sequence interruptions. These contribute flexibility 
to the collagen IV network, potentiate interchain crosslinking and serve as cell binding sites 
(Khoshnoodi et al., 2008). High resolution electron microscopy of collagen IV networks has 
revealed an irregular polygonal structure that is maintained by lateral interactions along the 
length of the helix and between end terminal domains (Yurchenco and Ruben, 1987). 
Twisting into a supercoil also stabilises the structure (Yurchenco and Ruben, 1987). The 
collagen molecules are also extensively modified co-and post-translationally by a number of 
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specific and non-specific enzymes. Examples of processing and modifications include: the 
removal of signal peptide in the endoplasmic reticulum, addition of hydroxylate to proline and 
lysine residues, glycosylation of hydroxylysines and the addition of mannose rich 
oligosaccharides (reviewed by Khoshnoodi et al., 2006; Khoshnoodi et al., 2008).  
 
Figure 1.11: Diagrammatic representation of collagen IV network formation. 
Three collagen monomers each comprising an amino terminal glycosylated 7S domain, 
central collagenous Gly-X-Y domain and carboxy-terminus non-collagenous (NC1) domain 
trimerise to form a protomer with central helical domain in a mechanism that is initiated by 
the NC1 domains. Two protomers dimerise by end-to-end interaction of the two NC1 
trimers forming an NC1 hexamer. Subsequent interaction of four dimers at the amino 
terminal forms the tetramer. Tetramers can assemble into higher order supramolecular 
organisations and three dimensional networks.   
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1.4.3 Fibronectin 
Fibronectin is a large multidomain, dimeric glycoprotein (Figure 1.12) that is one of the 
main non-collagen scaffolding proteins of the extracellular matrix. It is present in all tissues 
where it has an essential role throughout all stages of life. The constituent monomers are 
joined end-to end in the dimer by disulfide bonds. Maturation of the fibronectin matrix 
involves further clustering of individual fibrils into thicker bundles, a process that is directed 
by the actomyosin cytoskeleton.  
Unlike collagens, fibronectin fibrils do not self assemble. Rather, additional cell-surface 
proteins assist with their polymerisation. In particular, the fibronectin binding integrin, 51, 
associates with fibronectin fibrils at sites called fibrillar adhesions (fibrillar adhesions are 
distinct from focal adhesions and involve a different array of adaptor proteins) and links 
fibronectin to the actin cytoskeleton. Contraction of the actin cytoskeleton stretches the fibrils 
exposing hidden binding sites for the clustering of fibrils.  
Fibronectin monomers comprise several domains that are connected by lengths of flexible 
polypeptide chain. These domains are further subdivided into a number of repeated modules 
that have different functions. The main modular units include types I, II and III fibronectin 
(Figure 1.12). Several domains of the protein have been identified to have roles in the 
assembly of fibronectin fibrils and in their binding to other components of the extracellular 
matrix, such as collagen, heparin and syndecans. For example, the RGD motif in module III10 
and the synergy site in III9 are important for cell mediated assembly of the fibronectin matrix 
via integrin 51 binding (reviewed by Alberts et al., 2002; Singh et al., 2010).  
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Figure 1.12: Diagrammatic representation of a fibronectin subunit.  
Fibronectin is a 500kDa dimeric molecule formed through the interaction of two subunits 
via a pair of antiparallel disulfide bonds between the C-termini. Each subunit comprises 
three types of repeating unit (type 1 (hexagon); type 2 (rectangle); type 3 (oval) that follow 
a curved contour similar to the shape illustrated. Assembly involves domains I1-5 and the 
III1-2 domains. Other modules provide binding sites for collagen/gelatine (I6-9), integrin 
51 (synergy site in III9 and RGD sequence in III10), fibronectin (II1-2, III4-5 and III12-
14/hepII), heparin and syndecans (III12-14/hepII) and other extracellular molecules. 
Alternative splicing at EIIIA and EIIIB and exon subdivision at V generates multiple 
isoforms of fibronectin (20 in humans). Adapted from Singh (2010). 
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1.4.4 Extracellular matrix proteins as chemotactic and haptotactic stimuli 
The individual contributions of ECM components to chemotactic and haptotactic 
migration are incompletely understood and appear to be cell-type dependent but several 
studies, summarised in this section, have demonstrated the potential of ECM molecules to 
influence the migratory behaviours of cells in response to gradients of growth factors and to 
themselves act both as chemoattractants and haptotactic signals.  
Boyden chamber, checkerboard analysis of the effect of fibrinogen on endothelial cell 
migration indicated both chemoattractant and chemokinetic effects of this interstitial ECM 
component (Dejana et al., 1985) and dermal microvascular endothelial cells migrated in an 
integrin 11 and integrin dependent fashion in both a gradient of immobilised 
collagen I and in a uniform collagen I matrix toward VEGF (Senger et al., 2002).  
The study by Dejana et al (1985) did not observe a chemotactic effect of fluid-phase 
fibronectin (5-300g/ml) on endothelial cell migration; however, haptotactic properties of 
fibronectin on endothelial cells have been demonstrated using a novel method involving the 
cross diffusion of functionalisable alkanethiols to generate gradients of fibronectin between 0 
and 1.23ng fibronectin/mm3 (Smith et al., 2006; Smith et al., 2004). Fibronectin gradients 
supported a higher drift speed of both bovine aortic and human microvascular endothelial 
cells than uniform fibronectin when cells were either migrating away from a confluent 
monolayer or were growing as individual ‘free’ cells (Smith et al., 2004). The increase in drift 
speed increased with increasing gradient slope between 0 and 1.23ng/mm3 (Smith et al., 2006) 
Similar to fibrinogen in the work by Dejana et al (1985), collagen IV, when added to the 
lower chamber of a Boyden chamber, stimulated the directional migration of aortic 
endothelial cells in a concentration gradient dependent fashion. An insoluble substratum 
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adsorbed gradient of collagen IV mirrored this effect of fluid phase collagen IV in promoting 
migration, indicating that collagen IV acts as a haptotactic stimulus. Laminin was less 
effective on a molar basis at promoting endothelial cell migration in the study (Herbst et al., 
1988). Nonetheless, the lack of observation of an effect for laminin might have been due to 
the particular laminin isoforms predominating in the Engelbreth-Holm-Swarm (EHS) mouse 
sarcoma that was used as the source of laminin (laminin 111 as opposed to laminins 411 or 
511), as cells do not demonstrate uniformity in their capacity to bind and migrate on different 
laminins (Cherepanova et al., 2002; Kalmykova et al., 2002).  
Most of the more recent studies looking at the effects of laminin on cell migration have 
focussed on laminin 332, the laminin underlying skin, rather than endothelium. Nonetheless 
these studies indicate that the processing of laminin subunits and/or the patterns in which they 
are deposited in the matrix may be important in regulating the potential of laminin to 
influence cell migration. For example processing of the 3 chains of laminin-332 was found 
to underlie hemidesmosome formation while intact 3 chains supported migration 
(Goldfinger et al., 1998). This might be because processing exposes an internal binding site 
for the 64 integrin which supports hemidesmosome formation and inhibits migration 
(Hintermann et al., 2005). Certain fragments released upon cleavage by proteases might also 
promote migration. For example, DIII fragments cleaved from the laminin 2 chain of laminin 
322 by membrane type-1 MMP promoted breast cancer cell migration through ligation of the 
EGF receptor (Koshikawa et al., 2005).  
There is considerable variation in the patterns in which different cells deposit laminins in 
culture. A rosette-like pattern of laminin-322 was found for non-migratory human 
keratinocytes whereas actively migrating keratinocytes had laminin-322 assembled into trails 
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(Sehgal et al., 2006). Whether, the degree of variation in arrangement extends to intact 
basement membranes in vivo is nonetheless unclear (Hamill et al., 2009). However, the 
importance of basement membrane organisation in governing migration is supported by 
observations that integrin 4-deficient skin cells, which migrate in an abnormal circular 
pattern in vitro, show processive migration when plated onto a laminin-322 matrix deposited 
by wildtype cells (Sehgal et al., 2006).   
1.5 EFFECTS OF KSHV INFECTION ON ENDOTHELIAL CELL IDENTITY 
As mentioned previously, this study aimed to extend current knowledge on KS 
pathogenesis by furthering understanding of the impact of KSHV infection upon endothelial 
cell functions. The effect of the virus on endothelial cell behaviour was of interest because the 
tumourigenic spindle cells of KS lesions have endothelial characteristics, notably they express 
the markers: cluster of differentiation molecule (CD)-34, C-X-C chemokine receptor 
(CXCR)-4, VEGFR3, lymphatic vessel endothelial hyaluronan receptor-1 (LYVE-1) (Dupin 
et al., 1999; Regezi et al., 1993; Weninger et al., 1999).  
Prior to the work in this thesis, studies observing the infection of endothelial cells, both 
primary (Ciufo et al., 2001; Flore et al., 1998; Grossmann et al., 2006) and cell lines (Milligan 
et al., 2004; Moses et al., 1999) had affirmed the induction of a characteristic spindle cell 
shape following KSHV infection; thus supporting an endothelial origin for the KS spindle cell 
which is infected with KSHV in vivo (Boshoff et al., 1995a; Colman and Blackbourn, 2008). 
Furthermore, ectopic expression of the single KSHV gene, viral FLICE inhibitory protein 
(vFLIP), in endothelial cells had generated a spindle morphology providing additional 
evidence that KSHV infection of endothelial cells underlies induction of the spindle shape and 
the possible modulated properties of these cells. NFκB activation downstream of vFLIP was 
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implicated in this morphological transformation (Grossmann et al., 2006). However, in view 
of the mixed blood vascular (CD34, CXCR4) and lymphatic (VEGFR3, LYVE-1) endothelial 
phenotype of KS spindle cells (Dupin et al., 1999; Regezi et al., 1993; Weninger et al., 1999); 
(Carroll et al., 2004; Hong et al., 2004; Wang et al., 2004a) and the fact that both types of 
endothelial cell are equally susceptible to KSHV infection (Wang et al., 2004a), it continues 
to be debated whether the spindle precursor cell during KS pathogenesis is of either vascular 
or lymphatic lineage. 
Studies addressing the effect of KSHV infection upon the transcription profile of 
endothelial cells have highlighted that the dual blood vascular and lymphatic phenotype might 
have arisen because the virus reprogrammed the transcriptome of the infected cell. Using gene 
expression microarrays, Wang et al (2004a) observed a drift in the transcriptomes of both 
LEC and blood vascular endothelial cells (BEC) following infection with KSHV, such that 
the gene expression profiles of infected LEC and BEC were closer than those of untreated 
cells. In agreement, Hong et al (2004) reported KSHV-induction of (~70%) lymphatic lineage 
specific genes in human dermal microvascular endothelial cells and similar responses in 
human umbilical vein endothelial cells (HUVEC). Concurrently they also noticed the 
downregulation of several blood vascular genes (CXCR4, CD44, intercellular-adhesion 
molecule-1, laminin, neuropilin-1, PlGF and VEGFC).  
Prospero homeobox protein-1 (PROX-1) is a master regulator of lymphatic vessel 
development and differentiation and is not expressed by BEC. It was down regulated in LEC 
by KSHV infection (Wang et al., 2004a), which might explain the loss of lymphatic 
phenotype and increased blood vascular character in these cells. KS tumour cells and KSHV-
infected BEC both express PROX-1. However, while PROX-1 might contribute to the KSHV-
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induced drift in phenotype toward that of lymphatic vasculature, transfection with small 
interfering ribonucleic acid (siRNA) to inhibit PROX-1 upregulation in BEC infected with 
KSHV only partially inhibited the upregulation of lymphatic genes suggesting that additional 
transcriptional regulators are involved (Hong et al., 2004). Recent work has demonstrated that 
the reprogramming of LEC toward a BEC phenotype might involve KSHV-encoded micro-
RNAs, notably miR-K12-11 and miR-K12-6, which silence the transcription factor 
musculoaponeurotic fibrosarcoma oncogene homolog (MAF) thereby inhibiting its role in the 
differentiation of LECs (Hansen et al., 2010). 
Several lines of evidence reported by Wang et al (2004a) support LEC as the spindle-cell 
precursor: (1) using gene expression microarray the neoplastic cells of KS lesions were found 
to resemble lymphatic endothelial cells; (2) although susceptibility to infection was equal 
across BEC and LEC, LEC supported a higher KSHV genome copy number; (3) KS lesions 
arise at sites that are rich in lymph vessels (e.g. skin, lymph nodes and mucosa) but not in 
organs that are without lymphatics (e.g. brain). Nonetheless, the genetic drift of BEC toward a 
lymphatic phenotype provides support that BEC or an endothelial progenitor (Wang et al., 
2004a) could be the precursor of spindle cells. Accordingly, both BEC, in particular HUVEC 
and LEC continue to provide current models for investigating the effects of KSHV infection 
on endothelial cells. Dermal microvascular endothelial cells are also often used and these 
represent mixed populations of BEC and LEC. In view of the expertise of Professor Nash’s 
lab in the culture of primary HUVEC and the availability of multiple donor umbilical cords 
from the local maternity department within the Birmingham Women’s Hospital it was decided 
to use primary HUVEC as the target endothelial cell type for these studies.  
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1.6 IMPACT OF KSHV INFECTION UPON ENDOTHELIAL CELL MOTILITY  
To my knowledge, prior to the studies presented in this thesis, no work had been 
published on the effect of whole virus infection on the motility of primary endothelial cells. 
Literature on the association between KSHV and cell migration had only considered the 
influence of single KSHV gene products by methods of ectopic overexpression. Genes that 
had been examined included the viral G protein-coupled receptor (vGPCR) (Couty et al., 
2009); the M type K15 transmembrane protein (K15M) (Tsai et al., 2009) and the 
transmembrane ubiquitin ligase K5/MIR2 (Mansouri et al., 2006). Different effects upon cell 
migration are reported according to the gene of study highlighting the importance of studying 
the effect of infection by the whole virus in order to resolve what the overall effect of KSHV 
infection is on cell motility.  
Tsai et al (2009) reported that the K15M protein had pro-migratory and pro-invasive 
effects. This was demonstrated in assays across several cell types. Ectopic K15M expression 
increased the transmigration of NIH-3T3 cells through transwell filters and transfection of 
BC-1 cells with K15M specific siRNA to silence endogenous K15M suppressed BC-1 
transmigration through transwell filters compared to BC-1 cells transfected with a siGFP 
control oligonucleotide. In addition, co-transfection with siRNA oligonucleotides to either 
miR-21 or miR-31 inhibited the K15M induced increase in migration through transwell filters 
of cells of the human microvascular endothelial cell line HMEC-1. 
In contrast to K15M, Mansouri et al (2006) demonstrated that Adenovirus-K5-transduced 
HUVEC immortalised with the human papilloma virus E6 and E7 proteins were slower at 
closing scratch wounds compared to AdGFP-transduced control cells (Mansouri et al., 2006). 
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This the authors attributed to downregulation of CD31 by K5. CD31 has been demonstrated 
by others to have a role in the recovery of scratch wounds (Gratzinger et al., 2003).  
Finally, studies by Couty et al (2009) which investigated the effects of vGPCR on 
migration, found that basal signalling by the viral receptor inhibited the migration of 
immortalised mouse lung endothelial cells (MLEC) in a transwell assay. When considering 
that vGPCR-transgenic mice present lesions that resemble those of human KS (featuring 
prominent angiogenesis and vascular permeability) (Jensen et al., 2005; Montaner et al., 
2003), and ectopic vGPCR expression in vitro induced expression of angiogenesis-related 
genes (Ma et al., 2010), this result seems somewhat counterintuitive. Instead, a migration-
enhancing effect of the viral receptor might have been expected. However, interferon gamma-
induced protein-10 (IP-10), which acts as an inverse agonist to vGPCR (Geras-Raaka et al., 
1998; Rosenkilde et al., 1999), countered the suppressive effects of vGPCR on MLEC 
migration, improving wound recovery of vGPCR-expressing cells and stimulating the directed 
migration of vGPCR-expressing cells compared to controls by 237% in a transwell 
chemotaxis assay. IP-10 also had slight chemokinetic effects on vGPCR-expressing cells but 
the chemokine had no regulatory impact upon the behaviour of mock transfected cells.  
Overall the work by Couty et al (2009) indicates that the interaction between viral genes 
and the chemokine milieu, possibly governed by the effects of additional viral gene products, 
is likely to be important in dictating the influence of individual viral genes on host cell 
functions. Thus it strengthens the importance of the study in this thesis which set out to 
interrogate the effect of whole virus infection on endothelial cell migration. 
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1.7 OBJECTIVES OF THIS THESIS 
The research presented in this thesis set out to determine the overall impact of KSHV 
infection on the motility of primary endothelial cells and to investigate the effect of the virus 
on properties of endothelial cells that if altered might underlie changes in their migratory 
behaviour. The underlying hypothesis for this work was that alterations in endothelial cell 
motility imposed by the virus KSHV might support the generation of the extensive aberrant 
vasculature that is a hallmark of KS. Determining the mechanisms involved might lead to the 
identification of suitable targets for novel prophylactic or therapeutic drugs against KS.  
The main specific objectives included: 
 To establish a protocol for high efficiency in vitro infection of primary endothelial 
cells (HUVEC) with KSHV.  
 To characterise the temporal changes in percent infection within inoculated 
cultures over ten–days and assess the extent of sideways transmission of infection 
occurring from infected to non-infected cells within inoculated cultures. 
 To develop in vitro assays to test the effect of KSHV infection on rates of HUVEC 
migration. 
 To examine the effect of KSHV infection on the relative amounts of each of the 
major basement membrane proteins deposited by HUVEC including: collagen IV, 
fibronectin and laminin. 
 To examine the effect of KSHV infection on the profile of integrin receptors 
expressed on the surfaces of HUVEC.  
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 To characterise the effect of KSHV infection on the F-actin cytoskeleton and on 
the formation of focal adhesion structures in HUVEC. 
 To investigate the roles of chemokines and growth factors in KSHV-induced 
changes to HUVEC migratory behaviours. 
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CHAPTER TWO 
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2.1 CELL CULTURE 
2.1.1 Maintenance of cell lines 
All cells were cultured in a humidified incubator at 37C, 5%CO2 except where stated. Their 
media and other cell-type specific methods are detailed in the following sections. 
2.1.1.1 BCBL-1 cells 
BCBL-1 cells were cultured in RPMI medium (Sigma) supplemented with: 10% (v/v) foetal 
bovine serum (FBS) (PAA Laboratories), 2mM glutamine (Gibco, Invitrogen), 50U/ml penicillin 
(Gibco, Invitrogen), 50g/ml streptomycin (Gibco, Invitrogen). Cells were passaged 1:5 every 3-
4 days or plated at 0.2106 cells/ml. 
2.1.1.2 HEK293 cells 
HEK293 cells were cultured in Dulbecco’s Modified Eagle Medium (Gibco, Invitrogen) 
supplemented with: 10% (v/v) FBS (PAA Laboratories), 2mM glutamine (Gibco, Invitrogen), 
50U/ml penicillin (Gibco, Invitrogen), 50g/ml streptomycin (Gibco, Invitrogen) and 1% (v/v) 
non-essential amino acids (Sigma, catalogue number M7145). Cells were cultured in 25cm2 (or 
75cm2) flasks and passaged 1:6 every 3-4 days. 
To passage, culture medium was removed, cells washed once with phosphate buffered saline 
(PBS) and incubated with 0.05% (w/v) trypsin-ethylene diaminetetraacetic acid (EDTA) (Gibco, 
Invitrogen, catalogue number: 25300054) (room temperature) until detached. Trypsin was 
quenched with culture medium and an appropriate volume of cell suspension transferred to the 
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culture flask. The volume was made to 5ml (25cm2 flask) or 15ml (75cm2 flask) with culture 
medium. 
2.1.1.3 VK219 cells 
The VK219 cell line is a Vero cell line latently infected with the recombinant KSHV strain, 
rKSHV.219 (Vieira and O'Hearn, 2004). This virus expresses the green fluorescent protein (GFP) 
gene from the EF-1 promoter as a marker of latent infection and the Ds red fluorescent protein 
(RFP) gene from the PAN RNA promoter as a lytic cycle marker. The puromycin N-
acetyltransferase (pac) gene for puromycin resistance is also included as a selectable marker. 
Ectopic expression of the KSHV lytic switch replication and transactivator (RTA) protein, 
encoded by ORF50, induces reactivation of rKSHV.219 from latent to lytic replication (Figure 
2.1). 
Cells were cultured in Minimum Essential Medium Eagle-AQmedia™ (Sigma) supplemented 
with: 10% (v/v) FBS (PAA Laboratories), 10U/ml penicillin (Gibco, Invitrogen), 10g/ml 
streptomycin (Gibco, Invitrogen), 5g/ml puromycin (Sigma) and 1% (v/v) non-essential amino 
acids (Sigma). Cells were cultured in 175cm2 flasks and passaged 1:5 every 3-4 days.  
To passage, culture medium was removed, cells washed once with 10ml PBS, incubated with 
7ml 0.02% (w/v) EDTA (Sigma) (5mins, 37C) followed by 0.05% (w/v) trypsin-EDTA (Gibco, 
Invitrogen) (5mins, 37C). Trypsin was quenched with 10ml culture medium and cells pelleted 
(5mins, 500 x g). Cells were resuspended in 5ml medium and 1ml added to 20ml medium in a 
175cm2 flask. 
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Figure 2.1: Schematic diagram of the rKSHV.219 genome  
Recombinant rKSHV.219 was generated by recombination of the 4.8kb BamHI fragment of the KSHV 
genome into the wildtype KSHV genome of JSC-1 cells. This fragment contains the RFP/GFP/PURO 
cassette inserted in a non-coding region between ORFK9 and ORF57. GFP is expressed under the control 
of the human elongation factor 1 promoter, which is active in all cells, and RFP is under the control of 
the lytic PAN RNA promoter which is activated in cells undergoing lytic reactivation. The pac gene is 
included to confer puromycin resistance (PURO) on infected cells and therefore provides a selectable 
marker. Taken from Vieira and O’Hearn (2004). 
 
2.1.1.4 Human dermal lymphatic endothelial cells (LEC) 
Primary human dermal lymphatic endothelial cells (LEC) (PromoCell) were cultured in 
MV2 basal medium supplemented with: 50μl/ml foetal calf serum (FCS), 5ng/ml recombinant 
human EGF, 10ng/ml recombinant human bFGF, 20ng/ml insulin-like growth factor, 0.5ng/ml 
recombinant human VEGF165, 1μg/ml ascorbic acid and 0.2μg/ml hydrocortisone (all from 
PromoCell).   
2.1.1.5 Isolation of neutrophils from whole blood 
Whole blood was collected in an EDTA-containing tube (Sarstedt). For isolation of 
neutrophils from 5ml whole blood, 2.5ml Histopaque 1119 (Sigma) was added to a 10ml tube 
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and 2.5ml Histopaque 1077 (Sigma) layered on top. 5ml EDTA-blood was layered on top of the 
Histopaque gradient and centrifuged (40mins, 1400 x g). The upper plasma and PBMC bands 
were discarded. The neutrophil band was transferred to a clean tube and washed twice with Ca2+ 
and Mg2+-containing PBS (Sigma) supplemented with 0.5% (w/v) bovine serum albumin (BSA) 
(Sigma) (5mins, 500 x g). 
 
2.1.2 Production of KSHV  
2.1.2.1 Production of KSHV from BCBL-1 cells 
Two weeks prior to KSHV harvest, two T225 cell culture flasks were plated with BCBL-1 
cells at 0.2106/ml and cultured for four days. Cultures were pooled and six T225 flasks plated at 
0.2106/ml. After three days, cell suspensions were decanted into wide-necked straight centrifuge 
pots and cells pelleted using a Sorvall RC5B Plus centrifuge fitted with an SLA3000 rotor 
(10mins, 500 x g). Cells were re-plated at 0.5106/ml in eight T225 (100ml per flask) and 
reactivated by the addition of Phorbal Myristate Acetate (PMA) (Sigma) (final concentration 
20ng/ml) and sodium butyrate (Sigma) (final concentration 300M). Cells were cultured for five 
to six days. For reactivation, 300mM sodium butyrate solution (dissolved in sterile distilled 
water) was prepared fresh, filter sterilised and 100l added to each 100ml culture. PMA was kept 
as a frozen stock of 1mg/ml in Dimethyl sulfoxide (DMSO) (Sigma) and diluted in culture 
medium to give a 1g/ml working solution on the day of reactivation. 2ml of the working PMA 
solution (1g/ml) was added to each 100ml culture.   
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On the day of virus harvest, cell cultures were transferred to wide-necked straight centrifuge 
pots and pelleted using a pre-chilled Sorvall RC5B Plus centrifuge fitted with SLA3000 rotor 
(20mins, 1500 x g, 4C). The supernatant was decanted into sterile, wide-necked, straight 
centrifuge pots for harvest of KSHV by the sucrose cushion method or into side-opening, 400ml 
centrifuge pots for harvest by the standard method.  
2.1.2.1.1 Sucrose cushion method for harvest of KSHV from supernatants of 
reactivated BCBL-1 cells 
8ml 25% (w/v) sucrose in TNE buffer (150mM NaCl, 10mM Tris pH8, 2mM EDTA) pH8 
were aliquoted to each of six Ultra Clear 13.5inch (2589mm) tubes (Beckman) and overlain 
with 29ml virus-containing supernatant. Tubes were placed into Beckman SW32 rotor buckets 
and balanced by adding or removing virus-containing supernatant. Virus was pelleted from the 
supernatant by centrifugation using a Beckman Optima LE-80K Ultracentrifuge (2hours, 133668 
x g, 4C). Supernatants were discarded and the tubes inverted on tissue to drain remaining 
supernatant. 300l EBM-2 medium (without heparin) (PromoCell) were aliquoted onto each 
pellet and incubated on ice overnight in the cold room (4C) to resuspend. To complete 
resuspension, virus preparations were pipeted gently and pooled in 1.5ml microfuge tubes. 
Microfuge tubes were centrifuged to pellet any debris (30secs, 16,000 x g). The cleared 
supernatant was transferred to clean microfuge tubes and either used immediately or aliquoted 
and stored at -80C.  
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2.1.2.1.2 Standard method for harvest of KSHV from supernatants of reactivated 
BCBL-1 cells 
Virus was pelleted from the supernatant in side-opening centrifuge pots using a pre-chilled 
Sorvall RC5B Plus centrifuge fitted with SLA3000 rotor (3hours, 16927 x g, 4C). The 
supernatant was discarded and virus resuspended in culture medium on ice in the cold room 
overnight. The volume of medium added was just below that required for 100-fold concentration 
of the virus compared to the original culture supernatant volume. The next day suspensions were 
gently pipeted to ensure complete resuspension of the pellet. The suspension was transferred to a 
15ml tube and the volume made to that required for 100-fold concentration of the virus using 
culture medium. The resulting preparation was filter sterilised using a 0.45m-pore filter and 
either used immediately or aliquoted and stored at -80C.  
Before using a virus preparation to prepare an inoculum, it was allowed to thaw, if frozen, 
and was mixed thoroughly. Before inoculating the cells, the diluted virus was warmed in a 37C 
water bath for 10 minutes.  
2.1.2.2 Production of rKSHV.219 from VK219 cells 
Three days prior to expansion for reactivation, two stock 175cm2 flasks were plated. On the 
day of expansion, cells were detached from the two culture flasks and ten 175cm2 flasks plated at 
2-3106 cells per flask in complete medium (containing puromycin). Cells were cultured 
overnight or until ~60% confluent. 
To reactivate rKSHV.219 from its latent to lytic cycle, culture medium was removed, cells 
washed with 10ml PBS to remove traces of puromycin, and 20ml medium without puromycin 
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added. ‘Reactivation mixture’ containing BacK50 at the dilution determined by titration (section 
2.1.2.4) and sodium butyrate was prepared in culture medium without puromycin and 2.27ml 
added to each flask. The final sodium butyrate concentration was 1.25mM. Cells were cultured 
for 48hours before harvesting rKSHV.219 from the culture supernatant.  
On the day of harvest, RFP fluorescence and cell death confirmed reactivation. Supernatants 
were transferred to 50ml tubes, cleared of cellular material by centrifugation (15mins, 500 x g, 
4C) and decanted to six ultracentrifuagtion Ultra Clear 13.5inch (2589mm) tubes (Beckman). 
Tubes were balanced in SW32 rotor buckets and virus pelleted from the supernatant by 
ultracentrifugation in a Beckman Optima LE-80K Ultracentrifuge (4hours, 31,073 x g, 4C). 
Supernatant was decanted and tubes inverted on tissue to drain fully. Virus pellets were covered 
with 50l EBM-2 medium (without supplements) and left to resuspend overnight at 4C. Pellets 
were pooled in a 1.5ml microfuge tube and cleared of debris by centrifugation using a bench top 
microfuge (4mins, 1520 x g). Supernatant was transferred to a fresh microfuge tube and stored at 
4C unless otherwise stated.  
2.1.2.3 Production of Baculovirus K50 (BacK50) 
BacK50 is a recombinant baculovirus engineered to express the KSHV lytic switch protein 
RTA that is encoded by ORF50. Baculovirus is an insect virus that is unable to replicate within 
mammalian cells but which will infect and express encoded proteins. BacK50 was used in this 
system to ectopically express RTA within VK219 thereby reactivating rKSHV.219.   
BacK50 was produced in insect SF9 cells that were grown in either 500ml or 1litre flasks 
shaken at 27C, 5%CO2. Growth medium was Sf-900 II medium (Gibco, Invitrogen) 
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supplemented with 10% (v/v) FBS (PAA Laboratories), 50U/ml penicillin (Gibco, Invitrogen), 
50g/ml streptomycin (Gibco, Invitrogen). For BacK50 production, SF9 cells were expanded to 
four 1litre flasks. Once cells reached a viable density of 2106 cells/ml they were inoculated with 
BacK50 and returned to the shaker. Three-to-four days post-inoculation, cells were decanted to 
50ml tubes and centrifuged (20mins, 450 x g). Supernatants containing BacK50 were pooled, 
filtered through a 0.45m-pore filter and stored at 4C. 
2.1.2.4 Determination of BacK50 titre 
The BacK50 titre was determined by titration on VK219 cells. VK219 cells were plated in a 24-
well plate at 2104 cells/well and incubated overnight to reach ~60% confluence. Reactivation 
solutions containing 1.25mM sodium butyrate were prepared in VK219 culture medium without 
puromycin. BacK50 was titrated between 1:5 and 1:50. Untreated and sodium butyrate–only 
controls were included and for standardization purposes, the previous BacK50 batch was also 
tested in parallel. To reactivate the VK219 cells, the culture medium, containing puromycin, was 
removed, cells washed once with 500l PBS and 300l reactivation solution added. Each 
condition was set up in duplicate. Cells were returned to culture. The following day, HEK293 
cells were plated in a 96-well plate at 2104 cells/well and cultured overnight.  
48hours post-reactivation, the reactivation supernatants were collected into 1.5ml microfuge 
tubes, centrifuged (15mins, 1000 x g, 4C) to remove debris and diluted 1:200 and 1:400 in 
EBM-2 medium without supplements. Medium was removed from HEK293 cells and 100l of 
each diluted VK219 supernatant aliquoted in duplicate. Cells were centrifuged in the presence of 
the virus (30minutes, 328 x g), then the virus incubated with the cells for a further 90minutes 
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(37C, 5%CO2) before removal. Cells were washed once with culture medium then returned to 
incubation for 48hours during which time infected cells transcribed GFP. Two days post-
inoculation the number of GFP positive HEK293 cells per well was counted and the RTA titre 
calculated assuming that one infectious unit generates one GFP positive HEK293 cell in 48hours. 
2.1.2.5 Determination of rKSHV.219 titre 
HEK293 cells were plated in a 96-well plate at 2106 cells/well and incubated overnight. 
Immediately before inoculation, serial dilutions of rKSHV.219 were prepared between 1:100 and 
1:80000 using EBM-2 medium without supplements. Culture medium was removed and replaced 
with 100l inoculum. Each dilution was tested in duplicate. Cells were centrifuged in the 
presence of the virus (30minutes, 328 x g), then the virus incubated with the cells for a further 
90minutes (37C, 5%CO2) before removal. Cells were washed once with culture medium then 
returned to incubation for 48hours during which time infected cells transcribed GFP. The plate 
was viewed on a fluorescence microscope and a dilution selected that gave a countable number of 
GFP expressing cells in the entire well. The total number of GFP positive cells per well was 
counted and the titre calculated (infectious units per mililitre) assuming that one infectious unit 
generates one GFP positive HEK293 cell in 48hours. Throughout the studies reported in this 
thesis, multiplicities of infection (MOIs) for KSHV inoculations, where stated, refer to the 
number of infectious units supplied per cell (as determined by titration of the virus on HEK293 
cells). MOI was based on KSHV infection of HEK293 because HEK293 were found to be 
permissive to KSHV. Inter-donor variability in infectability was seen among HUVEC; thus to 
ensure use of a constant MOI would have required titration of the virus on cells from each donor 
prior to the use of the donor in an assay. This was not feasible due to the limited availability of 
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cells for each donor, inability to expand HUVEC cultures across multiple passages and the need 
to infect HUVEC for use in an assay within one week of their isolation. The decision was 
therefore taken to keep the amount of KSHV added per cell constant as opposed to inoculating 
with virus according to its titre on each donor.   2.1.2.6 UV irradiation of rKSHV.219 
Ultraviolet (UV) irradiated preparations of rKSHV.219 were made at the time of the assay so that 
the UV-irradiated and non-UV irradiated virus were of the same batch. 50-70l volumes of 
rKSHV.219 were aliquoted into wells of a 96 well plate and the plate put into the GS Gene 
Linker UV Chamber (BIO RAD) with its lid removed. The sterilization (Str) program was 
selected and the virus exposed to 400mJ radiation for two consecutive periods of 10minutes. In 
between the irradiations the plate was swirled gently. In the preparation of the inoculums the UV 
irradiated virus was diluted equivalently to the non-irradiated sample from which it derived so 
that cells received either productively infectious or inactive virus originally at the same MOI.  
 
2.1.3 Isolation and culture of human umbilical vein endothelial cells (HUVEC) 
Primary HUVEC were isolated and sub-cultured in Medium 199 (M199) (Gibco, Invitrogen) 
supplemented with 20% (v/v) FCS, 2.5g/ml amphotericin B, 50U/ml penicillin, 50g/ml 
streptomycin, 1ng/ml EGF, 28g/ml gentamycin and 1g/ml hydrocortisone (all from Sigma).  
Each experiment used a separate HUVEC donor. 
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2.1.3.1 Isolation of HUVEC from umbilical cord veins 
Umbilical cords still attached to their placentas were received from the Birmingham 
Women’s Hospital with donor consent. Cords were cut from their placentas, and after clearing 
surface blood, were inspected for clamp marks, punctures or sites of large hemorrhage. The vein 
of each cord was cannulated and flushed with PBS (Sigma) until the through flow was clear. 
Each volume (20ml) of PBS was followed by a full syringe of air (20ml) to expel all PBS.  
Next, the opposite end of the vein was cannulated and the vein filled with 1X collagenase 
type 1a (1mg/ml) (Sigma) that was diluted in PBS from 100X or 10X frozen stocks stored at -
20C. The cord was incubated (15mins, 37C, 5%CO2) to allow digestion of collagen in the 
extracellular matrix and thus detachment of endothelial cells. The cord was then massaged and 
flushed with 30ml PBS and the flow through collected in a 50ml tube. Cells were pelleted 
(5mins, 500 x g), re-suspended in culture medium and aliquoted to 25cm2 flasks, 4ml per flask 
(~10cm of cord were allowed for each 25cm2 flask). Cells were allowed to settle and adhere for a 
minimum of 2hours or overnight before the medium was changed. Culture medium was changed 
every two or three days until cells were confluent (typically within four to six days). Cells were 
then passaged for experiment.  
During a period of limited HUVEC availability it was necessary to expand the cell stocks. 
Cells were passaged for expansion when ~80-90% confluent, frozen and stored in liquid nitrogen. 
Cells isolated in-house were cultured in M199-based culture medium and frozen at P2 or P3. 
Cells purchased from PromoCell were expanded in supplemented EBM-2 medium (PromoCell), 
transferred from 25cm2 to 75cm2 flasks at first passage and frozen at P3.  
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2.1.3.2 Detachment of HUVEC from 25cm2 flasks 
Culture medium was removed, cells washed once with 2ml 0.02% (w/v) EDTA (Sigma) then 
incubated with 2ml 0.25% (w/v) trypsin (Sigma, catalogue number: T4424) diluted 1:1 with 
0.02% (w/v) EDTA (Sigma) (Sigma) at room temperature until cells rounded and detached. 
Trypsin was quenched with 7ml culture medium and cells pelleted (5mins, 500 x g).  
For expansion of the culture, the cell pellet was resuspended in culture medium and divided 
between two 25cm2 flasks or transferred to a 75cm2 culture flask (HUVEC purchased from 
PromoCell).  
To plate cells for an experiment, the cell pellet (from one 25cm2 flask) was resuspended in 
400-600l culture medium and the live cell density determined by trypan blue staining. A four-
factor dilution of the HUVEC was suitable for counting. Cells were diluted to an appropriate 
number of cells/volume and aliquoted into plasticware. 
2.1.3.3 Detachment of HUVEC from 24-well plates 
To detach cells from 24-well plates the culture medium was removed, cells in each well were 
washed once with 500l 0.02% (w/v) EDTA then incubated (room temperature) with 200l 
0.25% (w/v) trypsin (Sigma) diluted 2:5 with 0.02% (w/v) EDTA (Sigma) (trypsin-EDTA) (room 
temperature) until rounded and detached. Trypsin was quenched with 500l culture medium. To 
encourage complete cell detachment, the cell suspension was gently pipeted. Cells were 
transferred to 1.5ml microfuge tubes (or 15ml tube if pooling cells from a large number (10-12) 
wells) and pelleted (5mins, 425 x g). Pellets were resuspended in an appropriate volume for 
counting the density and/or replating.   
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2.1.3.4 Freezing HUVEC for storage in liquid nitrogen 
Cells were detached from the culture flask and the cell pellet resuspended in ice-cold Cryo-
SFM freezing medium (PromoCell) (1ml/25cm2 flask). The resulting cell suspension was 
aliquoted to ice-cold cryovials (1ml/vial) and placed in a cell cryopreservation container at -80C 
to freeze gradually. The following day, cells were transferred to storage in liquid nitrogen.   
2.1.3.5 Reviving HUVEC from storage in liquid nitrogen 
9ml supplemented EBM-2 medium was warmed to 37C. A vial of frozen HUVEC was 
warmed between the hands until the cell suspension had almost thawed then was added to the 
EBM-2 medium and cells pelleted (5mins, 500 x g). The cell pellet was resuspended in 4ml 
EBM-2 medium and transferred to a 25cm2 flask. Cells were cultured until a confluent monolayer 
was attained. The culture medium was changed to M199-based culture medium either one day 
prior to use (if cells were to be infected on the day of plating) or at the time of plating (if cells 
were to be infected following overnight incubation). It was necessary to revive cells in EBM-2 
culture medium since pilot studies revealed poor recovery in M199-based medium. For 
successful infection and functional assays however, cells needed to acclimate to M199-based 
medium since infection efficiency in EBM-2 is low, possibly due to inclusion of heparin as a 
supplement. HUVEC functions might also be altered by differences in the nutrient/growth factor 
availability and balance between the two media.  
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2.1.4 Inoculation of HUVEC with rKSHV.219 
HUVEC were plated in culture medium at the required density required for the experiment the 
day before inoculation unless otherwise stated. Following overnight culture, cells were washed 
once with culture medium to remove non-adhered cells and inoculums prepared by diluting the 
required volume of virus (to give MOI10 unless otherwise stated) in EBM-2 medium without 
supplements to a total volume of 100l (96 well plate) or 420l (24 well plate) or 60l (-slides) 
(for -slides, 30l were required to fill the channel and an extra 30l to fill the ports in order to 
prevent the cells from drying out during centrifugation). Cells were centrifuged in the presence of 
the virus (30minutes, 328 x g), then the virus incubated with the cells for a further 90minutes 
(37C, 5%CO2) before removal. Cells were washed once with culture medium and then cultured 
until the timepoint of interest post-inoculation. The medium was changed throughout this period 
every two or three days (plates) or every one or two days (-slides). 
 
2.2 FLOW CYTOMETRY 
2.2.1 Antibodies 
All antibodies used in this thesis for applications including: flow cytometry, enzyme linked 
immunosorbent assay (ELISA), immunofluorescence assay and functional assays are listed in 
Table 2.1. Details of their working concentration/dilution, isotype, clone and source are given.   
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2.2.2 Determining the percentage infection of rKSHV.219-inoculated cell cultures 
Cells were removed by trypsinisation and fixed in 1ml 4% (w/v) formaldehyde (Sigma) 
diluted in PBS (15mins, room temperature), pelleted (5mins, 500 x g), washed with 2ml PBS 
(5mins, 500 x g) and resuspended in 300l PBS for data acquisition on a Dako Cyan flow 
cytometer. A minimum of 3000 events were counted. Data were analysed using FlowJo (Tree 
Star) or Dako Summit 4.3 software. Cells were considered infected if their GFP fluorescence 
intensity was greater than that of 99% of untreated cells (Figure 2.2).  
 
2.2.3 Staining surface antigens 
To detach HUVEC from 24-well tissue culture plates (~7-9x104 cells/well), the culture 
medium was removed and the cells in each well were washed once with 500l 0.02% (w/v) 
EDTA (1min) then covered with 500l enzyme free cell dissociation buffer (Gibco, Invitrogen) 
and incubated (37C, 5%CO2) until rounded and detached. 1ml cold culture medium was added 
and the cell suspension gently pipeted to encourage complete cell detachment. The cell 
suspension was transferred to FACS tubes (BD Falcon) (~4-9x104 cells/tube), 2ml ice-cold 2% 
(w/v) BSA in PBS (2%PBSA) added and the cells pelleted (5mins, 500 x g, 4C). The 
supernatant was aspirated and the cell pellet resuspended in 50l primary antibody (Table 2.1) 
diluted in 2%PBSA (30-40mins, on ice, dark). For staining of VEGFR3, in accordance with the 
manufacturer’s instructions, cells were blocked in 40l 2% (v/v) goat serum in 0.5%PBSA 
(20mins, room temperature) prior to addition of the antibody (in 10l) into the cell suspension 
and incubation on ice (30-40mins, dark).  
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Excess antibody was washed out in 3ml ice-cold 2%PBSA (5mins, 500g, 4C). Samples 
stained with fluorophore-conjugated primary antibodies were washed a second time (3ml 
2%PBSA, 5mins, 500 x g, 4C) then resuspended in 200l 4% (w/v) formaldehyde to fix 
(15mins, room temperature). Samples to stain with a secondary antibody were resuspended in 
50l secondary antibody (30-40mins, on ice, in dark). Excess antibody was washed out in two 
3ml-volumes of ice-cold 2%PBSA before resuspension in 200l 4% (w/v) formaldehyde to fix 
(15mins, room temperature). Fixative was washed out in 2ml PBS (5mins, 500 x g) and cells 
resuspended in 300l PBS for data acquisition on a Dako Cyan flow cytometer. A minimum of 
3000 events were collected. Data were analysed using FlowJo (Tree Star) or Dako Summit 4.3 
software. 
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2.2.4 Staining intracellular antigens  
2.2.4.1 Staining intracellular antigens using the Fix and Perm Kit by Invitrogen 
Cells to be stained were detached from 24-well plates using trypsin-EDTA and transferred to 
FACS tubes (3.5-7x104 cells). 2ml wash buffer (PBS supplemented with 5% (v/v) FCS) were 
added and cells pelleted (5mins, 500g). Cells were fixed and stained using the Invitrogen Fix and 
Perm Kit according to the manufacturer’s instructions. Cells were resuspended in 50l Medium 
A (15mins, room temperature, in dark) to fix. The fixative was washed out in 2ml wash buffer, 
and cells resuspended in 50l primary antibody (Table 2.1) diluted in Medium B (1hr, 37C, 
dark). Excess antibody was washed out in 3ml wash buffer (5mins, 500 x g) and cells 
resuspended in 50l secondary antibody (Table 2.1) diluted in Medium B (40mins, 37C, dark). 
Excess antibody was washed out in 3ml wash buffer followed by 1ml PBS then resuspended in 
300l PBS for analysis on a Dako Cyan flow cytometer. A minimum of 3000 events were 
collected. Data were analysed using FlowJo (Tree Star) or Dako Summit 4.3 software.  
2.2.4.2 Staining phospho-p38 MAPK 
Cells (~8x104) to be stained were detached from 24-well plates using trypsin-EDTA, quenched 
with 500l medium and 77l 16% (w/v) formaldehyde added immediately to fix. 2ml PBS were 
added and cells pelleted (5mins, 500 x g). To complete fixation, cells were resuspended in 500l 
2% (w/v) formaldehyde (10mins, room temperature). Cells were then washed with 4ml ice-cold 
PBS (5minutes, 500 x g) followed by a second 1ml ice-cold PBS wash (5mins, 500 x g). Cells 
were permeabilised in 100l 100% (v/v) methanol (30mins, 4C). The methanol was removed by 
one wash in 2ml ice-cold PBS followed by one wash in 2ml ice-cold 2% (w/v) BSA in PBS 
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(2%PBSA). Cells were resuspended in 30l primary antibody (Table 2.1) diluted in 2%PBSA 
(1h, room temperature, dark). Excess antibody was removed by two washes with 2ml 2%PBSA 
(5mins, 500 x g). Cells were resuspended in 300l PBS and analysed immediately after staining 
on a Dako Cyan flow cytometer. A minimum of 10000 events were collected. Data were analysed 
using FlowJo (Tree Star) or Dako Summit 4.3 software.  
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Figure 2.2: Assessment of percent KSHV infection by flow cytometry quantifying GFP 
expression. 
The expression of GFP under the human elongation factor-1 promoter in the rKSHV.219 
genome meant that cells infected by rKSHV.219 expressed GFP. The ‘live’ HUVEC population, 
identified from its scatter on the forward scatter (FS) v side scatter (SS) flow cytometry plot was 
examined for its GFP fluorescence. Cells were concluded to be infected with the virus  (denoted 
V) if their GFP fluorescence exceeded that of 99% of untreated (UT-EC) cells. If their 
fluorescence was not greater than that of 99% of untreated cells, and thus they fell within the 
subset of UT-EC negative for GFP signal, they were concluded to be non-infected (NI).  
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Table 2.1: Antibodies used in the studies reported in this thesis 
Antibody Clone Isotype Company Catalogue 
number 
Conjugation Application Dilution/ 
concentration 
Primary antibodies 
Collagen IV COL-94 Mouse IgG1 Sigma C1926 Unconjugated ELISA 1/5000 (0.02g/ml) 
CXCR1 42705 Mouse IgG2a R&D Systems FAB330P PE Flow cytometry 1/20 
CXCR2 48311 Mouse IgG2a R&D Systems FAB331P PE Flow cytometry 1/20 
Fibronectin FN-3E2 Mouse IgM Sigma F6140 Unconjugated ELISA 1/5000 (0.02g/ml) 
Integrin  HAS3 Mouse IgG2a R&D Systems BAM1233 Biotinylated Flow cytometry 1/20 
Integrin 3 P1B5 Mouse IgG1 Dako M0608 Unconjugated Flow cytometry 1/20 
Integrin v3 23C6 Mouse IgG1   Unconjugated Flow cytometry 1/400 
Integrin 6 GoH3 Rat IgG2a R&D Systems FAB13501P PE Flow cytometry 1/50 
Integrin 6 NKI-GoH3 Rat IgG2a,κ AbDSerotec MCA699EL Unconjugated 
low endotoxin 
Function block 10g/ml 
Integrin 1 P5D2 Mouse IgG1 R&D Systems FAB17781P PE Flow cytometry 1/50 
Integrin 3 PM6/13 Mouse IgG1 AbDSerotec MCA728 Unconjugated Flow cytometry 1/50 
IP-10/CXCL10 33036 Mouse IgG1 R&D Systems MAB266 Unconjugated Function block 2g/ml 
Laminin-4 3H2 Mouse IgG1 Santa Crutz Sc-130540 Unconjugated Flow cytometry 
ELISA 
1/20 
1/1000 
Laminin-5 4B12 Mouse IgG1 Santa Crutz Sc-130542 Unconjugated ELISA 1/50 
Laminin-P1 HL-4H3 Mouse IgG1 Calbiochem IF10L Unconjugated 
(100g/ml) 
Flow cytometry 
ELISA 
1/20 (5g/ml) 
1/1000 (0.1g/ml) 
LANA-1 LN53 Rat IgG Advanced 
Biotechnologies  
13-210-100 Unconjugated IFA  
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LANA-1 LN25 Mouse IgG Gift from Dr Ian Milton Unconjugated IFA 1/50 
p38MAPK 
pT180/pY182 
36/p38 Mouse IgG1 BD Pharmingen BD612595 Alexa Fluor 647 Flow cytometry 1/4 
VEGFR3 54733 Mouse IgG1 R&D Systems FAB3492A APC Flow cytometry 1/20 
Vinculin hVIN-1 Mouse IgG1 Sigma V9264 Unconjugated IFA 1/500 
Isotype control antibodies 
Mouse IgG1 DAK-GO1 Mouse IgG1 Dako X0931 Unconjugated Flow cytometry 
IFA 
1/20 
1/100 
Mouse IgG1 PPV-06 Mouse IgG1 Immunotools 21275514 PE Flow cytometry 1/50 
Mouse IgG2a 20102 Mouse IgG2a R&D Systems IC003P PE Flow cytometry 1/20 
Mouse IgG1 MOPC-21 Mouse IgG1 Biolegend 400122 APC Flow cytometry 1/20 
Rat IgG2a eBR2a Rat IgG2a Ebioscience 16-4321-82 Unconjugated Function block 10g/ml 
Secondary antibodies 
Anti-Mouse IgG 
AF594 
- Goat IgG Invitrogen MP A21125 Alexa Fluor 594 IFA 1/100 
Anti-Mouse IgG 
AF633 
- Goat IgG  Invitrogen MP A21050 Alexa Fluor 633 Flow cytometry 
IFA 
1/1500 
1/500 
Anti-Rat IgG 
AF633 
-  Invitrogen MP  Alexa Fluor 633 IFA  
Anti Mouse IgG 
RPE 
- Rabbit F(ab’)2 AbD Serotec STAR12A RPE Flow cytometry 1/20 
Streptavidin 
Conjugate 
- - Invitrogen MP S11222 Pacific blue Flow cytometry 1/100 
Anti mouse IgG 
HRP 
- Goat IgG Dako P0447 HRP ELISA 1/2000 
MP stands for Molecular Probes                 AF stands for Alexa Fluor 
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2.3 MIGRATION ASSAYS 
2.3.1 Transmigration assay 
At the time point of interest post-inoculation (day-seven unless otherwise stated), KSHV-
inoculated and untreated HUVEC were detached from wells of the 24-well inoculation plate 
using trypsin-EDTA, pelleted in 1.5ml microfuge tubes (5mins, 425 x g) and re-suspended in 
culture medium at a density of 1.4105cells/ml (2.7104 cells/200l). In preparation, 3 or 8m-
pore transwell chambers (BD Falcon) had been set out in a 24-well plate and 700l culture 
medium aliquoted to the lower chamber. 200l cell suspension was added to the upper chamber 
and cells incubated at 37C for 48hours.  
The medium was removed, the upper and lower surfaces of the filter washed once with PBS 
(200l) and cells on both surfaces fixed with 2% (w/v) formaldehyde (PFA) containing 
bisbenzimide (2g/ml) (Sigma) (15mins, room temperature, dark) (200l upper and 700l 
lower). The fixative was removed and the chambers filled with PBS. The filters were cut from 
their inserts using an 11-gauge scalpel and mounted using Vectashield mountant (Vector 
Laboratories Inc) on a glass microscope slide (76x26mm) (Thermo Scientific) beneath a 
2222mm glass coverslip (Menzel Glaser, Thermo Scientific). Filters were stored at 4C for 
analysis by fluorescence microscopy.  
Filters were viewed using a 20x objective lens and the number of cells on the top and bottom 
of the filter in each of 14-18 fields counted (Figure 2.3). The average percentage transmigration 
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was calculated. Two or three filters were prepared for each condition in each experiment and the 
average transmigration calculated.  
2.3.2 Transmigration assay to determine percent transmigration of KSHV-infected 
and non-infected HUVEC individually 
In parallel to the standard transmigration assay (section 2.3.1) filters were set up for analysis of 
the percentage of GFP positive cells in the cultures removed from the top and bottom surfaces of 
the filters after 48hours transmigration. At the 48hour timepoint, medium was removed from the 
upper and lower chambers and the surfaces of the filters washed with PBS. The chambers were 
filled with 0.02% (w/v) EDTA (200l upper and 700l lower) and incubated (10mins, 37C). 
Washings were transferred to FACS tubes and 0.25% trypsin (w/v) (Sigma) diluted 2:1 with 
0.02% EDTA (Sigma) added to the chambers (200l upper and 700l lower) and incubated 
(10mins, 37C). Trypsin was quenched with an equivalent volume of culture medium and the 
cells removed to FACS tubes, pooling them with those recovered in the wash. In the process, the 
bottom of the filter was carefully flushed by gentle pipeting to remove all cells. After removing 
the cell suspension from the upper chamber, the top surface of the filter was washed with 200l 
PBS to ensure total recovery of cells. Cells were pelleted (5mins, 500 x g) and fixed in 300l 2% 
(w/v) formaldehyde for data acquisition on on a Dako Cyan flow cytometer. The percentage of 
GFP positive cells in each culture was determined. These data were used together with the 
standard transmigration data to calculate the percent transmigrations of KSHV-infected and non-
infected HUVEC separately. The calculation strategy, illustrated by the raw data for this study is 
given in the appendix (Table 9.1).  
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2.3.3 Wound recovery assay  
On day-six post-inoculation, KSHV-inoculated and untreated HUVEC were detached from 
wells of the 24-well inoculation plate, pelleted in 1.5ml microfuge tubes (5mins, 425 x g) and re-
suspended in culture medium at densities of 2.1105cells/ml. In advance, a graph paper grid had 
been photocopied onto acetate and strips of grid of size 25mm x 75mm cut. A window (2mm 
wide) was cut lengthwise down the centre of each strip and the strips secured to the backs of 6-
well plates such that the central windows ran down the centre of the wells. A culture insert for 
wound recovery assays (Ibidi, Thistle Scientific) was placed in the centre of each well such that 
the central divider of the insert was contained within the window. 70l cell suspension were 
seeded into each well of the insert, on either side of the central divider, and incubated overnight 
(unless otherwise stated) (Figure 2.4A). Inserts were removed to reveal the ‘wounded 
monolayers’ and the cells washed once with culture medium to remove cells that had not adhered 
to the plate. Monolayers were covered with 2ml culture medium and three phase contrast images 
along the length of each wound taken using a 4x objective lens. The grid positions for the sites 
photographed at the start were recorded and returned to at the end of the recovery period of 
32hours (Figure 2.4B) The area of the wound at the start and end of the recovery period was 
measured using ImageJ software for each site of observation along the wound and the average 
percentage recovery calculated (Figure 2.5). Where possible, conditions were set up in duplicate 
and the average of those repeats calculated. 
To determine wound-recovery in relation to cell density, images were divided into thirds 
using the rectangular selection tool together with the draw command. The area of the wound in 
each third was measured for paired start and end images and the number of cells in each region of 
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the monolayer surrounding the wound was counted at the start and end. The average cell density 
across the wound was calculated for each third and plotted against the percent wound-recovery 
for that portion of the wound. The decision to divide images into thirds was taken because it was 
noticed that a gradation in density sometimes occurred along the length of the wound attributable 
to the well edge effect (cells tend to pool at the two ends of the insert wells giving higher density 
toward the ends). 
2.3.3.1 Wound recovery assay on 24hour sub-endothelial matrices deposited by 
KSHV-inoculated and untreated HUVEC 
On day-seven post-inoculation, KSHV-inoculated and untreated HUVEC were detached from 
wells of the 24-well inoculation plate, transferred to 1.5ml microfuge tubes, pelleted (5mins, 425 
x g) and re-suspended in culture medium to a density of 2.1105cells/ml. Culture inserts for 
wound recovery assays were placed into the centres of 6-well plate wells with an acetate grid 
behind and 70l cell suspension (KSHV-inoculated or untreated) or culture medium seeded into 
each well of each insert. Inserts were set up in duplicate. Cells were allowed to adhere and 
deposit sub-endothelial matrix proteins for 24hours after which the monolayers were washed 
once with 70l PBS per side of the insert and the cells stripped from the sub-endothelial matrix 
by incubation in 70l pre-warmed detergent lysis buffer (37C) (PBS containing 0.5% (v/v)  
Triton X-100; 20mM NH4OH). To remove all traces of lysis buffer, the monolayers were washed 
four times with 100l PBS followed by 100l culture medium. 70l first passage allogenic 
untreated HUVEC were seeded onto the sub-endothelial matrices at a density of 2.1105 cells/ml. 
After 6hours the inserts were removed, the monolayers washed once with culture medium and the 
start images taken. The grid positions of the imaged sites were recorded and returned to after 
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18hours of wound recovery. The area of the wound at the start and end of the recovery period 
was measured using ImageJ software for each of three sites of observation along the length of 
each wound and the average percentage wound recovery calculated across the duplicate wounds. 
2.3.4 Tracking the migration of HUVEC in isolation  
HUVEC were plated in 12-well plates at 3104 cells/well in 1ml culture medium. Seeding at this 
density created patches of isolated cells. Cells were allowed to adhere for 24hours then time-lapse 
images recorded for 150minutes observing cells using a 10x objective lens. 8-bit Tiff images 
were saved at 10minute intervals. To avoid problems of pH change, the culture medium was 
changed immediately before imaging from complete M199-based culture medium to pre-warmed 
cell imaging medium, (9.7g/l Hanks’s Balanced Salts Solution without sodium bicarbonate and 
phenol red (Sigma) supplemented with 10M HEPES (Sigma) and 20% (v/v) FCS, pH 7.4). Cells 
were incubated at 37C throughout recording.  
Cells to track were selected at random by assigning each cell in the view at the start a number 
and including those whose numbers were generated in a set of random numbers. The (x,y) 
coordinates of the cell centroids at each timepoint were determined using ImageJ software and 
the distance migrated between each timepoint calculated according to Pythagoras’ theorem 
(h=(a2+b2)), where ‘h’ is the distance migrated, and ‘a’ and ‘b’ are the differences between the x 
and y coordinates for the centroid at the timepoint of interest and those of the cell at the previous 
timepoint of measurement (Figure 2.6). KSHV-infected cells were identified from a GFP 
fluorescence image overlain at the start.  
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2.3.5 Tracking the migration of HUVEC during wound recovery 
KSHV-inoculated HUVEC were plated into a culture insert for wound recovery placed in the 
centre of a 6-well plate. At the start of wound recovery the insert was removed, the monolayer 
washed once with pre-warmed cell imaging media and covered with 2ml cell imaging media. 
Cells were imaged using a 6x objective lens and incubated at 37C throughout recording. 8-bit 
Tiff images were saved at 15minute intervals for a total of 8hours. KSHV-infected cells were 
distinguished using a GFP fluorescence image overlain at the start and cells to track, both 
infected and non-infected, were selected at random. The distance migrated between each 
timepoint was calculated according to Pythagoras’ theorem (section 2.3.4); however, in this 
study, the centroid used was that of the cell nucleus as opposed to the total cell surface area, since 
for cells in a confluent monolayer at low power magnification, nuclei were clearly defined but 
cell contacts prohibited accurate visualisation of the cell perimeter.  
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Figure 2.3: Transmigration assay set up and analysis.  
(A) HUVEC were allowed to transmigrate across 8m pore filters of 24-well size transwell 
chambers. After 48hours the cells were fixed on the filters and their nuclei stained. The filters 
were then cut out of the chambers and mounted on microscope slides. (B) Cells on the top and 
bottom surfaces of the filter were focused onto separately for the same field of view and the 
number of cells on each surface counted. The percentage of cells in the field that had 
transmigrated to the bottom of the filter was calculated according to the equation stated. Percent 
transmigration for each filter was the average percent transmigration of 14-18 fields.  
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Figure 2.4: Wound recovery assay set up. 
(A) Strips of grid on acetate were secured to the bases of 6-well plates to enable the same fields 
of cells imaged at the start to be re-imaged at the end. A window (2mm wide) had been cut in the 
centre of each strip to accommodate the wound. The wound recovery inserts were set in the 
centre of each well such that their central divisions were within the window. Each chamber was 
filled with 70l cell suspension (1.5x104 cells). Once cells had adhered, the inserts were removed 
to reveal the wounds. (B) The microscope (using 4x objective lens) was focused onto the grid at 
the edge of the window. The microscope was fitted with a tool that gave a series of concentric 
rectangles in the field of view when looking through the microscope eyepiece. A corner of a 
square on the acetate grid at the edge of the window was aligned with the corner of a selected 
rectangle (white circle). The rectangle and grid square combination was recorded so that the site 
could be found again at the end of the recovery period. Without moving the x,y position of the 
microscope stage the microscope was focused onto the monolayer and a picture taken. The 
picture was saved in Tiff format. 
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Figure 2.5: Method for analysis of wound recovery. 
Images of the wound at the start and end of the recovery period were opened in ImageJ and the 
polygon tool used to draw around the perimeters of the wounds. The areas of the shapes created 
were measured and the percent wound recovery calculated according to the equation stated. 
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Figure 2.6: Strategy for analysis of isolated cell migration. 
Sequences of images captured during a timelapse recording of 2.5hours were opened in ImageJ 
and the polygon tool used to draw around the perimeters of the cells (selected at random) at 
10minute intervals. The (x,y) coordinates for the midpoint of each cell under analysis (as shown 
for the red cell) were recorded at each timepoint and the overall distance migrated calculated 
according to Pythagoras’ Theorem, where total distance travelled was the sum of the hypotenuses 
(h). Estimates of migration distance were also made for intervals of 30, 50 or 150minutes 
between measurement of the cell midpoint. Pictures shown illustrate for four cells, at 30minute 
intervals over the first 90minutes, how the movement of cells was followed by drawing around 
their perimeters. 
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2.4 ANALYSIS OF BASEMENT MEMBRANE COMPOSITION BY ENZYME-LINKED 
IMMUNOSORBENT ASSAY (ELISA) 
For deposition assays between days zero and four post-inoculation, cells were plated at 3104 
cells/well of 96 well plate  in 100l culture medium for 4-6hours then were inoculated with 
KSHV, UV-inactivated KSHV or non-supplemented EBM-2 (untreated control). For deposition 
assays between days seven and eleven post-inoculation, cells were detached from the inoculation 
plate on day-seven and replated at 3104 cells/well of 96 well plate. Medium was changed on 
day-two post-plating.  
On day-four post-plating, cells were stripped from the underlying basement membrane. To 
strip the cells, the monolayer was rinsed once with 100l PBS then incubated with 100l pre-
warmed (37C) detergent lysis buffer (PBS containing 0.5% (v/v) Triton X-100; 20mM NH4OH) 
for 2minutes or until cells had lysed. The lysis buffer was removed and membranes washed four 
times with 200l PBS then blocked with 1% (w/v) BSA in PBS (1%PBSA) (1.5-2h, 37C) before 
incubation with 50l primary antibodies (Table 2.1) diluted in 1%PBSA containing 2% (v/v) 
goat serum (2h, 37C). Membranes were washed five times with 1%PBSA then incubated with 
an HRP-conjugated secondary antibody, goat anti-mouse HRP (Table 2.1) diluted in 1%PBSA 
(1.5h, 37C). Excess antibody was removed through five washes with 1%PBSA before 
development at room temperature with 100l SIGMAfast OPD (Sigma) solution prepared 
according to manufacturer’s instructions. The reaction was quenched after 10minutes by addition 
of 100l 2N sulfuric acid and the endpoint absorbance read at 490nm using a BioTek synergy HT 
plate reader. The average of three technical repeats was calculated and absorbance for stained 
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wells that had contained medium only, as opposed to cells, subtracted as background. This 
background had been validated to be equivalent to staining basement membrane with an isotype 
control antibody but allowed conservation of cells.  
In some development assays, cells were removed by 4hour incubation (37C) in 100l 0.02% 
(w/v) EDTA as opposed to lysis buffer.  
 
2.5 LUMINEX 
A Luminex kit was purchased (Chemicon, Millipore) for analysis of the following cytokines 
in a single sample (50l) of supernatant: L; IL-1; IL-4; IL-6; IL-8; IL-10; IFN-IP-10, 
monocyte chemotactic protein-1 (MCP-1); TNF and TNF. For each cytokine, the kit included 
125µl of microparticle beads coated with capture antibody and 125µl of biotinylated detection 
antibody. The beads were dyed with differing concentrations of two fluorophores to generate 
distinct bead sets that could be differentiated by the Luminex 100 plate reader (Luminex 
Corporation, USA).  
The beads were vortexed for 30seconds to separate them into singlets then 125l volumes of 
all beads were mixed together with 4ml ‘bead buffer’. The resulting bead suspension was stored 
(on ice, dark) until required. 
100l BSA/Tween buffer (1% (w/v) BSA in 0.05% (v/v) Tween in PBS) was added to each 
well of the Luminex plate to moisten the bottom of the plate. The plate was attached to a 
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Millipore vacuum pump to remove the wash through the bottom of the plate. 50l of sample (or 
standard) were added to the plate followed by 25l of the bead suspension. The plate was 
covered and shaken for 2hours at room temperature.  
During the incubation period, the biotinylated antibody solutions were mixed and diluted in 
22ml ‘assay buffer’. The solution was kept on ice until required. After the 2hour incubation the 
plate was washed six times using the Millipore vacuum pump. 100l antibody solution were then 
added to each well and the plate shaken for 1hour. During the incubation period, the streptavidin-
phycoerythrin (S-PE) solution was prepared by dilution of the stock supplied in 22ml 
BSA/Tween buffer. Following the 1hour incubation, the plate was washed four times and 100l 
S-PE solution added to each well. The plate was shaken for 30minutes then analysed using the 
Luminex 100 machine which distinguished the analytes according to their microparticle bead 
fluorescences and measured the amount of analyte bound on the basis of PE median fluorescence 
intensity (MFI). 
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2.6 RNA ISOLATION AND POLYMERASE CHAIN REACTION (PCR) 
2.6.1 RNA isolation 
Total ribonucleic acid (RNA) was isolated by TRizol chloroform extraction with isopropyl 
alcohol precipitation of RNA. At the timepoint of interest post-inoculation, cells in 24-well plates 
(8x104 cells/well), were washed once with PBS and harvested in 1ml TRizol reagent 
(Invitrogen) per well into 1.5ml RNase free microfuge tubes. Samples were either stored at -80C 
or RNA isolated immediately. If processed on a different day, samples of cell lysates in TRizol 
were first thawed and equilibrated to room temperature. To isolate RNA, 200l chloroform 
(Sigma) were added, the mixture vortexed for 15seconds then incubated (2-3min, room 
temperature) before centrifugation (15mins, 15294 x g, 4C) to separate the aqueous and 
hydrocarbon layers. The upper aqueous layer was transferred into a clean 1.5ml RNase free 
microfuge tube and 500l isopropyl alcohol (Sigma) added. Following incubation (10mins, room 
temperature) samples were frozen at -80C for a minimum of 1hour or overnight. Samples were 
allowed to thaw then were centrifuged, (10mins, 15294 x g, 4C). Supernatants were removed 
and the pellets washed in 1ml ethanol; this involved a brief vortex followed by centrifugation 
(5mins, 5974 x g, 4C) to pellet the RNA. Supernatants were removed and pellets allowed to air-
dry before resuspension in 15l RNase free water.  
Samples were DNase treated using the ‘DNA-free DNase treatment and removal kit’ 
(Ambion) according to the manufacturer’s instructions: Buffer and DNase were diluted 1 in 10 in 
the RNA (1.5l of each added to the RNA) and incubated (30mins, 37C). Inactivator was added 
at 1 in 10 dilution (1.5l) and pulse vortexed to mix. Inactivator was removed by centrifugation 
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(2mins, 10621x g) followed by transfer of the RNA to a clean 1.5ml RNase free microfuge tube. 
The RNA concentration was measured using a Nano-drop 3300 fluorospectrometer.  
 
2.6.2 cDNA synthesis 
cDNA was synthesised from 125ng RNA. Samples with and without the reverse transcriptase 
enzyme were prepared in parallel to permit verification that expression measured was due to 
mRNA and not contaminating DNA. 20l cDNA reactions were prepared comprising: 8l 10mM 
dNTPs, 2l 50mM MgCl2, 2l 10X PCR buffer, 1l oligo dT, 1l RNase inhibitor, 1l MuLV 
reverse transcriptase (or pure water) (all from Applied Biosystems), 5l 125ng RNA diluted in 
pure water. All components were mixed and cDNA synthesised by a heating program of 42C for 
1hour followed by 95C for 5min. On completion of the program, samples were held at 4C.  
 
2.6.3 PCR   
 Laminin messenger RNAs (mRNA) for the main endothelial laminin chains including 4, 
5, 1, 2 and 1, were amplified by polymerase chain reaction using primers designed with the 
aid of the NCBI Primer designing tool (Table 2.2). Desalted laminin primers (Invitrogen) were 
reconstituted in pure water to a final concentration of 200ng/l. 25l PCR reactions were 
prepared comprising: 5l 5X GoTaq buffer (Promega), 0.5l forward primer, 0.5l reverse 
primer, 0.5l 10mM dNTPs (Bioline), 0.5l cDNA, 0.25l GoTaq DNA Polymerase (Promega), 
17.25l pure water. Amplification of -actin mRNA was used as an endogenous control and the 
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KSHV viral FLIP mRNA as a positive control for KSHV-infection. PCR reaction mixtures for 
these two controls were prepared according to the volumes used for PCR of the laminin 
transcripts although primer concentrations were unknown. vGPCR mRNAs were amplified using 
1.0l cDNA as opposed to 0.5l, volumes of all other PCR-reaction components were as for the 
laminin PCRs. Conditions of PCR amplification were: 2minutes at 95C, followed by between 21 
and 35 PCR cycles (Table 2.2) involving: chain separation (1min, 95C), primer annealing 
(45secs, primer-specific temperature (Table 2.2)) and elongation (45secs, 72C). Reactions were 
held at 72C for a final 7minutes then held at 4C. The number of PCR cycles was dependent 
upon the gene of interest (Table 2.2) and was such that differences in abundance would be 
evident from the ethidium bromide gel eletctrophoresis of the PCR product as determined by 
titration of cDNA into the reaction mixture across a range of cycle numbers.  
1% (w/v) agarose ethidium bromide gels (50ml) were prepared from electrophoresis grade 
agarose powder (Invitrogen) dissolved in 0.5x Tris-Borate-EDTA (TBE) buffer (0.5x TBE was 
prepared from a 10x TBE stock (108g tris base/litre; 55g boric acid/litre; 7.44g EDTA/litre). To 
prepare one gel (50ml), 0.5g agarose was dissolved in 50ml 0.5x TBE by heating in the 
microwave (3mins, 600W). Once the gel had cooled to hand temperature 2.5l ethidium bromide 
were added and the gel poured into a cast into which a comb had been positioned. Once the gel 
had set, the comb was removed and the gel submerged in 0.5x TBE running buffer. 5l 6x 
loading dye was added to the PCR samples and the samples loaded onto the gel. It was desirable 
to be able to use a similar exposure for visualisation of all transcripts; therefore the volumes of 
product loaded varied between transcripts (Table 2.2). A 100bp molecular ladder (Bio Labs) was 
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run in the first lane for determination of the product sizes. The gel tank was connected to a power 
supply (Bio-Rad powerpac 200) and the PCR products separated at 90V for 50minutes.  
The bands were visualised using a Gene Genius Bio Imaging System machine together with 
Genesnap (from Syngene software) and an image captured. The intensities of the product bands 
were measured using ImageJ software and the intensity of a control region above each band was 
subtracted. Results were finally normalised to that of the endogenous control gene (-actin).  
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Table 2.2: Primer sequences and conditions for PCR 
Target mRNA Primer (5’-3’) 
Amplicon 
length (bp) 
Annealing 
temp (C) 
Number of 
PCR  
cycles 
Volume 
loaded on 
EtBr  
agarose gel 
(l) 
LAMA4  Forward GCGCAGCCACCTCGGGATAC 
441 65 29 10.0 
LAMA4 Reverse CCGCTGGCAGTGCACACAGT 
LAMA5  Forward GCACCCCACGGGATCTTGCC 
563 65 30 14.0 
LAMA5 Reverse GGTCGACTTGGAGCGGGCAC 
LAMB1  Forward CGTGGAGTGCCGAGCCTGTG 
336 65 27 10.0 
LAMB1 Reverse GGGCTCTGCGCCAGGATGTC 
LAMB2 Forward GCAGGCTATACGGGGCTGCG 
454 65 30 12.5 
LAMB2  Reverse CGTTGCAGGTGGGGCCTCTG 
LAMC1  Forward GCCCGAGCTGATGCTGCCAA 
563 65 28 12.5 
LAMC1  Reverse AGCTGCCCCAGCTGCTCCAA 
-actin  Forward CATCACCATTGGCAATGAGC  
55 21 12.5 
-actin  Reverse CGATCCACACGGAGTACTTG  
vFLIP  Forward ATGGCCACTTACGAGGTTCT  
65 29 10.0 
vFLIP  Reverse ACGTGGAGAACAGTGAGCTG  
vGPCR  Forward CCCGTCAGGGGAGTGACAAG  
62 35 14.0 
vGPCR  Reverse CCAGACCTAACACACCCCTGTC  
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2.7 IMMUNOFLUORESCENCE ASSAY  
2.7.1 Immunofluorescence assay for LANA-1 following inoculation of HUVEC with 
BCBL-1 derived KSHV 
Cells were detached from the culture plate using trypsin and transferred to 15ml tubes. PBS 
was added to a total volume of 13ml and cells pelleted (5mins, 500 x g). The supernatant was 
decanted, cells resuspended in the residual volume and spotted onto a well of an IFA Multitest 8-
well slide (MP Biomedicals). Before the suspension dried, it was observed under a light 
microscope to ensure that the density of seeding was appropriate and suspension was added or 
removed as necessary. Generally ~3l were required. For each test, two wells were spotted to 
enable both LANA-1 and control staining (secondary antibody only) to be performed for each. 
Alongside each experiment, two wells of BCBL-1 cells were spotted to serve as a positive control 
for LANA-1 staining. Slides were set up in duplicate.  
Once spotted, slides were left to air-dry (5-10mins, room temperature) and cells fixed by 
immersing the slide in ice-cold 1:1 acetone-methanol solution (5mins). Once dry, slides were 
stored at 4C until staining.  
Solutions required for staining were freshly prepared on the day of staining. In order that 
different solutions could be contained over each of the eight wells during staining and smaller 
volumes of antibody used, a wax grid was drawn around the eight wells on each slide using a wax 
pen (Dako). Cells were permeabilised by incubation in 0.2% (v/v) Triton X-100 detergent in PBS 
(30mins, room temperature) and non-specific antigen binding sites blocked by incubation in 3% 
BSA (w/v) in PBS (3%PBSA) (15mins, room temperature). Slides were blotted on tissue to 
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remove excess solution and 20l of either primary antibody (mouse anti-LANA-1) (Table 2.1) 
diluted in 3%PBSA or 3%PBSA (secondary antibody only negative control) applied to each well 
for positive or negative staining respectively. Slides were incubated in a humidified chamber (1h, 
37C) then excess antibody washed off by swirling the slides twice in a beaker containing 0.1% 
BSA (w/v) in PBS (0.1%PBSA). Slides were blotted on tissue and 20l secondary antibody (goat 
anti-mouse IgG conjugated to Alex Fluor 594) (Table 2.1) diluted in 3%PBSA were then applied 
to each well, both positive staining and negative control wells, and the slide incubated in the 
humidified chamber (60mins, 37C). Slides were washed twice in 0.1%PBSA and the cell nuclei 
counterstained with 20l DAPI (1g/ml diluted in PBS) applied to each well (5mins, room 
temperature, dark). Excess stain was washed off by swirling the slides in a beaker of distilled 
water. Once dry, slides were mounted using Citifluor (Citifluor Ltd) and sealed with nail varnish. 
Slides were stored at 4C and viewed on a Nikon Eclipse E600 flurorescence microscope using a 
40x oil immersion objective lens.  
 
2.7.2 Immunofluorescence assay for analysis of LANA-1 dots and coincident GFP 
expression in rKSHV.219-infected HUVEC 
24hours post-inoculation, HUVEC in -slide IV channels (Ibidi, Thistle Scientific) were 
fixed with 4% (w/v) formaldehyde (15minutes, room temperature), permeabilised with 100% 
(v/v) methanol (10minutes, -20°C), washed with PBS and blocked with 5% (v/v) goat serum in 
PBS for 1hour. The blocking buffer was aspirated and cells incubated with rat anti-LANA-1 
unconjugated primary antibody (Table 2.1) (overnight, 4C). Cells were washed three times with 
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PBS and incubated with Alexa Fluor 633-conjugated goat anti-rat IgG secondary antibody (Table 
2.1) (1-2hours, room temperature, dark). Excess antibody was removed through five washes with 
PBS. Bisbenzimide (2g/ml) (Sigma) was included in one wash to stain nuclei. Channels were 
coated with ProLong Gold anti-fade mountant (Invitrogen, Molecular Probes) prior to 
visualization. Images were captured on a Zeiss LSM510 confocal microscope fitted with a water 
immersion, 63x objective lens and analysed using ImageJ software. This analysis involved 
determining whether cells expressed GFP and/or stained positively for LANA-1. The number of 
LANA-1 dots was also recorded for each cell.  
 
2.7.3 Immunofluorescence assay for analysis of actin cytoskeleton organisation 
and focal adhesion (vinculin) distribution in KSHV infected HUVEC 
HUVEC were plated at a density of 7.4x104 cells/24-well in 420l culture medium and 
inoculated with KSHV the following day at MOI10. Six days post inoculation, eight-chamber 
slides (BD Falcon) were gelatin-coated using a 1% (w/v) gelatin solution. Cells were detached 
from the inoculation plate using trypsin and pelleted in 1.5ml microgfuge tubes (5mins, 425 x g). 
Cells were resuspended in culture medium, 1320l per original 24-well and 200l aliquoted to 
each of six wells of an eight-chamber slide forming a sparse distribution of cells in each well. 
Spare wells were filled with 200l medium to avoid loss of media from cell-containing wells by 
capillary action. Cells were cultured for 24hours. On day-seven post-inoculation the medium was 
removed, cells washed once with 200l PBS and fixed in 300l 4% (w/v) formaldehyde (room 
temperature, 15mins). Fixative was removed and cells covered with 200l PBS. Slides were 
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either placed in the fridge wrapped in cling film and foil to prevent evaporation or were stained 
immediately.  
To stain, chambers were removed from the slides using the tool provided and moisture 
carefully removed from the divisions using a cotton bud. The divisions were then drawn over 
using a wax pen (Dako). Once dry, slides were washed once in a beaker of PBS then immersed in 
0.1% (v/v) triton X-100 (diluted in PBS) for exactly 4minutes. Slides were washed once in a 
beaker of PBS, the backs of the slides were dried with paper towel and surplus PBS removed 
from the tops of the slides using a cotton bud to absorb the liquid but taking care not to touch the 
cells. Slides were placed on a rack and 100l 4% (w/v) BSA in PBS (4%PBSA) aliquoted to each 
‘well’ created by the wax divisions. Cells were blocked at room temperature for 1hour. The 
4%PBSA solution was removed and cells incubated (50mins, room temperature, dark) with 100l 
primary antibody diluted in 4%PBSA or 4%PBSA only (unstained control). Primary antibodies 
used included mouse anti-vinculin and mouse IgG1 isotype control (Table 2.1). Staining was 
performed in duplicate.  
Next, slides were washed in a jar of PBS and dried using cotton buds to remove surplus PBS. 
Cells were incubated (40mins, room temperature, dark) with 100l secondary antibody staining 
solution containing: Alexa Fluor 633 goat anti-mouse IgG secondary antibody (Table 2.1); 
Phalloidin-tetramethylrhodamine B isothiocyanate (diluted 1 in 500) (Sigma); bisbenzimide 
(2g/ml) (Sigma) diluted in 4%PBSA solution. Slides were washed in a jar of PBS and then 
rinsed in a jar of distilled water, dried and mounted with ProLong Gold anti-fade mountant 
(Invitrogen, Molecular Probes). Slides were left to air dry at room temperature, in the dark, for 
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24hours then sealed with nail varnish and stored at -20C until viewing on a Zeiss LSM510 
confocal microscope with a water immersion 63x objective lens. Images collected were analysed 
using Image-Pro and ImageJ software. Conditions of capture for Rhodamine-labelled Phalloidin 
staining of filament actin (F-actin) were such that pixel intensity values were less than 255. 
2.8 SIRNA TRANSFECTION OF HUVEC 
2.8.1. Sources and preparation of siRNA. 
Three siRNAs to target laminin-4 chain mRNAs were chosen from the Sigma catalogue on 
the basis that they should target a region common to all laminin-4 chain mRNA variants (Table 
2.3). These siRNAs (10mol) were received lyophilised and were resuspended in 100l RNase 
free water (Qiagen) to a concentration of 100M. To distinguish between the three siRNAs they 
were assigned the letters A, B and C. 50l of each one was diluted to 20M with RNase free 
water, aliquoted and stored at -80C as the working stock. The remainder (50l) was stored at -
80C.  
AllStars negative control siRNA conjugated to Alexa Fluor 647 (20mol) (Qiagen) (Table 
2.3) was received lyophilised and resuspended in 1ml RNase free water (Qiagen) to a 
concentration of 20M. This was aliquoted and stored at -80C as the working stock. 
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Table 2.3: siRNA duplexes 
siRNA Duplex sequence Catalogue number Company 
Laminin-a4 
siRNA-A 
CUCAGCGGUUGGCAGGCAA[dT][dT] 
ASUUGCCUGCCAACCGCUGAG[dT][dT] 
SASI_Hs02_00324004 Sigma 
Laminin-a4 
siRNA-B 
GGGAGCUCAGCGGUUGGCA[dT][dT] 
ASUGCCAACCGCUGAGCUCCC[dT][dT] 
SASI_Hs02_00324005 Sigma 
Laminin-a4 
siRNA-C 
CUCAGCGGUUGGCAGGCAA[dT][dT] 
ASUUGCCUGCCAACCGCUGAG[dT][dT] 
SASI_Hs02_00324014 Sigma 
AllStars 
Negative 
Control 
siRNA 
AF647 
- 1027295 Qiagen 
 
2.8.2 Assay to examine the impact of laminin-4 knockdown on the transmigration 
of HUVEC and their intracellular synthesis and deposition of the laminin-4 chain.  
 HUVEC were plated in 46-48 wells of 24-well platesat 3.8x104 cells/24-well. The next day, 
cells in half of the wells were inoculated with KSHV at MOI10. On day-five post-inoculation, 
cells were detached using trypsin. Cells from like cultures were pooled. Cells were re-plated in 
24-well plates at 3.8x104 cells/well in HUVEC culture medium without antibiotics such that one 
well of cells could be used for each repeat of an assay (transmigration, ELISA or flow 
cytometry). On day-six post-inoculation, cells were transfected with siRNA at 100nM. 
Transfection conditions for each of KSHV-inoculated and untreated cultures included: RNAse 
free water (2 wells for flow cytometry), AllStars negative control siRNA conjugated to Alexa 
Fluor 647 (2 or 3 wells for transmigration assay, 4 wells for ELISA), siRNA C to laminin-4 (2 
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or 3 wells for transmigration assay, 4 wells for ELISA, 1 well for flow cytometry) and siRNA B 
to laminin-4 (2 or 3 wells for transmigration assay, 4 wells for ELISA, 1 well for flow 
cytometry). A sufficient volume of each transfection condition was prepared to transfect all wells 
requiring identical treatment. 
To prepare 300l of transfection solution (amount for 1 well), 1.5l siRNA (20M working 
stock) was added to 32.5l Optimem (Gibco, Invitrogen) and in a separate tube, 0.6l 
RNAiMAX Lipofectamine (Invitrogen) was added to 5.4l Optimem. The two were incubated at 
room temperature for 10minutes then combined, flicking the tube gently to mix. The mix was 
incubated for a further 10minutes at room temperature for complexes to form. During this time, 
HUVEC to be treated were washed twice with 500l PBS. 260l Optimem were then added to 
the siRNA-Lipofectamine mix and pipeted gently to give a uniform suspension. PBS was 
removed from the cells and transfection solution (300l) added. The cells were then cultured for 
4hours. Transfection solution was removed and the cells washed twice with 500l HUVEC 
culture medium without antibiotics. The cells were cultured overnight then re-transfected, 
following the same protocol, on the morning of day-seven. Following removal of the transfection 
solution, the cells were given a brief recovery period (45mins) before removing them from the 
transfection plates using trypsin in order to transfer them into the transmigration assay or into a 
96-well plate to verify knockdown of laminin-4 deposition by ELISA. Cells to be processed for 
verification of laminin-4 knockdown by flow cytometry were left in the transfection plate until 
the end of the experiment.  
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To conserve cells, they were pelleted (5mins, 425 x g) in 1.5ml microfuge tubes rather than 
15ml centrifuge tubes. Cell pellets were resuspended in HUVEC culture medium without 
antibiotics, 200l per original 24-well for plating into the transmigration assay or 120l for 
plating into the ELISA. Culture medium was aliquoted to six additional wells on the ELISA plate 
for measurement of background signal. The transmigration assay was ended after 48hours and 
filters prepared for analysis of percent transmigration (section 2.3.1). The ELISA was developed 
after 40hours and laminin-4 and fibronectin deposition assessed (section 2.4). Each condition 
examined by ELISA was restricted to analysis in duplicate rather than triplicate due to limited 
cell numbers. Assessment of fibronectin content was included in order to control for possible 
differences in cell number across the multiple treatments, since it was a concern that the siRNA 
treatments could affect the efficiency with which cells re-plated. The efficiency of knockdown 
was also examined by assessment of intracellular laminin-4 content by flow cytometry at 
40hours (section 2.2.4.1). Since the secondary antibody available and suitable for detection of 
laminin-4 in the GFP positive, rKSHV.219-infected cells was conjugated to Alexa Fluor 633, it 
was not possible to use the AllStars negative control siRNA (Qiagen) that was available in the lab 
for this assay as this was conjugated to Alexa Fluor 647. Therefore, the control transfection for 
flow cytometry was performed using water in place of siRNA. This was considered appropriate 
since by ELISA the AllStars negative control did not appear to disrupt laminin-4 transcription 
and secretion.  
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2.9 IMMUNOFLUORESCENCE IMAGE ANALYSIS 
2.9.1 Measurement of cell shape parameters 
Measurements of cell shape parameters including: area, perimeter, roundness and mean 
intensity of phalloidin staining (related to the amount of F-actin) were made from confocal 
images of phalloidin-stained cells using Image-Pro software. Working with the ‘Count/Size’ 
facility, the image was thresholded for observation of intensities in the range 1-255 and the ‘8-
connect’ and ‘fill holes’ settings were applied in order to create a mask of the cell. The lowest 
area limit by which objects within the range for analysis were defined was also increased until a 
single object was within range (by increasing the lower limit, small spots of debris/background 
staining were excluded). Once the cell of interest was counted as a single object (the ‘irregular 
AOI’ tool was used to select the cell of interest when more than one was present on an image) the 
data for the measurements of interest, as highlighted in the ‘set measurements’ menu, were 
exported to Excel.  
 
2.9.2 Concentric ring analysis of F-actin distribution 
A macro was devised in Image-Pro by David Kelly (Wellcome Trust Centre for Cell Biology, 
University of Edinburgh, UK) to quantify F-actin distribution within cells in order to study the 
possibility that KSHV infection redistributes F-actin. The macro divided the cell into four 
concentric rings of equal area and reported the total intensity of staining in each (Figure 2.7). 
The data for area and intensity were reported as cumulative values. Therefore, after exporting the 
results to Excel, the area and total fluorescence intensity associated with each ring was calculated 
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(i.e. area of ring 4 = (sum of areas of rings 1, 2, 3 and 4) – (sum of areas of rings 1, 2 and 
3)).Total intensity values for each ring were plotted normalised for ring area. 
 
 
Figure 2.7: The principle underlying the macro devised in Image-Pro for concentric ring 
analysis of F-actin distribution.  
Images of HUVEC stained with rhodamine-phalloidin were opened in Image-Pro and the macro 
for concentric ring analysis of F-actin distribution, that had been written in this software, was 
performed. Steps involved thresholding the image then selecting the cell of interest from among 
those on the image. Next the software divided the cell into four concentrically arranged rings of 
equal area (rings 1-4). The total intensity of rhodamine fluorescence in each of the four rings was  
determined from total intensity values reported that were the sums of the intensities in rings 1-4; 
1-3; 1-2 and 1. In the same way, the area of each ring was calculated (artoon not to scale). 
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2.9.3 Concentric ring analysis of F-actin distribution based on intensity line 
profiles for rhodamine-phalloidin  
A method was devised with ImageJ to quantify F-actin distribution within cells and study the 
possibility that KSHV infection redistributes F-actin. For greater clarity, a full description of the 
method is given in the figure legend (Figure 2.8).  
 
2.9.4 Analysis of focal adhesion size, number and distribution based on 
immunofluorescence assay for vinculin. 
Images were analysed using Image-Pro. Images were opened in Image-Pro and thresholded to 
clear background specs that fluoresced within the range examined, as well as cytoplasmic, 
perinuclear vinculin not recruited to focal adhesions, and establish sizes of focal adhesion 
structures. The ‘irregular AOI’ tool was used to draw around the region containing the focal 
adhesions of the cell of interest (comparison with the image of Phalloidin staining of F-actin for 
the same cell helped ascertain cell boundaries when cells neared their neighbours). The count 
facility under ‘Count/Size’ was used to count the number of focal adhesions using a minimum 
size boundary of 0.3m. Measurements of the area of each structure were also exported to Excel 
and the total area covered by focal adhesions was calculated (Figure 2.9). From knowledge of 
cell area and perimeter length, focal adhesion number and total area could be normalised to 
parameters of cell size.  
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Figure 2.8: Strategy for concentric ring analysis of F-actin distribution based on intensity 
line profiles of rhodamine-phalloidin staining. 
Images of HUVEC stained with rhodamine-phalloidin were opened in ImageJ and thresholded to 
establish the areas of the individual cells . The wand ‘tracing tool’ was used to highlight the cell 
of interest and the midpoint (x,y) coordinates for the cell were determined. A new copy of the 
image was opened and a line passing through the midpoint was drawn for the longest axis 
between the leading and trailing cell edges. A line through the midpoint and perpendicular to this 
longest axis was then drawn and the profile of the intensity of rhodamine-phalloidin staining 
along this short axis generated. The list of values was exported to Excel. The line drawn 
protruded beyond the edge of the cell. In the protruding regions intensity values were zero. To 
divide the line profie into five concentric rings to measure the distribution of F-actin across the 
cell, the total number of intensity values reported between the first positive value and the last 
positive value was divided by ten. This gave the number of intensity values to attribute to each 
segment of the profile. When the total number of intensities was not a multiple of ten, the start 
and end intensities associated with the segment were multiplied by the fraction that they were to 
contribute. For example if 9.5 values were included in each segment, the value given to segment 
1 was the sum of intensities 1 to 9 + (0.5 x intensity value 10). The value given to segment 2 was 
(0.5 x intensity value 10) + the sum of intensities 11 to 19. To account for differences in cell 
dimensions, these values were normalised by dividing the total intensity by the number of 
intensity values per segment. The concentric rings 1 to 5 were arranged such that 1 was innermost 
and 5 outermost. The intensity associated with each was the average intensity (normalised for 
width) for the contributing segments. Ring 1 = segments 5 and 6; ring 2 = segments 4 and 7; ring 
3 = segments 3 and 8; ring 4 = segments 2 and 9 and ring 5 = segments 1 and 10). Average 
normalised phalloidin intensity was plotted against ring number. 
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Figure 2.9: Strategy for analysis of focal adhesion size and number. 
(A) Images of HUVEC stained for vinculin were opened in Image-Pro and thresholded to identify 
the peripheral focal adhesions distinct from background and cytoplasmic/perinulear vinculin. The 
focal adhesions associated with the cell of interest were isolated using the area of interest tool. 
Images of the cells stained with rhodamine-phalloidin to identify F-actin helped to clarify the 
focal adhesions associated with the cell (B). The number and areas of the focal adhesion 
structures (>0.3m) were determined using the ‘Count/Size’ facility.  
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2.10 ANALYSIS OF THE EFFECT OF KSHV-INOCULATION UPON CELL DENSITY 
OVER TIME. 
HUVEC were plated in -slides VI channels (Ibidi, Thistle Scientific) (5.5x104 cells per 
60mm2 channel). Following overnight incubation, monolayers were imaged then inoculated with 
KSHV at MOI10. At timepoints up to day-ten post-inoculation, phase contrast, GFP fluorescence 
and RFP fluorescsence images were taken along the length of the monolayer. The monolayer was 
viewed with the 4x objective lens. After imaging, monolayers were washed four times with 
complete medium and images retaken of the monolayer so that the number of lytic cells that had 
not been washed out could be subtracted from the number observed at the next timepoint and the 
extent of lytic reactivation between timepoints calculated. 
The number of viable cells per complete image was too great to count manually. Therefore, 
areas of interest were positioned automatically onto the phase contrast image at six sites and the 
number of cells within the enclosed region counted using the ‘manual tag’ facility in Image-Pro. 
The number of cells counted was converted to a density of cells per mm2 (Figure 2.10). 
The number of lytic cells was determined from RFP fluorescence pictures. The images were 
thresholded and an automated count of the number of objects in the image performed using a size 
restriction of greater than 15m2 that would allow exclusion of background specs (Figure 2.10)  
Ibidi -slides were used for this study in preference to multi-well plates because:  
 Assessments of cell density over time were less sensitive to differences in the precise 
field of observation at each timepoint since HUVEC formed monolayers of uniform 
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density across the growth surface of -slide channels whereas in multi-well plates, 
cell density was higher in the centre and at the very edge of the well.  
 Optical interference in multiwell plates meant that only a proportion of the growth 
area near to the centre of the well could be viewed whereas in -slide channels the full 
growth area was observable.  
 The improved optics with -slides enabled the 4x objective lens to be used as opposed 
to the 10x or 20x lenses required for 24-well or smaller multi well plates. Using the 4x 
objective lens, only one image (phase contrast) or two images (RFP fluorescence) had 
to be captured at each timepoint in order to count sufficient cells. This was important 
considering the time taken to change the image capture conditions and acquire the 
fluorescence images for each of GFP and RFP in addition to phase contrast.  
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Figure 2.10: Strategy for analysis of viable and lytic cell densities. 
(A) Phase contrast images of HUVEC monolayers in -slide VI channels were opened in Image-
Pro and six areas of interest (0.07mm2) superimposed onto the image. The number of cells within 
each region was counted and converted to number of cells per mm2. (B) Images (0.98mm2) of the 
RFP fluorescent cells generated in HUVEC monolayers due to lytic reactivation were opened in 
Image-Pro and thresholded. The number of RFP positive cells was counted applying a size 
restriction of greater than 15m2 to exclude objects considered too small to be cells. The number 
of cells counted was converted to number per mm2. 
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2.11 ASSAY TO EXAMINE HORIZONTAL TRANSMISSION OF INFECTION 
THROUGH KSHV-INOCULATED HUVEC MONOLAYERS 
To determine if KSHV was transmitted horizontally through HUVEC monolayers, 
rKSHV.219 inoculated cells were co-cultured with untreated cells that had been labelled with a 
fluorescent tracer. In this way KSHV transmission to untreated cells could be identified by their 
dual fluorescence for GFP and the dye tracer. The methods are described below. 
Ten wells of a 24-well plate were seeded with HUVEC (9x104 cells/well) yielding a confluent 
monolayer overnight and three wells were inoculated with KSHV (MOI10) the next day. The 
remaining seven wells were left untreated. Either 2hours or three days post-inoculation, four 
wells of untreated HUVEC were labelled with the far-red fluorescent tracer, DDAO-SE 
(Invitrogen, Molecular Probes), which is a dye tracer  suitable for long-term cell labelling.  
Staining with DDAO-SE was done in the plate and involved: washing the monolayer twice 
with 1ml PBS to remove traces of serum in the culture medium, since serum proteins will quench 
the dye; incubating the cells in 200l dye (5M) solution (40mins, 37C); removing the dye 
solution; washing the monolayer with 500l culture medium; culturing in 1ml culture medium 
(20min); changing the medium and culturing for a further 2hours in a second 1ml volume of 
culture medium. Such prolonged and serial washes were to ensure full quenching of excess dye 
before mixing of cell populations.  
HUVEC in the ten wells (three KSHV-inoculated, non-labelled; four untreated, DDAO-SE-
labelled; three untreated, non-labelled) were then detached using trypsin and resuspended in 
300l culture medium per original well. 600l of cell combinations (i-v below) were prepared 
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and 300lfrom each aliquoted to a 48-well plate. The remainder was transferred to FACS tubes 
and fixed in 2% (w/v) formaldehyde for analysis by flow cytometry in parallel with the cultures 
after five-days of co-culture as a measurement of the starting/background percentages of each cell 
type (non-labelled, non-infected; non-labelled, KSHV-infected, DDAO-SE-labelled, non-
infected, DDAO-SE-labelled, KSHV-infected) within each culture.  
The culture plate was covered with silver foil due to the light-sensitivity of the dye and the 
cells cultured for five days. The culture medium was changed on day-two according to normal 
culturing procedures. Cells were detached from the culture plate on day-five and fixed in 2% 
(w/v) formaldehyde for analysis by flow cytometry using a Dako Cyan flow cytometer and 
analysed using Dako Summit 4.3 software.  
The single population controls and co-culture of non-labelled untreated and DDAO-SE-
labelled, untreated HUVEC were included to verify that the cells concluded as having been 
infected by transmission of KSHV-infection were unlikely to be products of  dye transfer or 
generous positioning of the gates in the analysis. In the analysis of the flow cytometry data, the 
GFP positive gate was set such that for non-labelled, untreated HUVEC at the end of five days of 
co-culture with KSHV-inoculated HUVEC, 1% of cells were GFP positive. The DDAO-SE 
positive gate was set such that for DDAO-SE-labelled, untreated HUVEC at the end of five days 
of culture, 99% of cells were DDAO-SE positive.  
Cell combinations assayed included: (i) non-labelled, untreated; (ii) DDAO-SE-labelled, 
untreated; (ii) non-labelled, KSHV-inoculated; (iv) non-labelled, untreated + DDAO-SE-labelled, 
untreated (1:1); (v) DDAO-SE labelled, untreated + non-labelled, KSHV-inoculated (1:1). 
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2.12 MICROSCOPES USED: 
Unless otherwise stated, the microscope used for phase contrast and GFP, RFP and UV 
(bisbenzimide) fluorescence imaging was an Olympus 1X70 invert microcope fitted with a 
Lumen 200 bulb (PRIOR) and Qicam Qimaging fast 1394 camera. The imaging software was 
Image-Pro Version 6.2. Image-Pro Version 7 was also used for offline analysis. 
 
2.13 STATISTICS 
Graphs were created using GraphPad Prism 3.02 or Excel 2007. Error bars represent the standard 
error of the mean (SEM). Parametric statistical tests were performed using GraphPad Prism 3.02 
following testing to confirm that the data were normally distributed using the Kolmogorov-
Smirnov (KS) test. To test for differences between the means of two populations, two-tailed 
paired or unpaired t-tests were performed. Where data for KSHV-infected and non-infected 
populations had been normalised to that of the untreated control population, t-tests comparing to 
a value of one were used. Two way Analysis of Variance (ANOVA) was performed to test the 
effects of both time and virus inoculation on a variable. One way ANOVA was used to test the 
effect of virus treatment (untreated, non-infected and KSHV-infected) on a variable. This was 
followed by Bonferroni’s multiple comparison post-hoc analysis to investigate which populations 
were significantly different. Pearson Product Moment Correlation Coefficients were calculated to 
test for correlation between two variables. Coefficients of variance, were calculated from the 
statistic: [Coefficient of variance = (standard deviation ×100)/(mean × √n)], where ‘n’ is the 
number of experiments. 
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2.14 SUPPLIERS OF THE REAGENTS, EQUIPMENT AND SOFTWARE USED IN 
THESE STUDIES  
Table 2.4: Addresses for the suppliers of equipment, reagents and software used in these 
studies 
Supplier Address 
AbD Serotec Endeavour House, Langford Lane, Kidlington, OX5 1GE, UK 
Advanced Biotechnologies Advanced Biotechnologies Inc, 9108 Guilford Rd, Columbia MD 21046-
2701, USA 
Becton Dickinson (BD) The Danby Building, Edmund Haley Road, Oxford Science Park, 
Oxford, OX4 4DQ, UK 
Bioline Bioline Reagents Ltd, Unit 16, The Edge Business Centre, Humber 
Road, London, NW2 6EW 
New England BioLabs New England BioLabs , 75-77 Knowl Piece, Wilbury Way, 
Hitchin, Herts, SG4 0TY 
BioLegend 
BioLegend UK Ltd, Munro House, Trafalgar Way, Bar Hill, Cambridge, 
CB23 8SQ, UK 
Calbiochem Merck Chemicals Ltd, Boulevard Industrial Park, Padge Road, Beeston, 
Nottingham, NG9 2JR, UK 
Chemicon, Millipore Millipore (U.K.) Limited, Suite 3 & 5, Building 6, Croxley Green 
Business Park, Watford, WD18 8YH 
Citifluor Ltd 18 Enfield Cloisters, Fanshaw Street, London, N1 6LD, UK 
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Dako Flow Cytometry Products and Specific Proteins, Alere Ltd (formerly 
Inverness Medical UK Ltd), Pepper Road Hazel Grove, Stockport, SK7 
5BW 
eBioscience 2nd Floor, Titan Court, 3 Bishop Square, Hatfield, AL10 9NA, UK 
Fischer Scientific Ltd Bishop Meadow Road, Loughborough, Leicestershire, LE11 5RG, UK 
Flowjo TreeStar Inc, 340 A Street Suite # 206, Ashland, OR 97520, USA  
Image-Pro Media Cybernetics Inc, 4340 East-West Hwy, Suite 400, Bethesda, 
MD, 20814-4411, USA 
ImageJ Public domain Java-based image processing program, developed at the 
National Institutes of Health 
Immunotools Altenoyther Strasse, 10, 26169 Friesoythe, Germany 
Life Technologies  
Corporation †  
5791 Van Allen Way, PO Box 6482, Carlsbad, 92008, California 
MP Biomedicals MP Biomedicals Europe, Parc d'Innovation, BP 50067,          Rue Geiler 
de Kaysersberg, Illkirch Cedex 67402, France 
PAA Laboratories PAA Laboratories Ltd, Termare Close, Houndstone Business Park, 
Yeovil, Somerset, BA22 8YG, UK 
Promega 
Delta House, Southampton Science Park, Southampton, SO16 7NS, UK 
PromoCell PromoCell, GmbH, Sickingenstraße 63/65, D-69126 Heidelberg, 
Germany, 
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Qiagen Qiagen House, Fleming Way, Crawley, West Sussex, RH10 9NQ 
R&D Systems Europe Ltd 19 Barton Lane, Abingdon Science Park, Abingdon, OX14 3NB, UK 
Santa Crtutz Santa Cruz Biotechnology, Inc, 2145 Delaware Avenue, Santa Cruz, 
California 95060, U.S.A 
Santa Cruz Biotechnology, Inc, Bergheimer Str. 89-2, 69115 Heidelberg, 
Germany 
Sarstedt SelectScience Ltd, Church Farm Business Park, Corston, Bath, BA2 
9AP, UK 
Sigma-Aldrich (Sigma) Fancy Road, Poole, Dorset, BH12 4QH,UK 
Thermo Scientific ABgene House, Blenheim Road, Epsom, Surrey, KT19 9AP, UK 
Thistle Scientific Thistle Scientific Ltd, DFDS House, Goldie Road, Uddingston, 
Glasgow, G71 6NZ, UK 
Vector Laboratories Inc 3, Accent Park, Bakewell Road, Orton Southgate, Peterborough,PE2 
6XS, United Kingdom  
†includes: Applied Biosystems, Gibco, Invitrogen, Invitrogen Molecular Probes (MP)
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CHAPTER THREE 
DEVELOPMENT AND CHARACTERISATION 
OF AN IN VITRO SYSTEM TO STUDY THE 
FUNCTIONAL EFFECTS OF KSHV INFECTION 
OF PRIMARY ENDOTHELIAL CELLS 
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3.1 INTRODUCTION 
In this chapter studies to optimise a protocol for the production of concentrated KSHV and 
generation of high efficiency (>50%) infection of primary endothelial cells are described. For the 
optimised inoculation conditions, the temporal changes in endothelial cell morphology, 
monolayer density and extents of latent infection and lytic reactivation are reported. Studies 
which determined the contribution of horizontal transmission of infection to the rise in percent 
infection with time post-inoculation are also described.   
Endothelial cells were the cell type chosen for the studies in this thesis into KS pathogenesis. 
This was because spindle cells, which are the major proliferative component of KS lesions, are 
infected with KSHV and are endothelial in nature, suggesting that KS development involves 
infection of an endothelial cell. It was desirable to use primary endothelial cells, as opposed to  
endothelial cell lines, for their closer physiologic relevance but previous studies that infected 
primary endothelial cells reported low (<10%) infection efficiencies (Ciufo et al., 2001; Flore et 
al., 1998; Guo et al., 2003; Sharma-Walia et al., 2005) which would be inadequate for the 
assessment of KSHV effects on endothelial cell functions. Other groups have used instead 
endothelial cell lines, which are easier to obtain, maintain and infect (Lagunoff et al., 2002; 
Moses et al., 1999).   
The aims of the initial studies in this thesis were therefore to establish a method for the 
production of infectious virus and inoculation of primary endothelial cells that would achieve 
over 50% infection. Human umbilical vein endothelial cells (HUVEC), which are macrovascular 
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primary cells, were the endothelial cell type chosen for these studies, since umbilical cords were 
available with consent from the nearby Birmingham Women’s Hospital.   
3.2 RESULTS 
3.2.1 Infection of HUVEC with BCBL-1 derived KSHV 
Infection of HUVEC with KSHV prepared from the supernatants of reactivated BCBL-1 cells 
by centrifugation (Figure 3.1A) or ultracentrifugation on a sucrose cushion (Figure 3.1B) was 
originally tested. Infection efficiencies using these virus preparations were quantified by 
immunofluorescence staining for the KSHV protein, LANA-1. Even at the lowest dilution tested 
(1:2), the virus preparations gave only ~20% infection (Figure 3.1) which was inadequate for 
functional studies. Alternative methods for KSHV production and HUVEC infection were 
therefore sought.  
3.2.2 Production of rKSHV.219 for use in infection studies 
The recombinant KSHV strain, rKSHV.219 (Vieira and O'Hearn, 2004) encodes GFP under 
the control of the human elongation factor 1- promoter and RFP under the control of the lytic 
PAN RNA promoter. Using this virus, latently infected cells become GFP positive and lytic 
infection is indicated by RFP expression; thus, KSHV-infected and non-infected cells can be 
distinguished in KSHV-inoculated cultures without relying on antibody staining of KSHV 
proteins, which expedites analysis. Collaborators at the Medizinische Hochschule, Hannover, had 
developed a method for the production of high titre rKSHV.219. We adopted and optimised this 
protocol for our purposes. 
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Concentrated rKSHV.219, hereafter referred to as KSHV, was titrated on HEK293 cells. 
Dilutions of the stock virus tested ranged between 1 in 100 and 1 in 80,000. It was assumed that 
one infectious unit generated one infected, GFP positive cell by 48hours. Monitoring the virus 
titre over time revealed a decrease in infectivity with prolonged storage at 4C (Figure 3.2). 
Titres were therefore re-determined if the virus was not used within three weeks of production.  
Next I determined whether storing aliquots of concentrated virus at -80C would maintain 
their titre. The aim was to produce high titre batches of KSHV. This approach would reduce the 
frequency of KSHV production needed and ensure consistent infection efficiency across 
experiments. One week after production, storage temperature did not affect the infection 
efficiency but by three-to-four weeks post production, storage at -80C reduced infection 
efficiency compared to storage at 4C (Figure 3.3). Virus used in the experiments in this thesis 
was therefore always stored at 4C. 
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Figure 3.1: Comparison of BCBL-1 derived KSHV preparations for infection of  HUVEC.  
KSHV from the supernatants of reactivated BCBL-1 cells was concentrated by (A) standard 
centrifugation or (B) ultracentrifugation on a sucrose cushion. The virus was diluted 2, 4 or 8-fold 
in EBM-2 medium and inoculated onto HUVEC monolayers. Four days post-inoculation the 
percent of infection was quantified by immunofluorescence assay, staining for the KSHV protein 
LANA-1. Data plotted are the mean  SEM across several fields of view for each of two 
experiments.  
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Figure 3.2: Effect of storage time upon KSHV titre.   
The titres of KSHV preparations stored at 4°C were analysed at timepoints up to twelve weeks 
post production by titration on HEK293 cells. Each line represents a different virus preparation.  
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Figure 3.3: Effect of storage temperature upon KSHV titre.  
KSHV preparations were aliquoted immediately following production and stored at 4C and        
-80C. Titres of these preparations were then assessed in parallel on HEK293 cells after one or 
three-to-four weeks storage. Week one represents the earliest titre established. Each point 
represents the test results for a separate preparation. The four preparations included in the ‘three-
to-four weeks storage category are paired with observations in the ‘one-week storage’ set.   
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3.2.3 Infection of HUVEC with rKSHV.219 
 KSHV was titrated on HUVEC with readout of percent infection on either day-three or day-
ten post-inoculation. A multiplicity of infection of 5 (MOI5) gave saturating infection (Figure 
3.4). However, since the titration assay was subject to error; KSHV titres decreased with time 
(Figure 3.2); and empirical observations had indicated variation in donor permissiveness to 
infection, HUVEC were inoculated with MOI10 for the assays performed in this thesis.  
To optimize the infection protocol, the effects of cell density were investigated. HUVEC 
monolayers, ranging in density from sparse to fully confluent, were inoculated with KSHV at 
MOI10. One-way ANOVA suggested however, that the efficiency of KSHV infection was not 
significantly altered by monolayer density (Figure 3.5) (ANOVA P>0.05).  
To characterise the temporal development of KSHV infection within the HUVEC monolayer, 
KSHV-inoculated HUVEC were observed up to day-ten post-inoculation by phase contrast and 
fluorescence microscopy. The prevalence of GFP expression was quantified by flow cytometry. 
A profound change in the morphology of infected cells from cobblestone to an elongated spindle 
shape was observed by day-three post-inoculation and became more exaggerated with time. 
Untreated control cells maintained a cobblestone shape throughout (Figure 3.6). The extent of 
infection as determined by percentage of GFP positive cells increased with time to 80% by day-
ten post-inoculation (Figures 3.6 and 3.7A). Following an early lytic burst, peaking at day-two 
as determined by RFP expression, the extent of reactivation subsided (Figures 3.6, 3.7B and 
3.11B).  
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Figure 3.4: Effect of KSHV titre on infection of HUVEC.  
HUVEC were inoculated with KSHV at multiplicities of infection (MOI) between 1.25 and 10 
and the percent infection on eiter day-three or day-ten post-inoculation assessed by flow 
cytometry for GFP. Data are mean ± SEM for three experiments, except MOI10 with readout at 
day-ten, which was two experiments. 
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Figure 3.5: Effect of HUVEC density upon KSHV infection efficiency.  
HUVEC were plated at densities between 2.5 and 7.5×104 cells/48-well and infected with KSHV 
at MOI10. Each well had a surface area of 75mm2. The percentages of infected cells at day-seven 
post-inoculation were assessed by flow cytometry for GFP.  ANOVA did not show a significant 
effect of density (P>0.05). Data are mean ± SEM for three experiments. 
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Figure 3.6: Effect of time post KSHV inoculation on cell morphology, GFP expression and 
RFP expression.  
KSHV-infected and untreated HUVEC were cultured in -slides and imaged at regular intervals 
up to day-ten post-inoculation using a 4x objective lens. Phase contrast, GFP and RFP 
fluorescence images were taken for each field to show the overall monolayer, the distribution and 
morphology of KSHV-infected cells and the extent of ongoing lytic reactivation respectively. 
Changing of the culture medium during the course of culture removed most dead, lytic cells, thus 
RFP positive cells primarily represent those evolved since the last washing rather than the 
cumulative numbers generated by the infection. The panel shown is a time course for one 
experiment but is representative of each infection. 
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Figure 3.7: Effect of time post-inoculation on the extent of KSHV infection within HUVEC 
monolayers. 
(A) HUVEC were infected with KSHV at MOI10 and the percentage of infected, GFP positive 
cells assessed by flow cytometry at timepoints up to day-ten post-inoculation. Data are mean ± 
SEM for four experiments. (B) HUVEC seeded in -slides were infected with KSHV at MOI10 
and RFP fluorescence images of the monolayers observed using a 4x objective lens, taken at 
timepoints up to 8.5 days post-inoclation. The numbers of RFP positive cells were counted before 
and after thorough washing of the monolayer at each timepoint and the numbers of cells evolved 
since the previous timepoint calculated.  Data are mean ± SEM for three experiments.  
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To determine whether the temporal increase in KSHV-infected (GFP positive) HUVEC was 
due to productive infection (as suggested by RFP expression peaking at day-2.5) leading to 
horizontal transmission of infection, untreated HUVEC labelled with DDAO-SE were mixed 
with non-labelled, KSHV-inoculated HUVEC from the same donor either immediately following 
inoculation (day-zero) or on day-three post-inoculation and co-cultured for five days. DDAO-SE 
positive, KSHV-infected (GFP positive) cells were quantified by flow cytometry (Figure 3.8).  
Consistent with an early lytic burst, the percentage transmission of infection to untreated cells 
decreased when co-cultures were established on day-three post-inoculation compared to day-zero 
(Figure 3.9A). 35% of non-infected cells within KSHV-inoculated cultures acquired infection 
between days three and eight post-inoculation in contrast to horizontal transmission to only 3.3% 
of untreated cells (Figure 3.9B). These data suggest that the extent of infection by day-ten was 
achieved by initial inoculation, and intracellular amplification of infection over time was required 
for quantification by GFP readout. In agreement, in our laboratory we have detected LANA-1 
expression (one or more LANA-1 dots) in 38% of GFP negative cells at 24hours post-inoculation 
(Figure 3.10) (Blackbourn and Butler, unpublished data). 
An alternative explanation is that KSHV-infected cells out-proliferate non-infected cells 
within KSHV-inoculated cultures. To investigate the effect of KSHV inoculation upon HUVEC 
numbers, uniform monolayers were seeded in -slide channels, inoculated with KSHV and the 
cell density counted at regular intervals up to day-ten post-inoculation (Figure 3.11A). KSHV 
inoculation caused a progressive decrease in density after 12hours post-inoculation. The 
reduction was significant (P<0.01) compared to the starting density by 4.5 days. In contrast, 
untreated monolayers showed no significant decrease in density for the duration of the assay.  
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The window of peak lytic reactivation was between 1 and 2.5 days; thereafter lytic 
reactivation subsided (Figures 3.7B and 3.11B).  15% of the culture died due to lytic death in the 
first 2.5 days. Lytic death explained the decrease in monolayer density up to 2.5 days but by 4.5 
days did not completely account for the cell loss observed (Figure 3.11B).   
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Figure 3.8: Quantification of the extent of horizontal transmission of KSHV infection 
through HUVEC monolayers.   
DDAO-SE-labelled untreated (UT-EC) HUVEC and KSHV-inoculated (KSHV-EC) HUVEC 
were mixed and co-cultured for five days before analysing the percentage of DDAO-SE positive 
cells that were also GFP positive by flow cytometry. GFP Log v DDAO-SE Log plots are shown 
for a representative assay fixed at the start and end of the five-day co-culture period begun on 
day-three post-inoculation. In the assay, single population controls including: non-labelled UT-
EC; DDAO-SE-labelled UT-EC; and non-labelled KSHV-EC single population cultures, as well 
as a co-culture control of non-labelled UT-EC and DDAO-SE-labelled UT-EC, were established 
in parallel to verify that double positive cells were not due to dye transfer or to the positioning of 
the quadrants for analysis. The GFP positive gate was set such that for UT-EC at the end of five 
days culture, 1% of cells were GFP positive. The DDAO-SE positive gate was set such that for 
DDAO-SE-labelled UT-EC at the end of five days of culture, 99% of cells were DDAO-SE 
positive. Quantification of the data is presented in Figure 3.9A. 
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Figure 3.9: Quantification of the extent of horizontal transmission of KSHV infection 
through HUVEC monolayers. 
(A) Co-cultures of DDAO-SE-labelled untreated (UT-EC) HUVEC and KSHV-inoculated 
(KSHV-EC) HUVEC were established immediately after inoculation (day-zero) and on day-three 
post-inoculation and cultured for five days before analysing the percentage of DDAO-SE positive 
cells that were also GFP positive by flow cytometry.  Data are mean ± SEM for two (day-three) 
or three (day-zero) experiments. (B) The percentage transmission of infection to uninfected cells 
during the five days of co-culture, for cultures established on day-three post-inoculation, was 
calculated for sub-populations that were originally untreated (DDAO-SE positive) or KSHV-
inoculated (DDAO-SE negative). Data are mean ± SEM for two experiments.   
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Figure 3.10: Quantification of the number of KSHV LANA-1 dots in the nuclei of GFP 
positive and GFP negative HUVEC from KSHV-inoculated cultures at 24hours post-
inoculation.  
KSHV-inoculated monolayers were fixed at 24hours post-inoculation, permeabilised with 100% 
methanol and stained for LANA-1. Nuclei were counterstained with bisbenzimide. Fields of the 
monolayer were imaged on an inverted laser scanning confocal microscope using a 63x water 
immersion objective lens and the number of LANA-1 dots found in each nucleus counted. The 
GFP status of each cell was also recored as GFP positive or negative. Individual points represent 
separate cells across two experiments. Horizontal lines indicate the mean number of LANA-1 
dots per cell. *** =  P<0.0001by unpaired t-test.  
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Figure 3.11: Effect of KSHV inoculation upon HUVEC monolayer densities.  
HUVEC seeded in -slides were infected with KSHV at MOI10 and imaged using a 4x objective 
lens at timepoints up to day-ten post-inoculation. (A) Viable cell densities were estimated from 
counts of cell nuclei observed under phase contrast. ANOVA revealed a significant effect of time 
post-inoculation upon density of both untreated (UT-EC) (P<0.05) and KSHV-inoculated 
(KSHV-EC) (P<0.0001) HUVEC monolayers. Stars indicate significant differences in density 
compared to the starting density (day-zero) as determined by the Bonferroni’s multiple 
comparison post-hoc test. ** = P<0.01; *** = P<0.001.  (B) The numbers of RFP positive cells 
were counted before and after thorough washing of the monolayer at each timepoint and the 
number of lytic cells evolved since the previous timepoint calculated and plotted cumulatively. 
The overall effect of lytic death upon cell numbers was calculated at each of the timepoints up to 
8.5 days post-inoculation by summation of the number of viable cells present and the cumulative 
number of and lytic cells generated. Data are mean ± SEM for three experiments. 
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3.3 DISCUSSION 
This chapter described the development of a method to infect primary endothelial cells 
(HUVEC) with KSHV in order to create an in vitro system with which to study the effects of 
KSHV infection on endothelial cell functions.  
Initial attempts to infect HUVEC with virus sourced from reactivated PEL (BCBL-1) cells 
yielded inadequate infection frequencies for examining the influence of virus infection on 
endothelial cell behaviour. Infection of up to only 20% was possible (Figure 3.1). Inoculating 
with the recombinant KSHV strain, rKSHV.219, achieved instead a highly successful primary 
infection that: (1) induced a transition in cell morphology from cobblestone to spindle shape, 
reminiscent of the tumour cells in KS lesions (Figure 3.6); (2) was predominantly latent (Figure 
3.7) and (3) increased with time: ~80% of cells were infected by day-ten post infection (Figure 
3.7). Such high infection of HUVEC required a virus to cell ratio (MOI) that was five-to-ten-fold 
greater than that needed to infect HEK293 cells (Figure 3.4). Others have similarly reported 
HEK293 cells to be more permissive to KSHV infection than other cell types (Foreman et al., 
1997; Renne et al., 1998). In my hands, the efficiency of rKSHV.219 infection was not 
influenced significantly by the density of the HUVEC monolayer (Figure 3.5) and infection was 
not transforming (Figure 3.11). This finding is in contrast to that of others who inoculate cultures 
at 60-80% confluence (Ciufo et al., 2001; Gao et al., 2003; Moses et al., 1999). For its use in this 
research I also determined that rKSHV.219 infectivity is best conserved by storage at 4C 
compared to -80C (Figure 3.3).  
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The result that KSHV concentrated from PMA-induced PEL cultures gave low percent 
infection of HUVEC agreed with most previous studies which reported low (<10%) infection 
levels following inoculation of several cell types (Blackbourn et al., 2000; Gao et al., 2003; 
Renne et al., 1998), including primary endothelial cells (Ciufo et al., 2001; Flore et al., 1998), 
with PEL-derived KSHV. To my knowledge, prior to this study, the only in vitro models that had 
accomplished greater than 50% infection of endothelial cells, using KSHV harvested from 
reactivated PEL cultures, had involved the inoculation of microvascular endothelial cell lines. 
The endothelial cells were immortalised by telomerase (Lagunoff et al., 2002) or the E6 and E7 
genes of Human Papilomavirus (Moses et al., 1999).  
50% infection or greater was desired for experiments in this thesis but the use of similar 
immortalised endothelial cell systems was unfavourable because whilst immortalisation does 
render cells more permissive to KSHV latent infection, it also confounds observation of virus-
imposed changes to cell behaviour (Lagunoff et al., 2002). For example, Lagunoff et al (2002) 
identified that in the generation of telomerase-immortalised microvascular endothelial (TIME) 
cells, the immortalisation by transduction with the hTERT retrovirus induced spindle morphology 
in the absence of KSHV infection and further elongation with KSHV infection was not evident. 
Using rKSHV.219, however, I achieved infection of HUVEC that was similar in efficiency to 
that seen with these immortalised cell systems. In fact the timecourse of rKSHV.219 infection of 
HUVEC, based on GFP percentage positivity (56%  12.6 at day-three rising to 80%  0.96 at 
day-ten (Figure 3.7A)) closely mirrored the infection profile of transformed endothelial cells 
reported by Moses et al (1999).  
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To my knowledge, at the time of these studies, only one model had been reported that gave 
higher percent infection of primary HUVEC than our system. That model used the recombinant 
KSHV reactivated from BAC36 propagated in HEK293 cells (Zhou et al., 2002) and attained 
~90% infection by day-two post-inoculation (Gao et al., 2003). However, in our hands BAC36 
titres are too low to provide a tractable model (Chanas and Blackbourn, unpublished data). Thus 
we question the reproducibility of 90% de-novo infection as observed by Gao et al (2003) and the 
BAC36-derived virus was not considered for use in these studies. Interestingly, recently 
duplication of a 9kb fragment of the long unique region within the terminal repeat region of the 
BAC36-KSHV genome was identified that is thought to have originated during BAC cloning 
since it is not detectable in BCBL-1 cells (Yakushko et al., 2011). It is possible that this 
disruption of the terminal repeat impairs productive lytic replication and generation of infectious 
virus. However, by genetic engineering of the BAC36 genome to drive constitutive expression of 
RTA a virus that caused cytopathic effect when inoculated onto various cell lines was generated 
(Budt et al., 2011). This counters the hypothesis that BAC36-KSHV cannot encode the synthesis 
of proteins required to form infectious virions. Nonetheless, while BAC36 might serve as a tool 
in mutagenesis studies to examine the functions of KSHV genes in the context of the KSHV 
genome, the genetic duplication is a concern for studies aiming to properly model the effects of 
natural KSHV-infection since it alters the balance of gene expression compared to wildtype virus.  
With the aid of RFP as a surrogate marker for rKSHV.219 lytic reactivation, I determined that 
KSHV infection of HUVEC featured an early lytic burst which subsequently declined (Figures 
3.6, 3.7B and 3.11B):  during the two days between days 0.5 and 2.5, 15% of the culture died due 
to virus undergoing lytic reactivation whereas between days 6.5 and 8.5 only 1.5% of the culture 
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died due to reactivation of the virus (Figure 3.11B). Thus, in agreement with previous studies 
observing KSHV infection of endothelial cells (Ciufo et al., 2001; Flore et al., 1998; Gao et al., 
2003; Lagunoff et al., 2002; Moses et al., 1999), chronic infection in this system was 
predominantly latent. Accordingly, this system provides a valid model for KSHV-infected 
spindle cells in in vivo disease, where, following primary infection, KSHV establishes latent 
infection in the host and productive lytic infection is found occurring spontaneously in a small 
proportion (2-5%) of cells (Moses et al., 1999; Orenstein et al., 1997; Staskus et al., 1997; Zhong 
et al., 1996). 
The rise in percentage infection that we and others (Moses et al., 1999) observed over the first 
seven-to-ten days post-inoculation was previously hypothesised to be a consequence of either 
horizontal transmission of infection or the proliferation of infected cells (Moses et al., 1999). 
However, the data in this chapter, for the co-culture of untreated and KSHV-inoculated HUVEC, 
strongly suggest that horizontal transmission contributed little to the temporal rise in percentage 
infection during this period. This finding was especially clear when comparing the percentage 
transmissions of infection to non-infected and untreated cells, originating from KSHV-inoculated 
(DDAO-SE negative) and untreated (DDAO-SE positive) cultures respectively during the five-
day period of co-culture between days three and eight post-inoculation. In contrast to 35% of 
non-infected cells that acquired infection after five days, transmission of infection to only 3.3% 
of untreated cells occurred (Figure 3.9B). The observation that cell numbers within KSHV-
inoculated monolayers decreased, largely due to lytic death, during the first week following 
inoculation, suggested that the increase in percent infection was also not attributable to a faster 
proliferation rate of infected compared to non-infected cells (Figure 3.11). 
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The data summing the number of viable cells in the monolayer with the cumulative number of 
cells lost by lytic death suggested a 15% deficit in the number of cells accounted for at day 8.5 
post-inoculation compared to day 2.5: whether the additional cells that died were predominantly 
KSHV-infected or non-infected could not be determined (Figure 3.11B). If, in the establishment 
of this deficit, KSHV infection induced the death of bystander, non-infected cells whilst aiding 
the survival of KSHV-infected cells, percentage infection would have increased. Such an impact 
of KSHV infection could provide an alternative or contributory explanation for the increase in 
percentage infection that occurred with time. By microscopic inspection, KSHV-infected cultures 
often appeared to have greater resilience than untreated cells. Nonetheless, it has been 
demonstrated that KSHV-infection enhances, through paracrine signalling, the survival of both 
infected and non-infected cells in inoculated cultures (Flore et al., 1998), dissuading the 
hypothesis of KSHV-induced death of non-infected cells.  Moreover, the idea that KSHV should 
enhance the survival of infected cells, whilst promoting the death of non-infected cells, is 
counterintuitive as a viral survival strategy since it would reduce the number of cells available as 
potential hosts.  
In this regard, in vivo establishment of latency is considered inefficient and requires a low 
level lytic replication to render infection of uninfected cells that can replace those infected cells 
which lose the viral episome upon cell division (Grundhoff and Ganem, 2004). Altogether, the 
hypothesis that suggests a disproportionate increase occurred in the death of non-infected 
compared to infected cells and contributed significantly to the rise in infection with time, is not 
favoured. From evaluating the limitations of this assay, it is felt that errors in counting cell 
numbers might explain much of the deficit reported. For example, as cells became more elongate 
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their cell bodies became more difficult to identify and this feature most probably resulted in 
underestimation of the viable cell number. At the same time, the demise of lysed cells might have 
caused under reporting of the number of cells lost by lytic death. The latter would have become 
of greater influence when the times between observations were increased beyond the 2.5-day 
timepoint. 
The number of infectious units that infect each cell is modelled by the Poisson distribution 
(Figure 3.12) (Condit, 2007). 
P(k) = e-mm-k/k 
where: P(k) is the fraction of cells infected by k infectious units and m is the MOI. 
This means that although cells are inoculated with virus at a specific ratio of infectious units to 
cells, the number of infectious units that enters each cell is not equal. Accordingly, I propose that 
the increase in percentage infection, toward 80% by day-ten, occurred primarily as a consequence 
of variation in the number of copies of virus entering each cell at inoculation.. In cells where the 
initial virus load received was lower, more time was required for the amplification of the viral 
episomes within the cell to be adequate for the cell to be identified as infected by GFP positivity.  
In our system KSHV was titrated on HEK293 as opposed to HUVEC. According to the Poisson 
distribution for the proportion of cells infected by k infectious units, our observation of 80% 
HUVEC infection at day-ten (P(0) = 0.2) suggests that the actual MOI used for inoculation of 
HUVEC did not exceed 1.6. We observed 33.2%  11.6% infection at 24h and 56.2%  12.5% at 
day-three. According to the Poisson distribution for MOI1.6 (Figure 3.13) 48% of the population 
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would be expected to be infected with two or more infectious units and 22% with three or more. 
Therefore these data suggest that intracellular amplification of the viral episome, to give a 
minimum of between two and three infectious units per cell, was required for visualisation of the 
cell as infected by GFP positivity.  
According to the proposed requirement for episome amplification to render an infected 
phenotype, it is possible that upon infection, detectable GFP expression and full spindle 
transformation are delayed markers of infection. Our observation that a subset of the GFP 
negative population of KSHV-inoculated HUVEC cultures stains positively for the KSHV 
protein LANA-1 at 24hours is consistent with this hypothesis (Figure 3.10). This hypothesis 
might also help to explain the 25-day delay between inoculation and observation of KSHV-
infected cell colonies in the studies by Ciufo et al (2001).  
In-cell accumulation of infection appeared to predominate in this system as the mechanism by 
which rKSHV.219 established an increasingly prominent infection with time in the first ten days 
post-inoculation. However, the fact that percentage transmission was greater for co-cultures 
prepared in advance of the lytic burst (Figure 3.9A) agrees with the premise that horizontal 
transmission, involving the release of new virions and re-infection within the monolayer, 
contributed to some extent to the temporal increase in infection. The co-culture period was 
limited to five days in this study, due to the decrease in DDAO-SE fluorescence that occurs with 
time, but if a longer period before analysis were possible, based on the principle that in-cell 
accumulation of infection is necessary for observation of infection by GFP read-out, a higher 
percentage of transmission might have been evident.  
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Figure 3.12: Poisson distributions for the proportion of cells in a population that are 
expected to be infected with k infectious units when inoculated with virus at multiplicities of 
infection (MOIs) between 0.1 and 10.  
 
CHAPTER THREE: KSHV infection of HUVEC 
 
160 
 
 
Figure 3.13: Poisson distribution for the proportion of cells in a population that are 
expected to be infected with k infectious units when inoculated with virus at a multiplicity 
of infection (MOI) of 1.6. 
 
Serial infection transmission, albeit of low percentage without chemical induction, has been 
routinely described in manuscripts presenting novel systems for studying de novo KSHV 
infection, and models for KS lesion progression propose that a background of spontaneous lytic 
replication is critical to maintain fundamental latent infection (Grundhoff and Ganem, 2004; 
Zhong et al., 1996). Consistent with this concept, ganciclovir treatment, which blocks lytic but 
not latent KSHV infection, decreased KS risk in patients with advanced AIDS (Martin et al., 
1999). Thus, the incidence of a low background of spontaneous lytic replication of rKSHV.219 
during infection of HUVEC, and the potential for some horizontal transmission of infection, is 
further support for the validity of this in vitro system as one in which to study the effects of 
KSHV infection of endothelial cells that are relevant to disease.  
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In summary, this chapter described the development of a protocol that yielded up to 80% 
infection of primary endothelial cells with KSHV and characterised this infection up to day-ten 
post inoculation: the time-period over which studies conducted in this thesis will be performed. 
For the following reasons the in vitro system established here was considered highly suitable for 
investigating, in subsequent chapters of this thesis, the impact of KSHV infection upon 
endothelial cell functions within the context of KS pathogenesis: (1) KSHV infection occurred at 
high efficiency (up to 80%) even using primary endothelial cells; (2) Primary endothelial cells, as 
opposed to transformed endothelial cells, were used as the target host-cell population; hence 
observation of any KSHV-induced effects was not obscured by the underlying transformed state 
of the cell; (3) KSHV infection was latent in most cells with only a small proportion of cells 
entering spontaneous lytic reactivation. A predominant latent infection is reminiscent of KSHV 
infection in the malignant endothelial-like spindle cells of KS lesions; (4) Infected and non-
infected cells could be distinguished on the basis of GFP positivity and lytic reactivation by RFP 
fluorescence. Alterations in phenotype and whether they were infected-cell specific or paracrine 
in nature could thus be readily identified without the use of antibody staining for KSHV-specific 
antigens.   
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4.1 INTRODUCTION 
KS lesions have a large abnormal vasculature. The vessels are poorly developed, appearing as 
vascular spaces. The cells lining these spaces are infected with KSHV, suggesting a direct role 
for KSHV in the development of the aberrant angiogenesis.  
Since endothelial cell migration is involved in angiogenesis it was hypothesised that KSHV 
infection might alter cell migration. Prior to this thesis, a restricted number of KSHV genes had 
been examined for their influence upon cell migration and had demonstrated opposing effects: 
K15M (Tsai et al., 2009) increased cell migration whilst vGPCR (Couty et al., 2009) and K5 
(Mansouri et al., 2006) inhibited migration. To my knowledge, no study had explored the effect 
of infection by whole KSHV upon the migration of any endothelial cell lines or primary 
endothelial cells.  Thus in this chapter, migration assays were developed and used to examine the 
effect of the virus upon the migration of primary endothelial cells.  
Cell migration can be examined by techniques that monitor the passage of cells between seeding 
and destination chambers that may be arranged vertically, separated by a porous membrane, or 
arranged either concentrically (Dunn chamber) or side by side (Zigmond chamber), separated by 
a bridge. Such assays were originally developed to study the chemotactic behavior of cells by the 
addition of chemoattractants to the destination chamber, but their principles may be adopted to 
examine intrinsic cell motility. Techniques that monitor closure of a ‘scratch-wound’ can also 
provide an indication of migration rates when cells are not proliferating rapidly; analysis may be 
endpoint or continuous monitoring by time-lapse microscopy. The latter enables total migration 
distances, migration rates and direction paths to be assessed.  
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The assays developed in this chapter to assess the effect of KSHV infection on primary 
endothelial cell migration quantified endothelial cell migration in terms of: (1) transmigration 
(the migration of cells across a porous membrane, from an upper seeding chamber to lower 
destination chamber); (2) wound recovery; (3) distance, rate and/direction of movement. 
4.2 RESULTS 
4.2.1 Development of a transmigration assay 
Membranes with 8m-pores have been recommended for monitoring the transmigration of 
endothelial cells by manufacturers (Becton Dickinson Labware). The membranes are sometimes 
coated with extracellular matrix proteins such as collagen or fibronectin or a reconstituted tumour 
cell matrix termed ‘Matrigel’ (e.g. Dawson et al., 2008; Qin et al., 2011; Tsai et al., 2009). 
However, since deposited patterns of basement membrane proteins might influence migration 
(see Hamill et al., 2009; Sehgal et al., 2006), non-coated filters were selected for these studies.   
To conserve reagents and scarce primary and infected cells, 24-well format cell culture 
inserts, termed in this thesis ‘transwell chambers’, were chosen as they have a growth area of 
only 30mm2. Despite this small area, percentage transmigration could be calculated for multiple 
fields, thereby achieving a reliable estimate of the average transmigration rate.  
Although most transmigration studies have used 8m-pore filters (e.g. Couty et al., 2009; 
Dawson et al., 2008; Tsai et al., 2009), we noticed that HUVEC could also pass through 3m-
pore filters. To establish a suitable duration for the assay and to compare sensitivity of the assay 
with different pore sizes, migration assays with untreated HUVEC were performed using 
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transwell chambers with 3m or 8m-pore filters for durations of 24 or 48hours. Migration was 
markedly slower using 3m-pore filters, and for either pore size only a small proportion of cells 
migrated in 24hours (Figure 4.1). All subsequent assays were conducted with 8m-pore filters 
and 48hour duration because under these conditions, percentage transmigration was at a level that 
if KSHV infection enhanced or decreased motility it could be detected. 
4.2.2 The effect of KSHV infection upon endothelial cell transmigration 
Since the spindle morphology of KSHV-infected HUVEC became more pronounced with 
time and the percentage infection of the inoculated cultures increased with time (Chapter 3), I 
considered that alteration of cell migration by KSHV might be dependent upon the timepoint of 
observation post-inoculation. To address fully whether KSHV inoculation altered endothelial cell 
migration, the transmigration of HUVEC was examined at one, three, seven and ten days post-
inoculation. By day-three and beyond, KSHV inoculation enhanced HUVEC transmigration 
compared with no treatment (Figure 4.2). Even though the increase was not significant at day-ten 
post-inoculation, the trend toward enhanced transmigration with inoculation was still present. 
Since KSHV repeatedly enhanced transmigration at day-seven post-inoculation, subsequent 
migration studies were conducted at day-seven post-inoculation.  
For the KSHV-inoculated cultures, it was not possible to ascertain the percentage 
transmigrations of KSHV-infected and non-infected cells separately by fluorescence microscopy 
alone. This was because the GFP fluorescence of infected cells was too faint, when observed on 
the fixed filters, to distinguish reliably between infected and non-infected cells. 
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To establish whether the enhanced transmigration of KSHV-inoculated cultures compared 
with untreated controls involved increased motility of both KSHV-infected and non-infected cells 
or one population only, cells were removed from the top and bottom surfaces of the transwell 
chamber filters at 48hours and the percentages of GFP positive cells in each population were 
assessed by flow cytometry. Percentages of GFP positive cells were consistently higher in the 
cultures removed from the bottom compared to the top of the filter (Figure 4.3A). In parallel 
with this analysis, the percentage transmigrations of the KSHV-inoculated and untreated 
monolayers were quantified by microscopy using separate filters. Combining these data, the 
percentage transmigrations of KSHV-infected and non-infected cells were calculated and 
revealed preferential migration of infected cells. Non-infected cells maintained a rate of 
transmigration equivalent to that of untreated control cells (Figure 4.3B and Appendix Table 
9.1). These data therefore suggested that enhancement of endothelial cell motility with infection 
was not due to the paracrine action of a secreted factor, but to effects on the infected cells 
themselves. To test this hypothesis further, transmigration assays for HUVEC that had not been 
previously treated with either KSHV or mock inoculums were performed in the presence of 
supernatants collected from KSHV-inoculated or untreated cultures. Consistent with the above, 
no effect of supernatant was observed (Figure 4.4).  
 
 
 
 
CHAPTER FOUR: Effect of KSHV upon endothelial cell motility  
 
167 
 
 
 
 
 
 
Figure 4.1: Effect of pore size and duration of assay upon the endpoint percent 
transmigration of HUVEC.  
HUVEC were seeded into 8m-pore or 3m-pore transwell chambers and the percentage 
transmigration after 24 or 48hours quantified by microscopy.  Data are mean  SEM for two 
(24hours) or three (48hours) experiments. * = P<0.05 by t-test. 
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Figure 4.2: Effect of duration of KSHV infection upon the transmigration of HUVEC.  
KSHV-inoculated (KSHV-EC) or untreated (UT-EC) HUVEC were seeded into 8m-pore 
transwell chambers on days one, three, seven or ten post-inoculation and the percentage 
transmigration after 48hours quantified by microscopy. Individual points represent separate 
experiments. Horizontal lines indicate mean percentage transmigration. Two way ANOVA 
revealed a significant effect of KSHV upon transmigration (P<0.01); ** =  P<0.01by paired t-
test. 
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Figure 4.3: Comparison of transmigration by KSHV-infected, non-infected and untreated 
HUVEC.   
KSHV-inoculated (KSHV-EC) or untreated (UT-EC) HUVEC were seeded into 8m-pore 
transwell chambers on day-seven post-inoculation and the proportion of cells above or below the 
filter that were GFP positive, and the percentage transmigration were analysed after 48hours.  (A) 
Percentage of GFP positive cells quantified by flow cytometry for KSHV-EC cultures removed 
from the top and bottom surfaces of  filters. ** =  P<0.05 by paired t-test. (B) Percentage 
transmigration of KSHV-infected (V), non-infected (NI) and UT-EC HUVEC as determined 
from the proportion of GFP positive cells each side of the filter and the percentage transmigration 
quantified by microscopy. ANOVA revealed a significant effect of KSHV upon  transmigration 
(P<0.01); ** =  P<0.01 by Bonferroni’s multiple comparison test. Data are mean  SEM for four 
experiments. 
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Figure 4.4: Effect of culture supernatants from KSHV-inoculated HUVEC on HUVEC 
transmigration.  
Transmigration assays for otherwsie-untreated HUVEC were performed in the presence of fresh 
medium (Control) or media containing 25% 48hour culture supernatants from 24-well plate 
cultures of KSHV-inoculated (KSHV-EC) or untreated  (UT-EC) HUVEC. 25% supernatants 
were used in order to recapitulate the lower concentrations of transmigration assay supernatants 
compared with 24-well plate supernatants. Data are mean  SEM for three experiments.  
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4.2.3 Development of a wound recovery assay 
To complement my observations of enhanced endothelial cell transmigration with KSHV 
infection, I developed a wound recovery assay. Using this system, the two-dimensional migration 
of cells in the absence of a barrier was studied.  
Typically, wound recovery assays involve making a scratch along the centre of the monolayer 
using a fine tool such as a sterile 20l pipette tip. During the migration period, cells migrate from 
the surrounding monolayer to recover the wound. Percentage recovery at a fixed endpoint and/or 
at intervals throughout the recovery phase is measured and compared across treatments.  
To conserve reagents, a 24-well plate format was first tested in preference to a 12- or 6-well 
plate format, but at the level of magnification required to view the entire width of the wound, 
only one central field had adequate optical quality under phase-contrast light microscopy for 
quantification of the percentage wound recovery. Outside of this central field, scattering of the 
light by the well edge disrupted the image (Figures 4.5A, B). Larger well formats were tried and 
12-well or larger found suitable for observation of at least three fields along the wound, as 
required for reliable quantification (Figure 4.5C).  
Wounding may be performed one-day after seeding (e.g. Sheldon et al., 2009) but to study 
the effect of KSHV-inoculation upon cell migration at day-seven post-inoculation, eight days 
of culture from seeding were required prior to wounding. Pilot studies to test whether wound 
recovery assays could be performed on such ‘aged’ cultures highlighted a problem. Upon 
wounding, these monolayers peeled generating an irregular wound (Figure 4.5D); the effect 
was also incurred four days after seeding (Figure 4.5E). It was suggested that coating culture 
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plates with 0.1% (w/v) gelatin might reduce the risk of peeling. I found that coating the plates 
with 0.1% (w/v) gelatin delayed the onset of monolayer peeling (Figures 4.5F, G) but the 
monolayers still peeled when wounded eight days after seeding (Figure 4.5H). Therefore, an 
alternative method was sought. 
Transferring cells to new culture surfaces on day-six post-inoculation and wounding the 
monolayer on day-seven would be expected to overcome the problems of peeling that 
establish with prolonged culture on the same surface. Of standard culture vessels, wells of 12-
well plates were the smallest available that were suitable optically. However, to seed a 
confluent monolayer for each test condition in 12-well plates required more cells than were 
available for each donor. Novel silicon culture inserts produced by Ibidi were used. The 
inserts were placed in the centre of a multi-well plate well (for example a well of a 6-well 
plate) and created two parallel 22mm2 patches of cells separated by a 500m (+/-50m) gap 
into which cells migrated during the assay. These inserts enabled wound-recovery assays to 
be performed using comparatively few cells (3104 cells/test compared to 1.5105 cells/test 
for a confluent well of a 12-well plate). 
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Figure 4.5: Developmment of a wound recovery assay to examine the effect of KSHV on 
HUVEC migration at day-seven post-inoculation.    
HUVEC were seeded to confluence, wounded down the centre of the well using a 20l pipette 
tip on the day indicated post-seeding and visualised under phase contrast using a 4x objective 
lens. Plates were left uncoated or were coated with 0.1% (w/v) gelatin as indicated. (A and B) 
Monolayers in uncoated 24-well plates wounded one day post-seeding. (C) Monolayer in 
uncoated 12-well plate wounded one-day post-seeding. (D) Monolayer in uncoated 12-well plate 
wounded five-days post seeding. (E and F) Monolayers in uncoated (E) or 0.1% (w/v) gelatin-
coated (F) plates wounded three-days post-seeding. (G) monolayer in 0.1% (w/v) gelatin-coated 
12-well plate wounded five-days post seeding. (H) Monolayer in 0.1% (w/v) gelatin-coated 12-
well plate eight days post-seeding. 
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4.2.4 The effect of KSHV infection upon endothelial cell wound recovery 
KSHV inoculation enhanced wound recovery at day-seven post-inoculation (Figures 4.6A, 
B).  
I considered that KSHV inoculation might modify cell-density of cultures and this might 
affect recovery. For instance, during wound recovery, regions of the monolayer where cells are at 
higher density might close more rapidly. To test whether wound recovery with KSHV inoculation 
was influenced by seeding density, the starting cell densities surrounding the wounds were 
counted from the phase contrast images and plotted against percentage recovery. Wound recovery 
increased with increasing cell density and across all densities was greater with KSHV inoculation 
(Figure 4.7A). For matched KSHV-inoculated and untreated cultures, density tended to be lower 
for the inoculated cultures but across all pairs of densities, wound recovery was still greater with 
KSHV inoculation (Figure 4.7B). Thus, the increase in wound recovery after inoculation was not 
through an effect on cell density. 
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Figure 4.6: Effect of KSHV infection on HUVEC wound recovery.  
KSHV-inoculated (KSHV-EC) or untreated (UT-EC) HUVEC were plated into culture  inserts 
on day-six post-inoculation. Inserts were removed on day-seven and the percentage wound 
recovery in 32hours measured. (A) Representative start and endpoint images of UT-EC and 
KSHV-EC monolayers.  (B) Average percentage wound recovery for KSHV-EC and matched 
UT-EC cultures. Each line represents a different experiment. * =  P<0.05 by paired t-test.  
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Figure 4.7: Effect of cell density on KSHV-enhanced wound recovery.  
KSHV-inoculated (KSHV-EC) or untreated (UT-EC) HUVEC were plated into culture  
inserts on day-six post-inoculation. Inserts were removed on day-seven. The starting 
density surrounding the wound was calculated and the percentage wound recovery in 
32hours measured. (A) Percentage wound recovery in relation to starting density for  
untreated (UT-EC) and KSHV-inoculated (KSHV-EC) HUVEC monolayers. Individual 
points represent separate wound sites analysed across 6 experiments. The Pearson 
Product Moment Correlation Coefficients for the relationship between density and 
wound recovery were: UT-EC: r = -0.1239, P>0.05 and KSHV-EC: r = 0.3430, P>0.05. 
(B) Data for the experiments in Figure 4.6B plotted to show the average cell density and 
percentage wound recovery of the UT-EC and KSHV-EC cultures in each of the six 
paired experiments.     
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Enhanced proliferation rates rather than, or in addition to enhanced migration might in 
principle contribute to increased rates of wound recovery. The lack of transformation toward an 
enhanced proliferative potential for KSHV-inoculated monolayers (Figure 3.11) makes this an 
unlikely explanation for faster wound recovery by inoculated monolayers. Nevertheless, I 
calculated ratios of endpoint cell numbers to initial numbers per field of view, and found them to 
be the same for untreated and KSHV-inoculated monolayers (Figure 4.8).  Thus, proliferation 
was not enhanced under KSHV-inoculation compared to no treatment and could not explain the 
increased wound recovery with inoculation. 
The transmigration studies indicated that KSHV-infected cells migrated preferentially to non-
infected cells (Figure 4.3). To address whether this followed in wound recovery, 15-minute 
interval time-lapse recordings of KSHV-inoculated monolayers were made over 8hours during 
wound closure. The cells tracked were selected at random from within a 120m band 
surrounding the wound: GFP fluorescence images overlayed onto the phase contrast image at the 
start of the recording enabled the KSHV-infected cells to be distinguished from the non-infected 
cells. The centroid coordinates of the cell nuclei were recorded every 2hours and the total 
distance migrated computed. No difference was found between the total distances migrated by 
infected and non-infected cells (Figure 4.9). The total distance of migration might remain 
constant but the directionality of migration be altered by infection. As a measurement of the 
directionality of migration, persistence, the ratio of final displacement to total distance migrated 
was calculated. This parameter was not altered by infection either. Thus these data suggest that 
the cellular mechanisms which underlay enhanced transmigration and enhanced wound recovery 
were different.  
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Figure 4.8: Effect of KSHV inoculation on start and endpoint cell numbers in fields 
analysed in the wound recovery assay.  
The number of cells per field of view was counted at the start and end of the wound recovery 
assay and expressed as a ratio. Individual points represent separate experiments. Horizontal lines 
indicate the mean.  
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Figure 4.9: Comparison of the distances migrated by infected and non-infected cells at the 
edges of wounded monolayers.  
Wound recovery of KSHV-inoculated monolayers was observed under 6x magnification at 15-
minute intervals over 8hours. (A) The positions of the cells at 2hour intervals were tracked and 
the total distances  migrated by KSHV-infected (V) and non-infected (NI) HUVEC computed. V 
and NI were distinguished on the basis of GFP positivity. (B) The persistence of migration for V 
and NI was calculated as the ratio of final displacement (compared to the starting position) to 
total distance migrated in 8hours. Individual points represent separate cells tracked from three 
experiments. Horizontal lines are the mean. 
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4.2.5 The effect of KSHV infection upon the motility of isolated endothelial cells 
I questioned whether KSHV infection would increase the intrinsic motility of endothelial 
cells when sparsely distributed rather than in a monolayer. To examine the effect of the virus on 
individual cells, untreated and KSHV-inoculated cultures were seeded at low density and 10-
minute interval time-lapse recordings made over 2.5hours. Overlay of GFP fluorescence images 
enabled infected cells and non-infected cells to be distinguished.  
Analysis of migration distances showed that total migration distances calculated by this 
protocol were affected by the time interval between the images analysed (Figure 4.10). This is a 
well-known phenomenon (arising because cells frequently change their direction of movement) 
and was the same irrespective of whether the cells were untreated, KSHV-infected or non-
infected. Regardless of interval, the analyses showed that KSHV-infection did not affect the total 
distance migrated by isolated HUVEC over 2.5hours (Figure 4.10). Whilst the shortest interval 
(10minutes) gave the greatest distance, there was a greater relative error in these measurements 
because individually they were very short (only ~2µm). 30-minute intervals between images 
were felt appropriate in order to identify an element of the non-directional migration occurring 
whilst minimizing the magnitude of the error and were chosen for subsequent studies.  
To examine the effect of KSHV upon migration direction and persistence, plots were 
constructed using the coordinates of the cells’ positions at 30-minute intervals relative to their 
positions at the start and persistence (ratio of final displacement to total distance migrated) was 
calculated. No striking differences in the migration pathways (Figure 4.11) or persistence 
(Figure 4.12) of cells were noticed according to their infection status.  
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Figure 4.10: Effect of KSHV infection on the distances migrated by sparsely distributed 
HUVEC.  
Untreated (UT-EC) or KSHV-inoculated (KSHV-EC) HUVEC were removed from 24-well 
inoculation plates on day-six post inoculation and seeded sparsely in 12-well plates. On day-
seven post-inoculation, cells were viewed under phase contrast using a 10x objective lens and 
images recorded every 10minutes for  2.5hours. The total distances migrated by untreated (UT), 
non-infected (NI) and KSHV-infected (V) HUVEC were calculated when the times intervals 
between the images included in the analysis were 10, 30, 50 and 150minutes. V and NI HUVEC 
were distinguished on the basis of GFP positivity. Data are mean  SEM for 18-21cells from 
from across three experiments. 
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Figure 4.11: Effect of KSHV infection on the migration pathways of sparsely distributed 
HUVEC. 
 Plots illustrating the migration pathways of untreated (UT), non-infected (NI) and KSHV-
infected (V) HUVEC were constructed by plotting (x,y) coordinates of the cell centroids at 
30minute intervals relative to their start position. The total period of observation was 
150minutes. Each coloured line represents the migration pathway for a different cell. Cells 
shown are from one experiment included in Figures 4.10 and 4.12 but are representative of the 
behaviours of cells from all three experiments.  
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Figure 4.12: Effect of KSHV on the persistence of migration of sparsely distributed 
HUVEC.  
Persistence of migration for untreated (UT), non-infected (NI) and KSHV-infected (V) 
HUVEC was calculated as the ratio of final displacement (compared to the starting 
position) to total distance migrated in 150minutes. The time interval between 
observations was 30minutes. Individual points represent separate cells tracked from three 
experiments. Horizontal lines are the mean persistence. Cells included were those for 
which total migration distance data are presented in Figure 4.10. 
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4.3 DISCUSSION 
The migration of endothelial cells is required for the formation of new vascular structures 
during angiogenesis. Extensive aberrant angiogenesis is a hallmark of KS lesions. Previous 
studies had identified both positive and negative effects of isolated KSHV genes upon cell 
migration but the impact of infection by the whole virus on cell migration was not known. Here I 
have shown for the first time that KSHV infection of primary HUVEC increases the migration of 
cells from confluent monolayers across a porous barrier (transmigration) (Figures 4.2 and 4.3) or 
into an adjacent space (wound recovery) (Figure 4.6). Interestingly, tracking individual infected 
cells at the edge of a ‘wound’ or when sparsely seeded did not reveal an increase in migration 
speed (Figures 4.9. and 4.10).  
In the study of transmigration, KSHV enhanced transmigration at day-three post-inoculation 
and beyond (Figure 4.2), the virus conferring increased transmigration potential specifically to 
the infected cells (Figure 4.3). By 48hours, the endpoint percentage transmigration of non-
infected cells was equal to that of untreated controls, suggesting that KSHV infection does not 
influence the migration of non-infected cells through a paracrine mechanism, and that if KSHV-
enhanced transmigration is coordinated by a secreted factor, it only acts on infected cells. Whilst 
KSHV infection is known to induce the release of promigratory factors such as VEGFA, bFGF 
and angiopoietins (Akula et al., 2005; Haddad et al., 2008; Masood et al., 2002; Montaner et al., 
2004; Naranatt et al., 2004; Sadagopan et al., 2009; Sivakumar et al., 2008; Vart et al., 2007; 
Wang et al., 2004a; Xie et al., 2005; Ye et al., 2007), the absence of an increase in the 
transmigration of untreated HUVEC in the presence of supernatants from KSHV-inoculated 
cultures (Figure 4.4) supported the conclusion that increased transmigration was an intrinsic 
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property of infected cells. In contrast, faster rates of two-dimensional migration for inoculated 
compared to untreated cultures appeared to be an integral property of the inoculated monolayer, 
rather than specific to KSHV-infected cells (Figures 4.6 and 4.9). KSHV-infected and non-
infected cells did not present different migration rates or persistence of migration when followed 
under time-lapse during wound recovery (Figure 4.9). Thus, the mechanisms that underlie the 
enhancement of migration with KSHV inoculation may in fact be different in the transmigration 
and wound recovery models. It is possible to speculate that the distinction in behaviour between 
the two models (preferential transmigration of infected cells but equal migration rates of infected 
and non-infected cells during wound recovery) is due to the different physical properties of the 
two systems such as the requirement for cells to negotiate the porous barrier of the transwell 
chamber filters during the transmigration assay. Perhaps the morphological transformation of 
infected cells, becoming longer but thinner, underlies their improved propensity to traverse the 
pores.  
In the wound recovery system, the absence of a discriminating barrier might make paracrine, 
chemokinetic signaling influential. For example, KSHV-induces VEGFA (Sivakumar et al., 
2008) and VEGFA signaling through VEGFR2 promotes focal adhesion turnover and endothelial 
cell migration (Lamalice et al., 2007). Alternatively, or in addition, provision for maintenance of 
cell-cell contacts during wound recovery might facilitate sheet-like rather than independent 
movement of cells enabling KSHV-infected cells to influence the migration rates of bystander, 
non-infected cells. Such communication might be important in the formation of the aberrant 
vascular structures of KS lesions where non-spindle endothelial cells do not harbour KSHV 
infection (Dupin et al., 1999).  
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Whilst KSHV genes were traditionally classified as lytic or latent, based upon expression 
profiles in PEL cells, in HUVEC this distinction is less clear (Ye et al., 2007) with many lytic 
transcripts, including K5, still detectable up to day-ten post-inoculation in our system (Butler and 
Blackbourn, unpublished data). K15 has similarly been reported by others to be expressed during 
both latent and lytic phases (Chen et al., 2009). Therefore there may be a role for KSHV ‘lytic’ 
proteins such as K5 and K15 (Tsai et al., 2009) in KSHV-induced enhanced migration despite the 
latent phenotype of the culture at day-seven in terms of RFP expression (Section 3.2.3). Although 
depletion of CD31 by KSHV-K5 overexpression reduced wound-recovery (Mansouri et al., 
2006), it may be that under conditions of modest expression as with whole virus infection, in 
contrast to ectopic overexpression, KSHV-K5 supports an increase in wound-recovery by 
reducing the strength of cell-cell contacts, thereby rendering both infected and non-infected cells 
in the same monolayer with greater freedom to migrate compared to untreated controls. 
The increase in cell migration with whole virus infection, as demonstrated here, suggests that 
the overall balance of KSHV gene functions, in predominantly latent cultures, promotes motility. 
This is in contrast to HHV6 infection of lymphatic and vascular endothelial cells, which, in a 
mechanism attributed to the HHV6 latency-associated U94/REP protein, inhibited migration and 
angiogenic properties of both types of endothelial cell:  Evidence for this inhibition included the 
impaired ability of HHV6-infected cells to close scratch wounds and to form capillary-like tubes 
in basal membrane extracts (Caruso et al., 2009). Similar to the enhanced transmigration with 
KSHV infection, however, HCMV infection increased the transmigration of arterial smooth 
muscle cells in a mechanism involving MCP-1 activation of the viral chemokine receptor US28. 
The enhanced transmigration was specific to infected cells, since whilst MCP-1 is generated by 
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non-infected smooth muscle cells it was only through the expression of the viral receptor that 
cells gained transmigration potential (Streblow et al., 1999). An analogous mechanism might 
underlie enhancement of HUVEC transmigration with KSHV infection in these studies. 
Aside from these studies on HHV6 and HCMV, there is a paucity of literature on the effects 
of infection by other herpesviruses and DNA-tumour viruses upon cell migration, with most 
studies addressing the effects of single viral proteins on cell migration. Phylogenetically, KSHV 
is closely related to the ubiquitous gammaherpesvirus EBV which is associated with infectious 
mononucleosis and cancers including Hodgkin’s lymphoma, Burkitt’s lymphoma and 
nasopharyngeal carcinoma (NPC). These diseases are characterized by different latency programs 
of the virus in which some or all of the latency genes are expressed. For relevance to the 
metastatic nature of late stage NPC, in particular, the latency genes latent membrane protein 
(LMP)1, LMP2A, LMP2B and EBV nuclear antigen-1 (EBNA1) have been studied for their 
effects on cell motility and migration and all shown to increase cell motility. Interestingly, there 
are structural and sequence similarities between the K15 protein of KSHV and LMP1 and 
LMP2A (Tsai et al., 2009).  
LMP1, formerly denoted the major transforming protein of EBV, appears to enhance cell 
motility through multiple mechanisms including induction of the transcription factor Ets1 (Kim et 
al., 2000), upregulation of Decoy receptor 3 via NFB and PI3K signaling (Ho et al., 2009), and 
activation of the ERK-MAPK pathway (Dawson et al., 2008). Whether KSHV proteins target 
similar pathways remains to be determined. Interestingly, LMP1-transformed Madin-Darby 
canine kidney (MDCK) cells (Kim et al., 2000) and SV40-immortalised nasopharyngeal 
epithelial (NP69) cells (Lo et al., 2003) migrated away from the monolayer edge into the 
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wounded area in contrast to control cells, which maintained smooth monolayer fronts during 
wound closure. Similar behaviour was not apparent with KSHV-infection at day-seven post-
inoculation in these studies, where instead, infected cells moved with the rest of the monolayer 
and since infected and non-infected cells migrated at the same rate, polarization of infected cells 
toward the wound front was also not evident. Analogous to KSHV infection, however, LMP1 
overexpression induced spindle morphology to the cells (Kim et al., 2000). Thus, cytoskeletal 
changes upon spindling might have significance to the property of enhanced motility. Indeed, loss 
of cell-to-cell contacts and remodeling of the actin cytoskeleton into filopodia and stress fibres, 
involving PI3K dependent activation of the small GTPases Rho and Cdc42, was reported upon 
LMP1 overexpression (Dawson et al., 2003). 
Analogous to KSHV infection in these assays, studies looking at the roles of the EBV integral 
membrane proteins LMP2A and LMP2B suggested LMP2 increases the transmigratory and in-
plane migration of cells (Allen et al., 2005; Pegtel et al., 2005). The promigratory effects of the 
LMP2 isoforms were linked to an improved ability of the cells to spread and establish focal 
adhesions rather than to form an initial attachment to the underlying extracellular matrix. This 
involved tyrosine kinase phosphorylation of FAK and structural proteins at focal adhesions 
(Allen et al., 2005; Lu et al., 2006). In contrast to LMP1, the activation of Protein Kinase C 
(PKC), ERK-MAPK or PI3K pathways was not evident for LMP2. Presumably therefore, in the 
context of whole virus infection, the signaling cascades most responsible for regulation of 
motility would be those activated by the viral proteins with predominant function.  
EBNA1 expressed in all EBV-associated malignancies is described as functionally analogous 
to the KSHV protein LANA1. Both are latent origin binding proteins that act to ensure the 
CHAPTER FOUR: Effect of KSHV upon endothelial cell motility  
 
192 
 
maintenance and segregation of the viral episome in infected cells. EBNA1 has also been shown 
to enhance cell migration through interaction with the suppressor of metastasis and cell 
migration, Nm23-H1. This interaction relocates Nm23-H1 from the cytosol to the nucleus, 
thereby relieving its inhibitory effect upon cell migration (Murakami et al., 2005). Targeting of 
Nm23-H1 appears to be a strategy harnessed by other viral proteins to promote cell migration as 
illustrated by EBNA3C and the E7 oncoprotein of Human Papillomavirus (Choudhuri et al., 
2006; Mileo et al., 2006).  A recent study looking at the effect of KSHV infection upon Nm23-
H1 identified that whilst KSHV infection upregulated Nm23-H1 expression, LANA1 induced its 
translocation to the nucleus thereby promoting an invasive phenotype (Qin et al., 2011).  
Overall, the fact that other herpesviruses encode genes with migration-promoting effects 
provides further support for the data presented here showing that KSHV inoculation increases 
cell migration, since it suggests that to increase host-cell migration might be of benefit to 
herpesviruses and is thus conserved as a viral survival strategy. Moreover, KSHV might use 
similar mechanisms and/or homologuos proteins to other herpesviruses to confer enhanced 
migration.  
In summary, assays to monitor endothelial cell migration were developed in this chapter and 
KSHV infection shown to increase the motility of primary endothelial cells, both in 
transmigration and in-plane migration assays. The assays were designed around the use of 
commercially available devices that would enable the number of cells required to be minimized 
and therefore also the amount of high titre virus: this was necessary since the supplies of both 
were limited.  
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The most detailed analysis of the effect of KSHV upon endothelial cell transmigration was 
provided by parallel microscopic counting and GFP flow cytometry assays, which enabled the 
percentage transmigration of untreated, KSHV-infected or non-infected HUVEC to be 
determined separately. However, the limitations over cell availability would not permit both 
analyses routinely. It was not desirable to expand HUVEC across multiple passages since we 
observe this to alter HUVEC functions in our assays.  
In considering the best method to use for further studies, I first considered the percentage 
transmigration by microscopy or the difference between percentage infection of cultures on the 
top and bottom surfaces of the transwell chamber filters. The coefficients of variation for the two 
methods were 25.4% and 26.6% respectively suggesting that they were comparable in terms of 
their power to assess the impact of KSHV on migration. Analysis of transmigration by 
microscopic analysis was chosen as the preferred method since each repeat assay required one 
instead of two transwell chamber filters, therefore enabling more duplicate assessments to be 
made, improving precision. The coefficient of variation associated with the wound recovery 
method was 31.8%; thus this method was less precise. Subsequently, it was decided that the 
underlying mechanisms for KSHV-enhanced cell migration would be addressed using the 
transmigration method with quantification by microscopy.  
Possible mechanisms underlying KSHV-enhancement of endothelial cell migration, such as 
alterations to: composition of the sub-endothelial matrix of basement membrane proteins; surface 
integrin expression profile; actin cytoskeleton and focal adhesion distribution; secretion of 
promigratory chemokines and growth factors and expression of their receptors; activation of the 
p38 MAPK pathway are addressed in the following three chapters.
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CHAPTER FIVE 
EFFECT OF KSHV INFECTION UPON 
ENDOTHELIAL CELL DEPOSITION OF 
BASEMENT MEMBRANE PROTEINS AND 
SURFACE EXPRESSION OF INTEGRIN 
RECEPTORS 
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5.1 INTRODUCTION 
In vitro endothelial cells deposit matrix proteins which form a basement membrane during 
prolonged culture (Butler et al., 2005). They attach to this matrix via integrin heterodimers and 
this binding activates integrin outside-in signaling cascades that promote, among other responses, 
changes to the actin cytoskeleton, potentially altering cell motility. The basement membrane may 
also serve as a reservoir for growth factors and chemokines enhancing their presentation to 
cellular receptors and affecting endothelial cell behaviour, including migration.   
In this chapter, in view of the possible regulatory influence of the basement membrane upon 
multiple facets of endothelial cell behaviour, including migration, an indirect ELISA method was 
used to analyse the composition of sub-endothelial matrix and to assess the impact of KSHV-
infection upon deposition of these proteins. Studies were performed to interrogate the molecular 
basis for the alterations in proteins deposited upon KSHV infection. Subsequently, a role for 
detected changes in matrix proteins in KSHV-enhanced endothelial cell migration was tested. An 
effect of the virus upon integrin surface expression was also examined, and changes detected 
tested for involvement in KSHV-enhanced migration.  
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5.2 RESULTS 
5.2.1 Establishment of a suitable cell removal method for subsequent analysis of 
the sub-endothelial matrix by ELISA.   
To study the composition of sub-endothelial matrix by ELISA the overlying cell monolayer 
needed to be removed. Detergent lysis buffer or incubation with EDTA were two methods 
previously used in our laboratory to expose the sub-endothelial matrix (Butler, 2005; Butler et al., 
2005). I compared these methods for their influence upon the levels of matrix-proteins detectable 
in subsequent ELISAs. ELISAs to analyse the main protein constituents of vascular basement 
membrane (collagen IV, fibronectin and laminin) were performed on four-day cultures since 
previous studies showed that in four days, basement membrane proteins deposited by HUVEC 
monolayers were detectable by ELISA (Butler et al., 2005). Endothelial cells were seeded 
directly on plastic, as was the case in migration assays. The method for HUVEC removal did not 
alter the detection of any of the matrix proteins screened, suggesting that possible release of 
intracellular matrix-protein stores upon cell lysis did not confound the assay and that EDTA, a 
gentler treatment that removes cells intact, did clear the monolayer thoroughly (Figure 5.1). 
Lysis buffer was chosen as the treatment for removing cells in all subsequent assays since it was 
the shorter method.  
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Figure 5.1: Comparisons of cell removal methods to expose the sub-endothelial matrix for 
analysis by ELISA.  
HUVEC were plated into 96-well plates,  cultured for four-days and stripped from the deposited 
matrix using detergent lysis buffer (PBS containing 0.5% (v/v) Triton X-100,  20mM NH4OH) or 
4hour incubation in 0.02% (w/v) EDTA at 37C. The composition of the sub-endothelial matrix 
was analysed by ELISA with absorbance readout at 490nm. Data are mean  SEM for three 
experiments.  
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5.2.2 The effect of KSHV infection on the production and secretion of basement 
membrane components by endothelial cells 
The effect of KSHV inoculation on the deposition of basement membrane proteins by 
endothelial cells was first analysed four days following inoculation. Cells were seeded to 
confluence and inoculated as soon as they had settled and adhered to the plate (~4hours) (no 
significant deposition of matrix proteins was anticipated in 4hours). Relative to no treatment, 
KSHV inoculation did not alter the amount of collagen IV or fibronectin deposited but reduced 
the amount of laminin by two-thirds. Using UV-irradiated KSHV, this reduction was not 
observed, indicating that it was a specific response to KSHV infection (Figure 5.2). 
In Chapter 3 I observed a decrease in cell density with KSHV inoculation. Here, there was 
reduction seen in laminin but not collagen-IV or fibronectin. Therefore, I decided to test whether 
cell number and protein deposition were similarly related for all three proteins. Untreated 
HUVEC were seeded at densities between 0.3x104cells/well and 3x104cells/well and the collagen 
IV, fibronectin and laminin composition of the four-day sub-endothelial matrix assayed by 
ELISA for each cell density. In parallel the number of cells per field of view was counted by 
fluorescence microscopy looking at bisbenzimide-stained cell nuclei. Plots of absorbance against 
density suggested that a positive relationship existed between cell density and matrix protein 
deposition for all three proteins tested (Figure 5.3). The Pearson Product Moment Correlation 
Coefficients were statistically significant for each protein (Collagen IV: r = 0.8465, P<0.01; 
Fibronectin: r = 0.6558, P<0.05; Laminin: r = 0.9791, P<0.0001) further supporting this 
hypothesis. In parallel with this study, KSHV-inoculated HUVEC, seeded at 3x104cells/well 
prior to inoculation, were assayed for matrix deposition and cell density. The absorbance values 
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for collagen IV and fibronectin deposited by inoculated cultures were comparable to those for 
untreated HUVEC at the same cell density but for laminin were lower with KSHV inoculation 
(Figure 5.3B). Thus the observed reduction in laminin deposition by inoculated cultures was not 
an artifact of differences in cell density.   
Having identified an effect on protein deposition during the four days immediately after 
KSHV inoculation, I tested whether this change extended to later timepoints, relevant to the 
modulation of endothelial cell migration seen at day-seven. To investigate this, untreated and 
KSHV-inoculated HUVEC were cultured until day-seven post-inoculation before seeding for 
ELISA. Four-day basement membranes generated between days seven and eleven also showed a 
reduction in laminin deposition with inoculation whilst amounts of collagen IV and fibronectin 
were not altered (Figure 5.4), implying that a reduction in deposition of laminin was maintained 
for a long period after inoculation.  
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Figure 5.2: Effect of KSHV inoculation on the protein content of sub-endothelial matrix.  
HUVEC were plated in 96-well plates and inoculated with KSHV (KSHV-EC), UV-irradiated 
KSHV (UV-KSHV-EC) or were left untreated (UT-EC). Cells were stripped from the sub-
endothelial matrix on day-four post-inoculation using detergent lysis buffer. The matrix 
composition was analysed by ELISA with absorbance readout at 490nm for each protein. 
Absorbance values for KSHV-EC and UV-KSHV-EC cultures are reported relative to values for 
UT-EC. Data are mean  SEM for three to eight experiments. *** = P<0.0001 compared to value 
of 1 by t-test.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
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Figure 5.3: Relationship between cell density and matrix protein deposition.   
Untreated HUVEC (UT-EC) were plated in 96-well plates at densities between 0.3104cells/well 
and 3104cells/well. Each well had a growth area of 32mm2. Cells were stripped on day-four 
post- seeding using detergent lysis and the amounts of (A) collagen IV, (B) fibronectin and (C) 
laminin present in the sub-endothelial matrix analysed by ELISA with absorbance readout at 
490nm. In parallel, cells at each density were fixed and nuclear stained using bisbenzimide 
(2g/ml). Absorbance was plotted against cell density for each protein (filled squares). Trend 
lines were fitted by linear regression. In parallel, HUVEC were plated in 96-well plates at 
3104cells/well and inoculated with KSHV (KSHV-EC) immediately following adherence. The 
four-day sub-endothelial matrix was analysed by ELISA and cell density determined. Data points 
for  absorbance and cell density of KSHV-EC are plotted superimposed on the scatter plots for 
UT-EC for reference but do not contribute to calculation of the trend lines for UT-EC. Data are 
the pooled results of two experiments.  
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Figure 5.4: Effect of long-term KSHV inoculation on the protein content of sub-endothelial 
matrix.  
KSHV-inoculated (KSHV-EC) and untreated (UT-EC) HUVEC cultures were transferred to 
wells of a 96-well plate on day-seven post-inoculation. Cells were cultured for four days then 
stripped from the sub-endothelial matrix using detergent lysis. The matrix composition was 
analysed by ELISA with absorbance readout at 490nm for each protein. Absorbance is reported 
for KSHV-EC basement membrane protein deposition relative to UT-EC.  Data are mean  SEM 
for three experiments. * = P<0.05 compared to value of 1 by t-test.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
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To assess the possibility that a secreted factor was responsible for the decrease in laminin, 
sub-endothelial matrix generated by four-day untreated HUVEC cultures was incubated in the 
presence of supernatants taken from untreated or KSHV-inoculated cultures. Since culture media 
were routinely changed every two days, 0-2 and 2-4 day post-inoculation culture supernatants 
were tested separately. Neither supernatant reduced the laminin or collagen IV content (Figures 
5.5A, B).  
Whilst the above suggested that a secreted factor was not responsible for KSHV-induced 
reductions in laminin, it was considered that the responsible factor(s) might have been at 
insufficient concentration in the culture supernatant or that a membrane-bound protease might be 
responsible. To further investigate the role of proteases, broad spectrum MMP and serine 
protease inhibitors, Galardin and Aprotinin respectively, and an MMP2/MMP9 selective 
inhibitor, were included in the culture media of untreated and KSHV-inoculated cultures 
throughout the deposition phase. None of these treatments impaired the reduction in laminin that 
occurred with KSHV inoculation (Figure 5.6) supporting the conclusion that secreted or 
membrane-presented enzymes did not reduce laminin deposition.  
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Figure 5.5: Effects of culture supernatants from KSHV-inoculated cultures on the 
composition of previously deposited sub-endothelial matrix.  
Four-day sub-endothelial matrices deposited by untreated HUVEC were exposed for two days to 
two-day supernatants (days 0-2 or 2-4 post-inoculation) collected from KSHV-inoculated 
(KSHV-EC) or untreated (UT-EC) HUVEC, before analysis of (A) laminin or (B) collagen IV 
content by ELISA. Absorbance at 490nm is reported for matrices exposed to culture 
supernatants relative to that for matrices treated with unconditioned medium. Data are mean  
SEM for two experiments.  
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Figure 5.6: Effects of inhibitors of matrix-metalloproteinases or serine proteases on 
KSHV-induced suppression of laminin deposition in the sub-endothelial matrix.  
HUVEC were plated in 96 well plates and inoculated with KSHV immediately following 
adherence (KSHV-EC) or were left untreated (UT-EC). Cells were cultured during the four-day 
matrix deposition period of the ELISA assay for laminin in the presence or absence of the 
broad-spectrum matrix-metalloproteinase (MMP) inhibitor Galardin (10M), the serine protease 
inhibitor Aprotinin (50mg/ml) or a selective inhibitor of MMP2/MMP9 (MMP2/9i) (50M). 
Endpoint absorbance at 490nm is reported relative to that for the UT-EC matrix treated with 
fresh medium. Data are mean  SEM for three experiments.  
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Since protease activity did not appear responsible for the reduction in laminin, it was 
hypothesized that KSHV infection might impair the production or secretion of the laminin 
constituent chains. Flow cytometry for intracellular laminin was used to examine this since a 
block in secretion would be reflected by intracellular accumulation and therefore an increase in 
intracellular staining, whilst either a decrease in production, or the targeted degradation of 
intracellular stores, would cause a decrease in staining. However, neither KSHV-infected nor 
non-infected cells showed an altered intracellular laminin content compared to untreated HUVEC 
by flow cytometry (Figure 5.7).  
It is possible however, that intracellular stores were maintained at a constant level if 
production and secretion were both reduced. For this to occur, regulation would be evident at the 
level of transcription or translation.  
To determine whether laminin transcription was affected by the virus, semi-quantitative 
reverse transcription polymerase chain reaction (RT-PCR) primers were designed to amplify 
transcripts of each of the ,  and  laminin chains present in the main endothelial laminins 
(laminins 411, 511, 421 and 521). -actin as an endogenous control and KSHV-ORF71/vFLIP as 
an infection control were amplified in parallel using primers already available. Titration of 
template cDNA confirmed that differences in the amount of template present could be resolved 
by this method when the number of amplification cycles was optimal as illustrated for -actin 
(Figure 5.8). The number of cycles for each pair of primers was such that the band generated on 
the ethidium bromide gel did not saturate the image, permitting densitometry of the banding 
pattern. For example, for -actin, using 0.5l cDNA per reaction, the optimum cycle number was 
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between 20 and 25 cycles. I settled for 21 cycles for -actin. Overall, no change in the transcript 
level was detected for any of the laminin chains studied (Figure 5.9). 
 
 
 
 
Figure 5.7: Effect of KSHV inoculation on intracellular levels of laminin. 
Intracellular levels of laminin were assessed by flow cytometry for KSHV-infected (V) (GFP 
positive), non-infected (NI) (GFP negative) and untreated (UT-EC) HUVEC. The median 
fluorescence of staining is expressed for the V and NI cell populations relative to the level for 
UT-EC. Data are mean  SEM for four experiments.  
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Figure 5.8: Effect of the number of PCR amplification cycles upon the resolution of a 
cDNA titration when analysed by ethidium bromide gel electropheresis. 
A two-fold dilution series of cDNA template was prepared and added to the PCR reaction 
mixture such that 0.5, 0.25 and 0.125l cDNA volumes were included per 25l reaction. 
Samples were amplified for 20, 25 or 29 PCR cycles. No products were detected for the no 
template (NT) and no reverse transcriptase (-RT) cDNA controls with 29 cycles of 
amplification. This confirmed the specificity of the PCR for mRNA and/or absence of DNA 
contamination in the preparation.      
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Figure 5.9: Effect of KSHV inoculation on transcript levels of endothelial laminin 
subunits.  
Total RNA was isolated from untreated (UT-EC) and KSHV-inoculated (KSHV-EC) cultures 
on day-four post-inoculation and mRNAs for the laminin chains that constitute laminins 411, 
511, 421 and 521 (4, 5, 1, 2 and 1 chains) amplified by PCR. -actin and KSHV-
ORF71/vFLIP mRNAs were amplified by PCR in parallel as endogenous and infection controls 
respectively. (A) Ethidium-bromide gel electrophoresis photographs for one HUVEC donor, 
representative of three. No template and without reverse transcriptase controls gave no 
detectable bands by ethidium bromide gel electrophoresis (not shown). (B) Densitometry of 
ethidium-briomide gel electrophoresis photographs. Normalisation is to -actin. Expression is 
reported for KSHV-EC relative to UT-EC. Data are mean  SEM for three experiments. 
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The laminin antibody used for ELISA was a monoclonal antibody generally assumed to give 
a measurement of total laminin. It was raised against the P1 pepsin-resistant fragment of human 
placental laminin but the precise location and conformation of the epitope recognised is not 
known. To investigate further the reduction in laminin, referred to as laminin-P1 in the remainder 
of this thesis, chain-specific antibodies against the main endothelial laminin alpha chains, 
laminin-4 and laminin-5, were used. In contrast to laminin-P1, ELISA for laminin-4 
identified a three-fold increase in the laminin-4 chain with KSHV-inoculation. The response 
was much reduced using UV-irradiated KSHV (Figure 5.10A). In addition, flow cytometry for 
intracellular laminin-4 showed a small but statistically significant increase in intracellular 
laminin-4 in KSHV-infected HUVEC (Figure 5.11). KSHV infection also appeared to increase 
laminin-5 deposition (Figure 5.10B) although the absorbance values for laminin-5 were very 
low.  
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Figure 5.10: Effect of KSHV inoculation on the laminin-alpha chain content of sub-
endothelial matrix.  
HUVEC were plated in 96-well plates and once adhered were inoculated with KSHV (KSHV-
EC), UV-irradiated KSHV (UV-KSHV-EC) or were left untreated (UT-EC). Cells were stripped 
from the sub-endothelial matrix on day-four post-inoculation using detergent lysis and (A) 
laminin-4 chain or (B) laminin-5 chain contents of the matrix analysed by ELISA using chain 
specific antibodies. Absorbance at 490nm is reported. Data are mean  SEM for four-to-six 
experiments (A) or two experiments (B). * = P<0.05; *** = P<0.0001 by paired t-tests 
comparing to UT-EC.   
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Figure 5.11: Effect of KSHV inoculation on intracellular levels of the laminin-4 chain. 
Intracellular levels of the laminin-4 chain were assessed by flow cytometry for KSHV-infected 
(V) (GFP positive), non-infected (NI) (GFP negative) and untreated (UT-EC) HUVEC. The 
median fluorescence of staining is expressed for the V and NI cell populations relative to the 
level for UT-EC. Data are mean  SEM for three experiments. ** = P<0.01 compared  to value 
of 1 by t-test.     
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5.2.3 The effect of deposited matrices on endothelial cell migration 
I hypothesised that the changes to sub-endothelial matrix laminins might underlie the 
enhanced motility of cells within KSHV-inoculated cultures. To test this, wound recovery assays 
were carried out on matrices deposited by KSHV-inoculated and untreated cultures. The wound 
recovery method was chosen since, based on previous studies (Butler et al., 2005) a basement 
membrane could be generated on plates then stripped and used as a substrate for newly deposited 
HUVEC.  
Untreated or KSHV-inoculated HUVEC cultures were seeded in wound recovery culture 
inserts for 24hours to deposit matrix proteins. The HUVEC were removed by cell lysis and fresh, 
untreated HUVEC seeded on to the matrix for six hours, before inserts were removed and wound 
recovery analysed. A short seeding period was used to minimise deposition of basement 
membrane by the untreated endothelial cells. Recovery was tested in parallel on uncoated plastic 
for comparison. There was a trend toward increased recovery on deposited matrices compared to 
uncoated plastic, with recovery consistently greater on matrix from KSHV-inoculated cultures 
than on plastic. However, there was no significant difference between recovery on the KSHV-
inoculated and untreated cell matrices (Figure 5.12).  
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Figure 5.12: Effects of matrix proteins, deposited by KSHV-inoculated (KSHV-EC) or 
untreated (UT-EC) HUVEC cultures, upon HUVEC migration.  
KSHV-inoculated (KSHV-EC) and untreated (UT-EC) HUVEC were seeded in wound recovery 
culture inserts on day-six post-inoculation, allowed to deposit matrix proteins for 24hours then 
stripped using detergent lysis. Untreated HUVEC were plated on the matrices and wound 
recovery in 18hours was measured for each surface. Results were also compared to migration on 
uncoated plastic-ware (None). These control inserts received culture media during the 
deposition phase and received lysis buffer and washings in parallel with matrix-protein coated 
inserts prior to seeding of cells for migration analysis. (A) Each line represents the matched 
results for a different experiment. Error bars represent the SEM for duplicate or triplicate 
wounds in an experiment. (B) Data in A illustrating the mean and SEM for the four (None) or 
five (UT-EC and KSHV-EC) experiments. ** = P<0.01 by paired t-test.   
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5.2.4 The effect of reducing laminin-4 chain expression on endothelial cell 
migration  
To study further the involvement of KSHV-induced modulation of the basement membrane 
on migration, in particular the substantial (three-fold) upregulation of laminin-4, the effect of 
knocking down laminin-4 using siRNA on transmigration was tested. The transmigration assay 
was chosen for its greater resolution, given no requirement for pre-deposition of a matrix. 
Three siRNA duplexes to laminin-4 were purchased (A, B and C) and tested in preliminary 
experiments at 5nM and 50nM concentrations. 48hours following transfection, cells were stained 
for intracellular laminin-4 expression and analysed by flow cytometry. siRNA duplexes A and 
C decreased intracellular laminin-4 48hours post-transfection but duplex B did not (Figure 
5.13). Since duplex C gave the greatest knockdown it was chosen for optimisation in subsequent 
preliminary experiments. Duplex B was also pursued as a possible control for the study.  
The duration of transmigration assays was 48hours (Chapter 4, section 4.2.1) and the assays 
began immediately upon seeding cells into the transwell chamber; thus knockdown of laminin-4 
had to be established prior to transferring cells to the transwell chambers and had to be sustained 
throughout the 48hour transmigration period. To satisfy these requirements, untreated and 
KSHV-inoculated HUVEC were transfected twice (double transfection) in subsequent 
experiments. The first transfection was on the day prior to seeding the cells into the 
transmigration assay and was performed in order to reduce laminin-4 in cells before they 
entered the functional stage of the assay. The second was immediately before seeding the cells 
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into the transmigration assay and was performed in order to maintain laminin-4 knockdown for 
the full 48hours.  
Using this protocol, transfection with duplex C gave approximately 70% reduction in 
intracellular laminin-4, combination of duplex A with duplex C gave no further reduction, and 
duplex B did not give significant reduction (Figure 5.14A). ELISA on two-day sub-endothelial 
matrices, for cells plated immediately following the second transfection confirmed that a 
reduction in laminin-4 deposition was achieved with duplex C (Figure 5.14B). Using duplexes 
C and A together did not improve the efficiency of knockdown judged by deposited laminin. 
Therefore it was decided to use duplex C alone in the transmigration assays. Duplex B and a non-
specific control siRNA were also used in order to verify that any effects of knockdown were 
specific.  
Using the optimal conditions for knockdown of laminin-4, transmigration assays were 
performed. Flow cytometry and ELISA confirmed knockdown of laminin-4 for untreated, 
KSHV-infected and non-infected cells treated with duplex C (Figures 5.15A, B). However, 
although the deposition of laminin-4 by siRNA-treated-KSHV-inoculated cultures was reduced 
to a level close to that produced by untreated control HUVEC using duplex C siRNA, their 
transmigration rates were not reduced (Figure 5.15C).  
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Figure 5.13: Comparison of the efficiency of siRNA duplexes in knockdown of the laminin-
4 chain in HUVEC. 
HUVEC were transfected with three different ‘off the shelf’ siRNA duplexes (A, B and C) using 
RNAiMAX lipofectamine reagent as the carrier. Duplexes were at final concentrations of 5 or 
50nM. Intracellular levels of laminin-4 were measured by flow cytometry 48hours post-
transfection. The median fluorescence intensity (MFI) of staining is reported relative to the 
value for control cells treated with lipofectamine alone. Results are from a single experiment. 
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Figure 5.14: Comparison of the efficacy of siRNA duplexes used singly and in combination 
in knockdown of the laminin-4 chain in HUVEC.  
HUVEC were transfected with 100nM siRNA duplexes (A, B or A+C (1:1)), or lipofectamine 
only (no siRNA). After 24hours cells were retransfected with the same siRNAs at 100nM 
concentration and either transferred to 96-well plate format for ELISA or kept in culture for a 
further 48hours before analyzing (A) intracellular laminin-4 chain levels by flow cytometry 
(relative to no siRNA) and (B) laminin-4 chain deposition by ELISA (relative to no siRNA). In 
B, to account for possible differences in cell number across treatments, parallel samples were 
analysed for fibronectin, and absorbance due to laminin was normalised to the absorbance due to 
fibronectin. Data are from a single experiment. 
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Figure 5.15: Effects of laminin-4 chain siRNA on laminin-4 content and deposition, and 
on transmigration for KSHV-inoculated (KSHV-EC) and untreated (UT-EC) HUVEC.  
HUVEC were transfected with lipofectamine only (no siRNA), or 100nM final concentration of 
either negative control siRNA (Control), or duplex B or duplex C on day six-post inoculation 
and were retransfected on day-seven. Cells were then either left in culture; transferred to wells 
of a 96-well plate; or transferred to 24-well format 8m pore transwell chamber filters for 
analysis after 48hours of: (A) intracellular laminin-4 chain content; (B) laminin-4 chain 
deposition or (C) transmigration. Data are mean  SEM for three experiments (A and C) or two 
or three experiments (B). * = P<0.05, ** = P<0.01 by paired t-test. In B, to account for possible 
differences in cell number across treatments, parallel samples were analysed for fibronectin, and 
absorbance due to laminin was normalised to the absorbance due to fibronectin.  
 
 
 
 
 
CHAPTER FIVE: Effect of KSHV upon the sub-endothelial matrix and cell surface integrins  
 
221 
 
 
CHAPTER FIVE: Effect of KSHV upon the sub-endothelial matrix and cell surface integrins  
 
222 
 
5.2.5 The effect of KSHV infection on the expression of endothelial cell surface 
integrins 
Transmembrane integrin heterodimers provide the functional connections between the 
extracellular matrix and the cell cytoskeleton and their binding regulates cell migration. 
Accordingly, I examined whether KSHV inoculation altered expression of surface integrins. 
KSHV-inoculated and untreated HUVEC were surface-stained using a panel of antibodies against 
integrin subunits (1, 3, 2, 6) or heterodimers (v3, 31) and the intensity of staining was 
analysed by flow cytometry (Figures 5.16 and 5.17). The greatest change observed was an 
approximate doubling in integrin 6 on KSHV-infected cells. There were smaller increases 
(~25%) in integrins 31 and v3 on the non-infected cells, but not infected cells. KSHV 
inoculation did not alter expression of integrins 1, 3 or 2 on KSHV-infected or non-infected 
HUVEC compared to untreated controls (Figure 5.17).  
I postulated that increased integrin 6 expression might contribute to preferential 
transmigration of KSHV-infected cells. To test this hypothesis, transmigration assays were 
performed in the presence of a function-blocking antibody against integrin 6. The antibody did 
not affect the transmigration of either untreated or KSHV-inoculated cultures although the 
difference between them was lost (Figure 5.18). 
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Figure 5.16: The effect of KSHV inoculation upon the HUVEC surface-integrin expression 
profile.  
KSHV-inoculated (KSHV-EC) and untreated (UT) HUVEC cultures were stained on day-seven 
post-inoculation for their surface expression of the integrin subunits/heterodimers: 1, 3, 2, 
31, v3 and 6. KSHV-infected (V) cells were distinguished from non-infected (NI) cells 
within KSHV-EC monolayers on the basis of GFP positivity. Representative histograms for 
integrin staining of UT, V and NI.  
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Figure 5.17: The effect of KSHV inoculation upon the HUVEC surface-integrin expression 
profile.  
KSHV-inoculated (KSHV-EC) and untreated (UT) HUVEC cultures were stained on day-seven 
post-inoculation for their surface expression of the integrin subunits/heterodimers: 1, 3, 2, 
31, v3 and 6. KSHV-infected (V) cells were distinguished from non-infected (NI) cells 
within KSHV-EC monolayers on the basis of GFP positivity. Integrin expression on V and NI 
was measured in terms of median fluorescent intensity and expressed relative to expression on 
UT. Data are mean  SEM for three-to-six experiments. * = P<0.05 compared to value of 1 by t-
test.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
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Figure 5.18: Effect of blocking integrin 6 on KSHV-enhanced transmigration of HUVEC. 
KSHV-inoculated (KSHV-EC) and untreated (UT-EC) HUVEC were plated into 8m pore 
transwell culture inserts on day-seven post-inoculation and the percentage transmigration after 
48hours examined by microscopy for cells in the presence or absence of a function-blocking 
antibody against integrin 6 (10µg/ml). Data are mean +/- SEM for  three experiments.  
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5.3 DISCUSSION 
In vivo, a thin sheet-like network of protein fibres, termed the basement membrane, interfaces 
the endothelium and underlying extracellular matrix and has critical regulatory effects upon the 
functions of the endothelium, including cell migration (Hamill et al., 2009; Kruegel and Miosge, 
2010). In this chapter the effect of KSHV infection upon the composition of the vascular sub-
endothelial matrix generated in vitro was studied by ELISA and subsequently the matrix was 
tested for its role in the enhancement of cell migration with KSHV infection. Alterations to the 
cell surface profile of integrin receptors of basement membrane proteins were also examined and 
tested for involvement in KSHV-increased cell migration. Clear changes in deposition of 
laminin-P1, and laminin-4 and upregulation of 6 integrin surface expression were found with 
KSHV infection but none of these changes was demonstrated to underlie KSHV-enhanced cell 
migration. 
The predominant proteins of the endothelial basement membrane include collagen IV, 
fibronectin and laminins. Whilst KSHV inoculation modulated the laminin composition, reducing 
laminin-P1 and increasing amounts of the laminin-4 chain it did not alter the abundance of 
either collagen IV or fibronectin (Figure 5.2). Inoculating with UV-inactivated KSHV, laminin-
P1 was not altered and the upregulation of laminin-4 deposition was much reduced (Figures 5.2 
and 5.10), confirming that KSHV infection and gene expression underlie these responses. The 
effects were evident for four-day matrices deposited between days zero and four post-inoculation 
(Figure 5.2) and also for two or four-day matrices started on day-seven (Figures 5.15 and 5.4). 
Thus, the changes incurred to the sub-endothelial matrix with KSHV inoculation were chronic 
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rather than acute. The underlying cause for the alterations in laminin with infection remains 
unclear but these studies ruled out several mechanistic possibilities.  
With KSHV inoculation, there was no evidence for changes in mRNA levels of any of the 
main endothelial laminin chains which could explain reduced trimer formation and thus reduced 
laminin-P1 deposition (Figure 5.9). Intracellular laminin-P1 was constant across untreated, non-
infected and KSHV-infected cells (Figure 5.7); therefore, KSHV inoculation did not appear to 
suppress laminin-P1 deposition by inhibiting either its translation or secretion. However, if cells 
have tight control over their intracellular laminin levels, then it is possible that even under 
conditions of impaired secretion, intracellular laminin-P1 content was maintained. This might be 
achieved by the upregulation of proteasomal activity or suppression of laminin translation.  
The observation that the transcription of one or more laminin chain mRNAs was not altered 
by KSHV inoculation was unexpected since Hong et al (2004) previously reported 
downregulation of laminin gene expression following KSHV infection. Titration of cDNA 
followed by PCR with readout of relative transcript abundance by ethidium bromide 
electrophoresis indicated that a three-fold difference in expression, as observed for laminin-4 
deposition by ELISA, should have been detectable by the semi-quantitative PCR method if 
enhanced transcription was responsible for the increase in laminin-4 with infection; thus it is 
unlikely that the discrepancy between the two studies was due to insufficient sensitivity of the 
semi-quantitative PCR approach used in the present study. 
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Proteolytic degradation of deposited protein by the action of secreted proteases was an 
alternative hypothesis for the decrease in laminin-P1. However, exposure of normal sub-
endothelial matrices to supernatants from KSHV-inoculated cultures failed to mimic the effects 
of KSHV inoculation (Figure 5.5) and adding protease inhibitors against enzymes known to act 
on laminins, including MMPs and serine proteases such as plasmin (reviewed by Tzu and 
Marinkovich, 2008) did not prevent the reduction in laminin-P1 with infection (Figure 5.6). This 
result was surprising since the expression of a number of MMPs has been reported in KS tumour 
cells and KSHV infection is known to upregulate the transcriptional expression, synthesis and 
activity of matrix degrading proteases including: MMP1, MMP2 and MMP9 (Meade-Tollin et 
al., 1999; Qian et al., 2007; Wang et al., 2004b). Nonetheless, increased MMP activity would be 
expected to have decreased the collagen-IV and fibronectin content too (Visse and Nagase, 2003; 
Zeng et al., 1999) but this was not observed, suggesting that the actual mechanism by which 
KSHV altered sub-endothelial laminins was more selective toward laminin. 
In contrast to observations for laminin-P1, the intracellular expression of laminin-4 was 
increased in KSHV-infected compared to untreated cells. There was also a trend toward 
upregulation in non-infected cells (Figure 5.11). Therefore, expression of the laminin-4 chain 
may have been enhanced at the level of translation by KSHV infection. The rise in laminin-5 
deposition, also identified with KSHV infection (Figure 5.10), suggested that KSHV may have 
altered the expression of multiple laminin chains. It might also have been interesting to examine 
the changes in deposition of the and  endothelial laminin chains individually in order to 
confirm whether the effect was specific to  chains but a panel of antibodies to single laminin 
chains was not available for the study.  
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Models for laminin heterotrimer formation and deposition describe trimerisation of the ,  
and  chains to precede secretion. However, when recombinant ,  and  chains of mammalian 
laminin 111 were expressed singly and in all combinations, only the  chain was detected 
secreted into the supernatant, both as intact protein and protein cleaved in the coiled coil domain, 
when expressed alone. This was in contrast to the  and  chains which remained intracellularly 
localised irrespective of whether they were expressed singly or together:  and dimers 
formed but heterotrimerisation with the chain was necessary for secretion. Thus  for the 
deposition of laminins, the  chain appears to drive secretion but it might also be secreted 
independently (Yurchenco et al., 1997). Increased laminin-4 chain secretion might therefore 
explain the opposite results obtained in the present study by ELISA using anti-laminin-P1 and 
anti-laminin-4 antibodies. 
Integrin 6 is a laminin-4 binding integrin. Possibly the upregulation of integrin 6 on the 
surface of KSHV-infected HUVEC (Figure 5.17) reflected a feedback mechanism induced by the 
increased ligand availability. The upregulation of integrin 6 was a specific response of KSHV-
infected cells and was therefore hypothesized to have a role in KSHV-enhanced transmigration 
but while the difference in transmigration of untreated and KSHV-inoculated cultures was not 
significant in the presence of a function blocking antibody to integrin 6, the reduction in 
enhanced transmigration was slight (Figure 5.18). Thus, upregulation of integrin 6 might 
contribute to the mechanism that underlies KSHV-enhanced transmigration but is unlikely to be 
the principle factor responsible for this behavior. The assessment of the percentage of GFP 
positive cells on either side of the transwell chamber filter at the 48hour timepoint in the presence 
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and absence of an integrin 6 blocking antibody would provide further verification of the extent 
of involvement of this integrin in enhanced endothelial cell migration.  
The absence of a convincing role for integrin 6 in this study might have reflected the 
cooperative actions of several laminin-binding integrins. In this regard one study identified that 
the addition of blocking antibodies to either integrin 3 or integrin 6 had minimal effect upon 
the adhesion of endothelial cells to the G919-1207 domain of recombinant laminin-4 (the region of 
laminin to which integrin-attachment had been attributed), whereas adding the antibodies in 
combination reduced adhesion by over 54% (Gonzalez et al., 2002). The use of multiple integrin 
receptors for binding laminin has also been reported by others (Lotz et al., 1990; Rabinovitz et 
al., 1995). Consistent with KSHV as the aetiologic agent for malignancies, elevated integrin 6 
expression is reported for other lesions. This is in contrast to a number of other integrins that are 
downregulated; for example integrins 3, 4, 5, 7 and v are reduced in prostate cancer (Goel 
et al., 2008).  
Although upregulation of integrin 6 was not demonstrated to affect motility in the assays 
reported in this thesis, studies in the context of other cancers have implicated increased integrin 
6 expression in the induction of a migratory and invasive phenotype important for angiogenesis 
and metastasis. There are suggestions that cleavage of integrin 6 by urokinase-type plasminogen 
activator may be important for promoting invasion and migration (Pawar et al., 2007) and disease 
progression (King et al., 2008). In addition, remodeling of the basement membranepacking the 
basement membrane beneath the cell and removing it from adjacent areasmight be involved. 
Such promigratory roles for integrin 6 were however observed for cells grown on exogenous 
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laminin-rich substrates (Primo et al., 2010; Rabinovitz et al., 1995); accordingly these reports 
cannot be directly compared with the uncoated transwell system used in this thesis and it is 
possible that on laminin-rich substrates, the migration of KSHV-infected cells would also be 
regulated compared to untreated HUVEC in an integrin 6 dependent manner.  
A promigratory function for integrin 6 is not however supported by all reports. For example 
one study concluded that integrin 31 is the predominant mediator of keratinocyte migration 
whereas integrin 64 functions to provide anchorage (Nguyen et al., 2000). In carcinogenesis, it 
is suggested that a major role of integrin 6 is the promotion of cell survival through activation 
of the PI3K-Protein kinase B (PKB) pathway leading to the induction of VEGF (Chung et al., 
2002). VEGF might in fact feedback positively to upregulate integrin 6 since studies on 
HUVEC have shown that VEGFA and FGF-2 stimulate HUVEC expression of integrin 6 
(Primo et al., 2010). In view of the latter, it is possible that induction of VEGF by KSHV 
infection, a previously reported response (Sivakumar et al., 2008), supported the increase in 
integrin 6 expression by infected cells. However, non-infected HUVEC also express receptors 
for VEGF. Therefore, it is predicted that an alternative stimulus, cell intrinsic or extrinsic, to 
which KSHV-infected cells selectively respond, upregulating integrin 6, underlies the 
upregulation of integrin 6 induced by KSHV infection of HUVEC.  
Although the studies in this chapter did not provide a link between an upregulated integrin 
and enhanced migration, other integrins not screened might be altered upon KSHV infection and 
function in this capacity. For example, HCMV infection of endothelial cells led to upregulation 
of the epithelial-associated integrin v6 (Tabata et al., 2008).  
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It is important to note here that after the research reported in this thesis was completed 
DiMaio et al (2011) published that latent KSHV infection of endothelial cells increased integrin 
expression at both the mRNA and total protein levels and led to a modest increase in integrin 
vsurface expression. Since the effect of KSHV on integrin mRNA transcript levels was not 
examined in this thesis; it is not possible to compare directly the results of the two studies. 
Moreover, the rise in 3 protein on KSHV infected endothelial cells, reported by DiMaio et al 
(2011), was at the level of total protein rather than surface protein as examined in this chapter. 
Although DiMaio et al (2011) showed by flow cytometry an increase in surface v3 on TIME 
cells, it was only a modest enhancement in comparison to the increase in total integrin 
expression. Therefore, considering that the inter-experiment variability would be expected to 
be greater with primary HUVEC compared to the TIME cell line, when using different HUVEC 
donors for each experiment, it is perhaps not surprising that no overall effect of KSHV infection 
on integrin v3 was found in the present study. However, it is also possible that different 
endothelial cell types respond differently and that time of observation post-infection is influential. 
Indeed DiMaio et al (2011) looked at 48hours post-inoculation of microvascular endothelial cells 
whereas the work on integrin expression in this thesis was at day-seven post-inoculation of 
macrovascular endothelial cells.  
In their study DiMaio et al (2011) also reported enhanced FAK and Src activity in infected 
cells and suggested that RGD peptide-binding integrins, such as v3, were necessary for the 
adhesion of infected cells to RGD peptide-containing proteins (fibronectin and vitronectin) and 
also for the formation of capillary-like structures by infected cells. For the same behaviours by 
untreated cells they were more dispensible. Since v3 was only modestly increased on infected 
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cells (DiMaio et al., 2011) the activity of an integrin rather than its surface expression level might 
be more indicative of its role in a cell behavior such as motility, thus it would be informative to 
perform transmigration assays in the presence of function blocking antibodies or siRNA to a 
panel of integrins before ruling out their role in the phenotype of KSHV-enhanced HUVEC 
motility on the basis of no change in surface expression.  
The alterations in laminin composition of the sub-endothelial matrix observed in this chapter 
invited the hypothesis that KSHV-enhanced migration is facilitated by the changes to the laminin 
profile. Despite the heterotrimeric structure of all laminin molecules, different patterns of laminin 
deposition are found in extracellular matrices generated by cultured cells (Hamill et al., 2009). It 
is proposed that the different organizations in vitromeshworks, fibrils, rosette, punctuate or 
linear arrays, strings and plaquesrelate to different stages in matrix formation and or 
differences in function, including support of migration of adhering cells. For example, laminin-
322 of non-migrating human keratinocytes has a rosette pattern whereas that of migrating 
keratinocytes is assembled into trails (Sehgal et al., 2006). Whether such distinctions in pattern 
underlie differences in motility, or whether they are manifestations of differences in migratory 
behavior is not known (Hamill et al., 2009), but in support of regulation of migration by 
basement membrane pattern, matrix generated by wildtype cells was able to recover a normal 
migratory phenotype to abnormally migrating integrin 4-deficent cells (Sehgal et al., 2006).  
Disappointingly, in these studies, sub-endothelial matrix deposited by KSHV-inoculated HUVEC 
was unable to confer enhanced migratory behaviour to untreated HUVEC, suggesting that if 
matrix composition and/or organization facilitate enhanced motility, the process of depositing the 
altered matrix is also important.  
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In view of the three-fold upregulation in laminin-4 deposition with KSHV infection, 
laminin-4 was hypothesized to be a laminin chain of major importance in the mediation of 
KSHV-induced basement membrane protein effects on endothelial cell behaviors, which might 
include migration. According to the ‘three arm hypothesis’ for the polymerization of laminin 
herterotrimers, laminin-4-containing laminins are incapable of self or co-polymerisation (Cheng 
et al., 1997). Hence, it is plausible that the enrichment of laminin-4-containing laminins in 
KSHV-infected sub-endothelial matrix renders a matrix with a looser structure which in turn 
influences motility.  
It was considered that if the actual process of depositing an altered matrix governs, at least in 
part, the propensity of cells to migrate, then reducing laminin-4 production might prevent 
enhanced endothelial cell migration. However, using siRNA to knockdown laminin-4 mRNA 
and reduce deposition of the laminin-4 chain to a level similar to or lower than that detected in 
matrices generated by untreated HUVEC failed to inhibit KSHV-enhanced transmigration 
(Figure 5.15). Although these data imply that laminin-4 is not a principal determinant of the 
migration phenotype with infection, the compensatory effects of other laminin chains also 
upregulated by KSHV-infection, such as laminin-5, or induced by laminin-4 depletion, might 
have contributed to the maintenance of a normal response when laminin-4 was depleted. 
Moreover, although laminin-4 abundance was reduced using siRNA, the pattern of deposited 
laminin might not have been restored to that laid down by HUVEC not treated with virus, thereby 
facilitating maintenance of enhanced transmigration if the patterning of basement membrane 
proteins was a significant regulator of cell migration. 
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As stated above, KSHV infection also affected laminin-P1. Had cell numbers permitted, it 
would have been interesting to examine by ELISA whether reducing laminin-4 also restored 
laminin-P1 levels as this would have provided greater insight into whether increased laminin-4 
deposition was a key determinant of KSHV-induced changes to basement membrane laminins 
and indicate whether the matrix laid down by inoculated cultures treated with siRNA against 
laminin-4 had been brought closer in composition to that of untreated cultures. Nonetheless, 
even if homeostatic amounts of laminins were re-established with laminin-4 knockdown, the 
patterns of assembly by inoculated cultures might have remained abnormal and affected cell 
migration rates. 
Whilst these studies failed to demonstrate an effect of KSHV-induced modulation of 
basement membrane laminins upon migration rates, a number of caveats are linked to the 
methods used. In the wound recovery assay performed to examine the migration of untreated 
HUVEC on matrix deposited by untreated and KSHV-inoculated cultures (Figure 5.12), the 
matrix was stripped using detergent lysis. Although it was possible to quantify basement 
membrane protein constituents following lysis treatment, the impact of the detergent upon the 
organization of the matrix is not known. Potentially it was unwittingly disrupted and 
consequently the influence of the matrix was not properly tested.  
A second issue was that by using culture inserts to generate the HUVEC monolayers in these 
assays, the sub-endothelial matrix substrate was only laid down beneath the migrating monolayer 
and did not coat the plastic in the region of the wound. Consequently, whilst cells within the 
monolayer migrated over basement membrane, cells at the wound front passed onto plastic. 
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Consequently, in the region of the recovering wound, untreated and KSHV-inoculated assays 
became essentially equivalent and whilst this assay was designed to recapitulate the original 
wound recovery systemwhere cells in the monolayer could migrate over matrix deposited 
between plating and the start of wound recovery but the intervening space was not coatedit was 
perhaps not the most discriminating of assays to address whether deposited matrix can influence 
migration rates.   
The role of sub-endothelial matrix in underlying KSHV-enhanced two-dimensional migration 
might have been better resolved had it been possible to coat the intervening space with matrix. 
For this, multi-well plates might have been used as the culture surfaces but the culture inserts for 
wound recovery would not stick to the wet surface after stripping the endothelium. If coated 
surfaces were allowed to dry before placing the inserts into position, they would form a seal but 
dehydration and denaturation of the substrate with this approach was a concern as was the effect 
on the integrity of the matrix of pulling the insert from the plate at the start of the assay. 
Moreover, the low power magnification (using a 4x objective lens) meant that 12-well plates or 
larger would have been required with this approach in order to provide suitable optics but they 
were not feasible as using them too many cells were needed to generate a confluent monolayer 
(section 4.2.3). Traditional scratch assays were therefore not an option either and were also not 
favoured due to the need to scratch the monolayer which might have perturbed the matrix 
integrity in the region of the scratch. Altogether it is felt that interrogation of a role for sub-
endothelial matrix composition and structure was limited in the present studies by technical 
constraints.   
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In summary, the effect of KSHV infection upon the composition of the sub-endothelial matrix 
of basement membrane proteins was examined in this chapter. The virus had a profound impact 
on the laminin component but had no effect on the abundance of either collagen IV or 
fibronectin. Laminin-P1 was reduced but there was three-fold upregulation of the laminin-4 
chain. In consort, increases in the surface expressions of laminin-4 binding integrins were 
identified. Most notable was a selective rise in integrin 6 on KSHV-infected cells. Roles for 
these changes to the sub-endothelial matrix or integrin 6 expression in KSHV-enhanced 
HUVEC migration were not found using the techniques available but this does not rule out their 
contribution to the mechanism. With regard to the sub-endothelial matrix, homeostasis of the 
laminin component, both its content and pattern, was unlikely to have been attained with 
knockdown of the laminin-4 chain alone, and thus a structure supportive of enhanced cell 
migration was maintained, possibly involving compensatory upregulation of other laminin- 
chains. Such dramatic changes to the basement membrane composition are unlikely to be without 
functional influence in KSHV-related malignancies and are worthy of further investigation. For 
example, modulation of basement membrane might lead to the formation of vessels with a 
primitive architecture and support inflammatory cell recruitment contributing to the generation of 
the inflammatory component that is a hallmark of KS lesions. 
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6.1 INTRODUCTION 
Cell migration occurs in response to chemotactic, haptotactic and mechanotactic stimuli and 
is mediated by cyclical changes to the polymerization state and organization of the actin 
cytoskeleton. Cells attach to their underlying substrate via transmembrane integrin receptors and 
complexes of proteins called focal adhesions assemble at the intracellular tails of these integrins 
to link the extracellular matrix to the intracellular actin cytoskeleton. The number, size and 
distribution of focal adhesions might also influence migration rates. Since increased 
transmigration and rates of wound recovery had been identified with KSHV inoculation, an effect 
of the virus on the organization of the actin cytoskeleton and on focal adhesions was investigated 
in this chapter using confocal microscopy.   
6.2 RESULTS 
In these studies, fluorophore-conjugated phalloidin and anti-vinculin antibody were used to 
stain F-actin and vinculin respectively in order to observe the effect of KSHV infection upon the 
organization of the actin cytoskeleton and the size, number and distribution of focal adhesions 
(Figure 6.1). Phalloidin is a bicyclic heptapeptide that binds more tightly to F-actin than to 
monomeric actin; hence it prevents actin depolymerisation, maintaining the filament structure. 
Vinculin is one of the intracellular proteins recruited into focal adhesions to aid stabilization of 
the protein complex. Absence of staining with isotype control indicated the staining was not due 
to non-specific binding of the fragment crystallisable (Fc) portion of the antibody (Figure 6.1). 
Analysis was on day-seven post-inoculation because an effect of the virus upon motility had been 
clearly demonstrated at that timepoint (Chapter 4).  
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Figure 6.1 Effect of KSHV infection on the organization of F-actin and the distribution of 
focal adhesions in HUVEC.  
KSHV-inoculated (KSHV-EC) or untreated (UT-EC) HUVEC were seeded sub-confluent into 8-
well chamber slides on day-six post-inoculation. On day-seven, cells were fixed, permeabilised 
with 0.1% (v/v) Triton-X-100 and stained for F-actin and vinculin or isotype control. Nuclei were 
stained with bisbenzimide. Cells were imaged on an inverted laser scanning confocal microscope 
using a 63x water immersion objective lens. KSHV-infected cells were identified by their 
positivity for GFP expression. Arrows indicate redistribution of F-actin to the edge of KSHV-
infected cells (F-actin panel) and localization of vinculin to the tips of spindle-shaped infected 
cells (vinculin panel). Images are representative of over 30 cells of each type from across three 
experiments. Scale bars are 50m. 
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6.2.1 The effect of KSHV infection on the size and shape of HUVEC 
The sizes and shapes of the cells (including total cell area, perimeter and roundness) were 
first determined to enable measurements of the staining of F-actin and vinculin to be normalised 
according to parameters of cell size or shape. The images of phalloidin-stained F-actin were 
thresholded to establish the outline of the cell shape from which measurements of the total cell 
area and perimeter were made and roundness was calculated. KSHV infection did not alter the 
cell area (Figures 6.2A and B) but the change in morphology with infection from cuboid to 
spindle-shaped resulted in a significant increase in the length of the cell perimeter (Figures 6.2C 
and D). Roundness, a statistic that is inversely related to circularity, also increased with KSHV 
infection, consistent with the elongated shape of infected cells (Figures 6.2E and F).  
 
6.2.2 The effect of KSHV infection on the organisation of F-actin in HUVEC 
KSHV-infection appeared to induce redistribution of F-actin to the edge of the cell. This 
pattern was in contrast to the maintenance of a seemingly uniform distribution of F-actin across 
the cell in untreated HUVEC (Figures 6.1 and 6.3). Image analysis software was therefore used 
to quantify the extent of this distribution difference on a population basis.  
The effect of KSHV infection on the total amount of F-actin within HUVEC was first 
assessed. The mean phalloidin intensity of staining did not change with infection (Figures 6.4A 
and B). Consistent with the above observation that KSHV infection did not change the total area 
of a cell, the total phalloidin staining per cell was also not altered (Figures 6.4C and D). 
Therefore, KSHV infection did not change the extent of actin polymerisation in HUVEC. 
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To investigate whether KSHV directed localization of F-actin to the edge of the cell, as 
postulated from the appearance of phalloidin stained cells (Figures 6.1 and 6.3), I designed a 
method for image analysis which involved dividing each cell into concentric rings of equal area 
proportional to the size of the cell, and measuring the total intensity of phalloidin staining in each 
ring. A novel macro which divided the cells into four concentric rings was written in Image-Pro 
by David Kelly (Wellcome Trust Centre for Cell Biology, University of Edinburgh, UK) 
especially to handle this analysis. Consistent with conclusions based upon qualitative 
observations (Figures 6.1 and 6.3), ring number had an effect upon the intensity of phalloidin 
staining in KSHV-infected cells: intensity was significantly greater in the outermost ring (ring 4) 
compared to the middle two rings (rings 2 and 3). No effect of ring number was found for 
untreated cells (Figure 6.5).  
The extent of reorganization of the actin cytoskeleton with KSHV-infection might have been 
under reported by use of the macro to analyse the images. Reasons include: (1) the macro was 
unable to process a subset of the KSHV-infected cells that had very pronounced spindle 
morphology and apparently marked redistribution of actin to the cell edge; (2) the macro divided 
the cell into only four concentric rings which were generally wider than the band of strongest 
staining at the edge of the cell. The adjacent regions of lower intensity within the same ring 
would therefore have reduced the difference between the intensities of neighbouring rings; (3) 
actin filaments mostly align along the longest axis through the cell and end at the leading and 
trailing edges; hence staining at the leading and trailing edges appeared less bright and might 
have reduced the effect of the prominent staining along the other sides of the cell.  
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 I devised a second complementary method of image analysis for assessment of the effect of 
KSHV-infection upon F-actin distribution which aimed to overcome the above mentioned 
limitations of the macro-aided concentric ring approach. This second method compared the 
phalloidin intensity profiles of untreated and KSHV-infected cells along the axis which passed 
through the midpoint of the cell perpendicular to the longest axis between the leading and trailing 
edges (Figure 6.6A). The intensity profiles generated were separated into ten sections that gave 
five concentric rings (Figure 6.6B) and the average total intensity for each ring, normalized for 
ring width, was plotted (Figure 6.6C). An effect of ring number on phalloidin staining was 
evident by this method of analysis for both KSHV-infected and untreated cells. However, post-
hoc tests indicated that while untreated cells showed a difference between only the innermost and 
outermost rings, there was a stepwise increase in intensity of staining across all five rings in 
KSHV-infected cells (Figure 6.6C). 
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Figure 6.2: Effect of KSHV infection on the size and shape of HUVEC.  
Images of KSHV-infected (V) and untreated (UT) HUVEC stained for F-actin were thresholded 
to create a mask for each cell. The image analysis software, Image-Pro, was used to measure the 
total area of each cell (A and B) and its perimeter (C and D) and to calculate its roundness 
according to the equation: (Perimeter)2/(4Area) (E and F). (A, C and E) Each square represents 
the measurement of the area, perimeter or roundness for a single cell. Data are the pooled results 
of three experiments. Horizontal lines indicate the mean measurement for each parameter. * =  
P<0.05 by unpaired t-test. (B, D and F) are the data in A, C and E separated according to 
experiment. Each line connects the mean measurements for the UT and V cells in a single 
experiment. Means were calculated from data on eight or more cells. * =  P<0.05 by paired t-test. 
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Figure 6.3: Effect of KSHV infection on the organisation of F-actin in HUVEC.  
KSHV-inoculated (KSHV-EC) or untreated (UT-EC) HUVEC were seeded sub-confluent into 8-
well chamber slides on day-six post-inoculation. On day-seven, cells were fixed, permeabilised 
with 0.1% (v/v) Triton-X-100 and stained for vinculin (not shown) and F-actin. Nuclei were 
stained with bisbenzimide (not shown). Cells were imaged on an inverted laser scanning confocal 
microscope using a 63x water immersion objective. KSHV-infected cells were identified by their 
expression of GFP. The UT-EC and KSHV-infected cells in the panel are examples of UT-EC 
and KSHV-infected cells from each of three experiments and are representative of over 30 cells 
of each type from across these experiments. Images of GFP expression and phalloidin staining of 
KSHV-EC are shown individually and as a merge for clarification of the infected cells. Only F-
actin images are shown for UT-EC since all cells were negative for GFP expression as illustrated 
in Figure 6.1. 
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Figure 6.4: Effect of KSHV infection on the amount of F-actin in HUVEC.  
Images of KSHV-infected (V) and untreated (UT) HUVEC stained for F-actin were thresholded 
to create a mask for each cell. The image analysis software, Image-Pro was used to measure the 
mean intensity of phalloidin staining for each cell (A and B) and the total cell area. The total 
intensity of staining was calculated as the product of the mean intensity multiplied by cell area (C 
and D). (A and C) Each square represents the measurement of mean phalloidin intensity for a 
single cell. Data are the pooled results of three experiments. Horizontal lines indicate the mean 
measurement for each parameter. (B and D) The data in A and C separated according to 
experiment. Each line connects the mean measurements for each of UT and V in a single 
experiment. Means were calculated for data on eight or more cells. 
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Figure 6.5: Concentric ring analysis of the effect of KSHV infection on the distribution of F-
actin in HUVEC.  
Images of KSHV-infected (V) and untreated (UT-EC) HUVEC stained for F-actin were analysed 
by a macro designed in Image-Pro which divided the cell into four concentric rings of equal area 
and reported the total intensity of phallodin staining of F-actin in each ring and the area of each 
ring. Intesnsity per unit area was calculated and is plotted against the ring number. Data are the 
pooled results of analysis on 30 UT-EC and 27 V HUVEC from across three experiments. Bars 
represent mean phalloidin intensity/m2  SEM. ANOVA revealed a significant effect of ring 
number upon intensity of staining for V (P<0.05). ** =  P<0.01 by Bonferroni’s Multiple 
Comparisons Test.  
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Figure 6.6: Line profile analysis of the effect of KSHV infection on the distribution of F-
actin in HUVEC.  
Images of KSHV-infected (V) and untreated (UT-EC) HUVEC stained for F-actin were analysed 
using ImageJ software. (A) The (x,y) midpoint of the cell of interest was determined and a line 
drawn through the midpoint at 90 to the longest axis between the leading and trailing edges of 
the cell. (B) The phalloidin intensity profile was generated for the axis marked in ‘A’ and was 
divided into ten sections to give 5 concentric rings of intensity indicated 1 to 5. (C) The 
intensities in each of the ten sections were summed and the average in each of the five concentric 
regions determined and plotted against ring number. Data are the pooled results of analysis on 18 
UT-EC and 18 V HUVEC across three experiments, six cells from each experiment. Bars 
represent mean phalloidin intensity of staining  SEM. ANOVA revealed a significant effect of 
ring number upon intensity of staining for both UT-EC (P<0.05) and V (P<0.0001) HUVEC. * =  
P<0.05, ** =  P<0.01; *** = P<0.001 by Bonferroni’s Multiple Comparissons Test. 
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6.2.3 The effect of KSHV-infection on the distribution of focal adhesions in HUVEC  
Anti-vinculin staining generated a punctate staining pattern at the perimeter of the cell in both 
untreated and KSHV-infected cells. However, while the focal adhesions appeared uniformly 
distributed about the perimeters of untreated cells, they were localized at the tips of KSHV-
infected, spindle-shaped cells (Figures 6.1 and 6.7). Localisation of the vinculin spots at the ends 
of actin filaments in both infected and untreated cells, consistent with vinculin as a focal adhesion 
protein, is more clearly demonstrated in (Figure 6.8). Hereafter, in this chapter, vinculin spots are 
referred to as focal adhesions. Prominent vinculin staining was also identified in the cytosol and 
was considered to be free vinculin not recruited into focal adhesions (Figures 6.1 and 6.7).   
To quantify the apparent decrease in the number and size of focal adhesions per cell with 
KSHV infection (Figures 6.1 and 6.7), images of vinculin staining were thresholded using 
Image-Pro software and the region containing the peripheral focal adhesions selected. The 
software reported the total number of focal adhesions per cell and the size of each one. KSHV-
infection reduced the number of focal adhesions per cell and the total area covered by focal 
adhesion complexes (Figure 6.9A to D). Normalising according to cell perimeter length, shown 
above to be increased with KSHV-infection (Figure 6.2C and D), the reduction in number of 
focal adhesions with KSHV infection was highly significant (Figure 6.9E).  
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Figure 6.7: Effect of KSHV infection on the size, number and distribution of focal adhesions 
in HUVEC.  
KSHV-inoculated (KSHV-EC) or untreated (UT-EC) HUVEC were seeded sub-confluent into 8-
well chamber slides on day-six post-inoculation. On day-seven, cells were fixed, permeabilised 
with 0.1% (v/v) Triton-X-100 and stained for vinculin and F-actin (not shown). Nuclei were 
stained with bisbenzimide (not shown). Cells were imaged on an inverted laser scanning confocal 
microscope using a 63x water immersion objective. KSHV-infected cells were identified by their 
expression of GFP. The UT-EC and KSHV-infected cells in the panel are examples of UT-EC 
and KSHV-infected cells from each of three experiments and are representative of over 30 cells 
of each type from across these experiments. Images of GFP expression and vinculin staining of 
KSHV-EC are shown individually and as a merge for clarification of the infected cells. Only 
vinculin images are shown for UT-EC since all cells were negative for GFP expression as 
illustrated in Figure 6.1. 
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Figure 6.8: Patterns of phalloidin and anti-vinculin staining in HUVEC.  
KSHV-inoculated (KSHV-EC) or untreated (UT-EC) HUVEC were seeded sub-confluent into 8-well 
chamber slides on day-six post-inoculation. On day-seven, cells were fixed, permeabilised with 0.1% (v/v) 
Triton-X-100 and stained for F-actin and vinculin. Nuclei were stained with bisbenzimide. KSHV-infected 
cells were identified by their positivity for GFP expression. Circles on the merge panel highlight 
localisation of vinculin at the tips of actin filaments. Images are representative of over 30 cells of each 
type from across three experiments. 
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Figure 6.9: Effect of KSHV infection on the number and size of focal adhesions in HUVEC.  
Images of KSHV-infected (V) and untreated (UT-EC) HUVEC stained for vinculin were 
analysed using Image-Pro software. Images were thresholded to identify the focal adhesions and 
the peripheral region of the cell containing focal adhesions was selected apart from the central 
region of non-complexed vinculin. The number of focal adhesions per cell was counted (A and 
B) and the area of each focal adhesion reported. By the summation of these areas, the total area of 
focal adhesion coverage per cell was calculated (C and D). From images of the same cells 
stained for F-actin, the lengths of the cells’ perimeters were measured (Figure 6.3) and used for 
normalization of focal adhesion number per cell (E and F). (A, C and E) each square represents 
the result of the parameter for a single cell. Data are the pooled results of three experiments. 
Horizontal lines indicate the mean. * =  P<0.05; *** = P<0.0001 by unpaired t-test.  (B, D and F) 
are the data in A, C and F separated according to experiment. Each line connects the mean 
measurements for each of UT and V in a single experiment. Means were calculated for data on 
eight or more cells. * =  P<0.05 by paired t-test. 
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6.3 DISCUSSION 
Cell migration involves cycles of assembly and disassembly of the actin cytoskeleton and of 
focal adhesion complexes. Since infection of HUVEC by KSHV increased cell migration 
(Chapter 4), the effect of KSHV on the organization of the actin cytoskeleton and the 
distribution, size and number of focal adhesion complexes in HUVEC was investigated in this 
chapter by confocal microscopy (Figure 6.1). Using novel strategies to quantify the amount of 
filament actin at increasing distance from the centre of the cell, this study provides the first 
quantitative evidence that KSHV infection of HUVEC induces partitioning of actin filaments 
from a mesh-like array covering the cytosol into bundles of actin filaments concentrated at the 
cell periphery and aligned parallel to the longest axis of the cell (Figures 6.3, 6.5 and 6.6). Focal 
adhesions were observed to localize to the tips of infected cells. Furthermore, infection caused a 
reduction in the number and size of focal adhesions presented by KSHV-infected cells compared 
with untreated HUVEC (Figures 6.7 and 6.9).  
To my knowledge, prior to the work in this thesis, no study had characterised the changes in 
F-actin abundance and organization occurring with long term KSHV infection of primary 
endothelial cells. The latest timepoint of observation reported was day-three post-infection 
(Grossmann et al., 2006). In that study, arrangement of F-actin into parallel bundles was noted in 
infected cells coinciding with the elongation of cell shape. However, the authors did not comment 
on whether these structures partitioned to the cell cortex, analogous to the observations described 
in this chapter, and the images that they presented were of insufficient magnification for such a 
phenotype to be distinguished by the reader.  
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Before this study, the major focus on KSHV-induced rearrangement of the actin cytoskeleton 
in endothelial cells had been in the context of virus particle entry to the cell and subsequent 
traffic to the nucleus. Thus observations of an effect of KSHV on F-actin organization had been 
made during the period immediately following infection (0.5minutes to four hours). Although the 
precise molecular mechanism for the endocytic entry of KSHV into endothelial cells continues to 
be debatedboth clathrin-mediated endocytosis (Greene and Gao, 2009) and macropinocytosis 
(Raghu et al., 2009) have been suggestedactin polymerization appears to be important for 
efficient infection of endothelial cells. For example, treatment of human dermal microvascular 
endothelial cells with the actin depolymerising agent, cytochalasin D, inhibited expression of the 
KSHV genes ORF50 and ORF73 by 58% and 66% respectively (Raghu et al., 2009) and 
treatment of HUVEC with inhibitors to disrupt actin dynamics (cytochalasin D, Latrunculin and 
Jasplakinolide) significantly reduced the number of virus particles docked at each nucleus 
(Greene and Gao, 2009).  
In further support of actin involvement in the KSHV infection process, temporal changes in 
F-actin structures were additionally described immediately after infection. Raghu et al (2009) and 
Greene and Gao (2009) both reported dissolution of cortical actin structures and the induction of 
stress fibres followed by formation of filopodia and lamellipodia protrusions between five and 
15minutes after infection of HUVEC and dermal microvascular endothelial cells. Naranatt et al 
(2003) identified a similar pattern of change to the F-actin cytoskeleton of fibroblasts following 
KSHV infection: within five minutes there was rapid actin polymerization and cell-wide 
assembly of stress fibres. This was followed by the appearance of filopodia by 15minutes and 
membrane ruffling by 30minutes. In contrast, untreated cells had a smooth surface, lacking 
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protrusions, and actin was peripheral and organized into cortical bundles (Naranatt et al., 2003). 
Subsequent work by the same group showed that signaling induced upon productive engagement 
of the KSHV envelope protein, gB, with the host-cell integrin entry receptor, 31, activated the 
host cell kinase cascade FAK-Src-PI3K-RhoGTPases and cytoskeleton rearrangements (Sharma-
Walia et al., 2004).  
In my studies at day-seven post-inoculation filopodia and lamellipodia were not evident on 
the surface of infected cells, and identification of prominent peripheral actin structures was in 
contrast to the dissolution of cortical actin filaments by 15minutes post infection (Greene and 
Gao, 2009; Raghu et al., 2009). Taking these observations together, it appears that as latent 
infection establishes and the cell becomes spindle shaped, remodeling of the actin cytoskeleton 
continues. The recent report by DiMaio et al (2011), published after the work in this thesis was 
completed, examined qualitatively the actin cytoskeleton of KSHV-infected primary dermal 
microvascular endothelial cells 48hours post-infection and suggested that the peripheral 
organization of actin in latently infected cells is attained even by 48hours.  
In agreement with the actin distributions reported for untreated and KSHV-infected cells in 
this thesis, expression of the KSHV K5 protein in dermal microvascular endothelial cells 
immortalized with human papillomavirus E6 and E7 proteins caused reorganization of F-actin 
from an array of cable-like filaments aligned perpendicular to the membrane and distributed 
throughout the cytosol to localization along the cell periphery (Mansouri et al., 2008). This effect 
of K5 was suggested to be a consequence of its transmembrane unbiquitin ligase activity in 
targeting the destruction of the VE-cadherin-catenin complex to which F-actin is linked. We have 
detected K5 transcripts in KSHV-infected HUVEC by RT-PCR (data not shown); thus K5 might 
CHAPTER SIX: Effect of KSHV upon the endothelial actin cytoskeleton and focal adhesions  
 
 
261 
 
have contributed to the establishment of the phenotype of peripheral actin structures which I 
observed. Alternatively, in studies by Grossmann et al (2006), overexpression of single KSHV 
latency genes in endothelial cells suggested a cell-autonomous role for vFLIP in the generation of 
the spindle phenotype of KSHV-infected LEC and BEC in which parallel arrays of actin fibres 
were observed. Our infected cultures also expressed vFLIP (Figure 5.9). Therefore, vFLIP 
activity might underlie reorganization of the actin cytoskeleton into the parallel cortical bundles 
at day-seven. 
To my knowledge the present study was the first to examine quantitatively the impact of 
KSHV infection upon the distribution, number and size of focal adhesions in primary endothelial 
cells. The reorganization of F-actin into bundles that extended the length of the cell and 
partitioned to the cell edge and the localization of focal adhesions to the tips of spindle cells were 
thought to be interdependent phenotypes. The reduction in the number of focal adhesions was 
likewise consistent with filament bundling, since the maintenance of total F-actin but generation 
of thick bundles would require fewer sites of contact between the ECM and intracellular actin 
filaments (Figure 6.4)  
The decrease in the size of focal adhesions in infected cells also agreed with the increased 
rates of infected cell migration reported in this thesis (Chapter 4), since focal adhesions mature 
and increase in size when cells make firm adhesions to substrate, while intermediate strengths of 
attachment to substrate have been linked to increased locomotion. For example, measurements 
of: percentage of motile cells; migration speed and persistence of migration, determined for 
human smooth muscle cells, were maximal at intermediate strengths of attachment to the 
substrates fibronectin and collagen IV (DiMilla et al., 1993). The decrease in vinculin recruitment 
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to focal adhesions with KSHV-infection and a concomitant increase in cell migration is supported 
by previous studies that have examined the relationship between vinculin availability and 
motility: increasing endogenous vinculin levels by 20% in BALB/c 3T3 cells inhibited closure of 
wounded monolayers (Rodriguez Fernandez et al., 1992) while transfection of BALB/c 3T3 cells 
with vinculin antisence cDNA, reducing vinculin expression to 10-30% of controls, increased 
two-fold the numbers of cells entering scratch wounds and the lengths of phagokinetic tracts 
produced by individual cells migrating on colloidal gold-coated coverslips (Rodriguez Fernandez 
et al., 1993).  
There was no apparent reduction in total vinculin expression with KSHV infection in the 
present study (Figure 6.7); thus the decrease in focal adhesion size with KSHV infection might 
be due to either a decrease in the recruitment of vinculin to focal adhesions or increased rates of 
focal adhesion turnover. The assembly and growth of focal adhesions is driven by mechanical 
force generated by actomyosin contractility (Bershadsky et al., 2003). While a decrease in 
myosin-II driven tension would cause disassembly of focal adhesions, reduced recruitment of 
vinculin to forming complexes might also arise as a consequence of the downregulation of 
upstream components that associate with vinculin and bring it into focal adhesions. Infection of 
human foetal foreskin fibroblasts with HCMV suppressed the expression of focal adhesion-
associated proteins including Hic-5, paxillin and -actinin (Stanton et al., 2007). Paxillin binds to 
integrins and recruits vinculin (Mitra et al., 2005); thus if KSHV infection also downregulated 
paxillin it might explain the reduction in appearance of focal adhesion size identified on the basis 
of vinculin expression.  
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The mechanisms underlying focal adhesion turnover are incompletely described. Both 
proteolysis and clathrin mediated endocytosis of integrins have been presented as possible 
mechanisms. For proteolysis, activity of the intracellular calcium-dependent protease calpain 
appears to be critical (Franco et al., 2004). Cleavage of talin and FAK promotes turnover (Chan 
et al., 2010; Franco et al., 2004) but the calpain cleavage products of paxillin serve to negatively 
regulate turnover and thus cell migration (Cortesio et al., 2011). To determine whether increased 
turnover rates explain the incidence of smaller sized focal adhesions in infected cells an effect of 
KSHV infection upon focal adhesion turnover could be examined by Total Internal Reflection 
Fluorescence microscopy. Since vinculin is a major but not essential component of focal 
adhesions (Coll et al., 1995), the expression profiles of other focal adhesion-associated proteins 
might also be examined to verify that the conclusion that infection reduces focal adhesion size, as 
made in the present study on the basis of vinculin expression, is not peculiar to vinculin. 
In summary, the effects of KSHV infection on the actin cytoskeleton and focal adhesions 
were examined in this chapter. This work at day-seven post-infection provides the first insight 
that KSHV infection continues to modulate the organization of the actin cytoskeleton and focal 
adhesions of endothelial cells beyond the first three days of infection. Taken together with the 
body of literature describing cytoskeletal changes during the early stages of infection, these data 
suggest that modulation of the cytoskeleton and its associated proteins has multiple functions 
during the virus lifecycle which might include the facilitation of virus entry and traffic to the 
nucleus of endothelial cells but also increased motility of the infected cell.  
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7.1 INTRODUCTION 
The preferential transmigration of KSHV-infected cells (Figure 4.3) suggested that KSHV 
infection enhanced migration through a cell intrinsic mechanism or via the release of a secreted 
factor that acted specifically upon infected cells. For instance, if KSHV infection caused 
secretion of an agent, and upregulation of its receptor that was lacking in non-infected cells, then 
a response only in infected cells might be seen.  
Angiogenic and inflammatory factors including VEGFA, VEGFC, bFGF, Ang-2, IL-6, IL-8, 
ephrin B2 and Growth regulated oncogene- alpha (Gro-) have been detected within KS lesions 
(Ye et al., 2007). Moreover, in vitro studies provide evidence that KSHV infection of endothelial 
cells induces generation of an angiogenic, inflammatory milieu. For example, infection of human 
dermal microvascular endothelial cells with KSHV induced sustained upregulation of VEGFA 
and VEGFC gene and protein expression (Carroll et al., 2004; Sivakumar et al., 2008) and 
infection of HUVEC and dermal microvascular endothelial cells caused sustained Ang-2 
expression in a mechanism involving ERK/JNK/p38 MAPK activation of activator protein-1 
(AP-1) and Ets1 transcription factors (Ye et al., 2007). Others have reported that KSHV infection 
or ectopic expression of the KSHV gene, vGPCR, activated the transcription factors AP-1 and 
NFkB leading to the upregulation of angiogenic cytokines, chemokines, growth factors and 
MMPSs (Montaner et al., 2004; Xie et al., 2005).  
Of these factors, pro-migratory effects of VEGFA, VEGFC and bFGF have been 
demonstrated on endothelial cells (for example: Fortier et al., 1999; Lee and Kay, 2006; Marchio 
et al., 1999; Olsson et al., 2006) and IL-8, a chemoattractant for neutrophils, has also been shown 
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to influence the migration of microvascular endothelial cells (Heidemann et al., 2003; Salcedo et 
al., 2000; Schraufstatter et al., 2003); the extent of chemotaxis correlating with the level of 
receptor expression by these cells (Salcedo et al., 2000). Therefore, in this chapter, the release of 
chosen factors, and/or expression of their receptors or downstream signaling proteins was 
investigated for the contribution of signaling pathways elicited by these ligand-receptor 
interactions to KSHV-enhanced endothelial cell transmigration. Justification for the choice of 
each factor examined and the study performed is given before its results in the following 
commentary. 
7.2 RESULTS 
7.2.1 The impact of KSHV inoculation on the secretion of IL-6, IL-8 and IP-10 by 
HUVEC 
A luminex screen of the chemokines within KSHV-inoculated cell supernatants identified 
strong upregulation of IL-6 and IP-10 and modest upregulation of IL-8 with inoculation (Figure 
7.1) 
IL-6 was not considered a likely mediator of increased transmigration of KSHV-infected cells 
and was therefore not considered further in these studies since previous work in our laboratory 
had demonstrated a profound paracrine effect of IL-6 upon endothelial cell function: IL-6 in 
KSHV-inoculated supernatants suppressed neutrophil transmigration across inflamed 
endothelium (Butler et al., 2011). IL-8 was not involved in the mechanism (Butler et al., 2011); 
therefore, a possible contribution of IL-8 to KSHV-enhanced transmigration was examined.  
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Figure 7.1: Effect of KSHV inoculation on the secretion of IL-6, IL-8 and IP-10 by HUVEC.  
2-day, 24-well culture supernatants from untreated (UT-EC) and KSHV-inoculated (KSHV-EC) 
HUVEC cultures were collected between days three and seven post-inoculation and analysed by 
Luminex for the presence of IL-6, IL-8 and IP-10. Median fluorescence intensity values are 
reported. To concentrate secreted factors for this study, monolayers (9x104cells/well) were 
covered with 200l culture medium as opposed to the usual culture volume of 420l. Data are the 
mean  SEM for two experiments.  
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7.2.1.1 Investigating a role for IL-8 in the enhanced transmigration of KSHV-
infected HUVEC 
Whilst microvascular endothelial cells express high levels of the IL-8 receptors CXCR1 and 
CXCR2 (Heidemann et al., 2003; Salcedo et al., 2000; Schraufstatter et al., 2003), most studies 
indicate that IL-8 receptor expression by endothelial cells is tissue specific with minimal 
expression detected on macrovascular HUVEC; accordingly, HUVEC demonstrate little 
migratory response to IL-8 (Li et al., 2003; Petzelbauer et al., 1995; Salcedo et al., 2000).  
In previous studies a high level of CXCR1 on KS cells had been identified by 
immunohistochemistry whereas expression on early passage HUVEC was low. The same trend 
was observed by RT-PCR for both CXCR1 and CXCR2. Similarly, spindle shaped cells in KS 
biopsies stained positively for CXCR1 but the receptor was not detected in normal skin biopsies 
for the same donor (Masood et al., 2001). On the basis of these observations I hypothesised that 
KSHV infection might induce upregulation of one or both of these receptors on HUVEC and 
render infected cells sensitive to IL-8. However, flow cytometry staining for CXCR1 and CXCR2 
revealed that neither CXCR1 nor CXCR2 was upregulated on HUVEC in response to KSHV 
infection (Figure 7.2) dissuading the feasibility of this hypothesis. Positive staining for CXCR1 
and CXCR2 on freshly isolated neutrophils provided a positive control for the assay. 
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Figure 7.2: Effect of KSHV infection on cell surface expressions of CXCR1 and CXCR2.  
KSHV-inoculated (KSHV-EC) and untreated (UT-EC) HUVEC were stained on day-seven post-
inoculation for their surface expression of the IL-8 receptors CXCR1 and CXCR2 and analysed 
by flow cytometry. KSHV-infected (V) cells were distinguished from non-infected (NI) cells 
within KSHV-EC monolayers on the basis of GFP positivity. Histograms for CXCR1 and 
CXCR2 staining of UT-EC (UT), V and NI populations are  representative of three experiments. 
Staining of CXCR1 and CXCR2 on freshly isolated human neutrophils was a positive control for 
the assay.    
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7.2.1.2 Investigating a role for IP-10 in the enhanced transmigration of KSHV-
infected HUVEC 
IP-10 is generally considered an angiostatic molecule (Boshoff et al., 1997). However, it has 
been shown to act as an inverse agonist upon the KSHV protein vGPCR (Geras-Raaka et al., 
1998; Rosenkilde et al., 1999) and to relieve the inhibitory effect of vGPCR overexpression upon 
lung endothelial cell migration, leading instead to enhanced transmigration (Couty et al., 2009).  
Although vGPCR is typically considered a lytic cycle protein and cultures of KSHV-
inoculated HUVEC present minimal lytic infection at day-seven post-inoculation, in our 
laboratory we had detected vGPCR transcripts in KSHV-inoculated HUVEC up to day-ten post-
inoculation (Figure 7.3). Therefore, the distinction between lytic and latent gene expression 
profiles might be small in a HUVEC host and lytic cycle proteins such as vGPCR might have a 
role in the mechanism of KSHV-enhanced transmigration. Others have similarly reported 
longterm expression of lytic genes following KSHV infection of HUVEC (Ye et al., 2007).  
In view of the above reports, I hypothesized that the IP-10 secreted by KSHV-inoculated 
cultures could act through vGPCR to selectively modulate the transmigration potential of KSHV-
infected cells. To test this hypothesis, a function blocking antibody against IP-10 was added to 
the culture medium throughout the 48hr transmigration period. Blocking IP-10 did not reduce the 
transmigration of KSHV-inoculated HUVEC cultures compared to no treatment control, although 
in the presence of anti-IP-10, the significant difference in transmigration between inoculated and 
untreated cultures was lost. Overall, these data suggest that the large upregulation in IP-10 alone 
did not coordinate the preferential transmigration of KSHV-infected cells (Figure 7.4). 
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Figure 7.3: PCR for KSHV-vGPCR.  
Total RNA was isolated from untreated (UT-EC) and KSHV-inoculated (KSHV-EC) HUVEC 
cultures and mRNA for KSHV-vGPCR amplified by PCR. Ethidium-bromide gel electrophoresis 
photograph for one HUVEC donor representative of three examined between days four and ten 
post-inoclation. -actin endogenous control bands for the donor represented are shown in Figure 
5.9A 
 
 
Figure 7.4: Effect of blocking IP-10 activity upon KSHV-enhanced transmigration of 
HUVEC. 
KSHV-inoculated (KSHV-EC) and untreated (UT-EC) HUVEC were plated into 8m-pore 
transwell culture inserts on day-seven post-inoculation and the percentage transmigration after 
48hours examined by microscopy for cells in the presence of monoclonal mouse anti-human IP-
10 function blocking antibody (2g/ml) or no treatment control. Data are mean  SEM for four 
experiments. ** = P<0.01 by paired t-test. 
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7.2.2 The impact of KSHV infection on the pro-angiogenic VEGFC/VEGFR3 axis  
Besides increasing the secretion of VEGF ligands, KSHV infection has been shown to induce the 
transcription (Carroll et al., 2004; Hong et al., 2004) and translation of the VEGFC specific 
receptor, VEGFR3 (Carroll et al., 2004) in microvascular endothelial cells. The possibility of an 
autocrine action of VEGFC was proposed by the authors. Accordingly, I hypothesized that 
KSHV-infected endothelial cell migration might be specifically induced through the autocrine 
action of VEGFC upon VEGFR3 upregulated on infected HUVEC. I began to investigate this by 
examining the relative surface expression of VEGFR3 on untreated, non-infected and KSHV-
infected HUVEC by flow cytometry seven days post-inoculation. The specificity and efficiency 
of the VEGFR3 staining protocol was verified by the positive staining of VEGFR3 on untreated 
LEC but no increase in VEGFR3 was observed on KSHV-infected HUVEC (Figure 7.5). The 
absence of increased VEGFR3 expression on KSHV-infected HUVEC precluded the hypothesis 
of an autocrine loop for VEGFC in promoting the transmigration of KSHV-infected cells. Further 
studies to quantify VEGFC levels in supernatants were therefore not pursued. 
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Figure 7.5: Effect of KSHV inoculation of HUVEC on cell surface expression of VEGFR3.  
KSHV-inoculated (KSHV-EC) and untreated (UT-EC) HUVEC cultures were stained on day-
seven post inoculation for their surface expression of the VEGFC receptor, VEGFR3 and 
analysed by flow cytometry. KSHV-infected (V) cells were distinguished from non-infected (NI) 
cells within KSHV-EC monolayers on the basis of GFP positivity. (A) Representative histograms 
for VEGFR3 staining of UT-EC (UT), V and NI populations and lymphatic endothelial cells 
(LEC) (positive control). (B) VEGFR3 expression was measured in terms of median fluorescent 
intensity (MFI) and expressed for V and NI relative to expression on UT.  Data are mean  SEM 
for three experiments.  
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7.2.3The impact of KSHV infection on p38 MAPK activity 
The p38 MAPK pathway is activated as part of the cellular response to stress stimuli such as 
cytokines, UV irradiation, heat shock, and osmotic shock wherein it coordinates processes of cell 
differentiation and apoptosis. Studies into the molecular basis of endothelial and smooth muscle 
cell migration in response to growth factors (VEGF and bFGF) and inflammatory cytokines have 
identified that activation of p38 MAPK, in particular the p38 and p38 isoforms, is also 
involved in coordinating cell migration in response to these factors (Denes et al., 2002; Hedges et 
al., 1999; Rousseau et al., 1997; Tanaka et al., 1999), Furthermore, p38 MAPK activation has 
been observed in response to KSHV infection of endothelial cells including HUVEC (Xie et al., 
2005), human microvascular endothelial cells and human foreskin fibroblasts  (Sadagopan et al., 
2007)), and the use of p38 inhibitors found to suppress KSHV-induced-ANG-2 release by 
HUVEC (Ye et al., 2007) and vGPCR induced transcription and secretion of VEGF (Sodhi et al., 
2000).  
Considering these associations of the p38 MAPK pathway with cell migration, and also 
KSHV infection, I postulated that activation of p38 MAPK might underlie the increase in 
HUVEC transmigration with KSHV infection. To test this, transmigration assays were performed 
in the presence and absence of 10 SB 203580, a pyridinyl imidazole derivative widely used as 
a specific inhibitor of the p38 and p38 isoforms. In the literature SB 203580 was used at 
concentrations in the range 1 to 25M (Rousseau et al., 2000; Rousseau et al., 1997). In 
agreement, in our laboratory we had previously found that 10M SB 203580 effectively inhibited 
sheer-induced suppression of neutrophil recruitment from flow under conditions of TNF 
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stimulation (Luu and Nash, unpublished data). Therefore 10M SB 203580 was used in these 
assays.  
Contrary to my hypothesis, an increase in migration was observed in the presence of SB 
203580 for both KSHV-inoculated and untreated HUVEC cultures relative to their no inhibitor 
control populations. However, the percentage increase in transmigration with inhibitor was only 
11% for KSHV-inoculated cultures compared to 50% for untreated controls and the difference in 
transmigration in the presence of inhibitor was rendered not statistically different for KSHV-
inoculated compared to untreated cultures (Figure 7.6). To investigate whether in contrast to 
growth factor promoted migration, enhanced migration of infected cells involved suppression of 
p38 MAPK activity, levels of baseline phospho-p38 MAPK were analysed by flow cytometry. A 
prominent increase in phospho-p38 MAPK with 10-minute TNF (100U) stimulation verified that 
the staining protocol was robust (Figure 7.7) but no effect of KSHV-infection on baseline 
phospho-p38 MAPK was detected at day-seven post-inoculation suggesting that neither 
upregulation nor downregulation of p38 MAPK activity explained the enhancement in 
transmigration with KSHV infection.  
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Figure 7.6: Effect of inhibition of p38 MAPK activity on KSHV enhanced transmigration of 
HUVEC.  
(A) KSHV-inoculated (KSHV-EC) and untreated (UT-EC) HUVEC were plated into 8m-pore 
transwell culture inserts on day-seven post-inoculation and the percentage transmigration after 
48hours examined by microscopy for cells in the presence of the p38 MAPK inhibitor, SB203580 
(10M), or DMSO or no treatment control. Data are mean   SEM for two-four experiments. (B) 
No effect of DMSO was apparent (panel A). Therefore, for robust statistical analysis of the effect 
of p38 MAPK inhibition, DMSO and no treatment control data in A were combined. Data are 
mean  SEM for three or four experiments. * = P<0.05; ** = P<0.01 by paired t-test.  
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Figure 7.7: Effect of KSHV-infection on baseline p38 MAPK activity.  
KSHV-inoculated (KSHV-EC) and untreated (UT-EC) HUVEC cultures were stained on day-
seven post-inoculation for levels of phospho-p38 MAPK and analysed by flow cytometry. 
KSHV-infected (V) cells were distinguished from non-infected (NI) cells within KSHV-EC 
monolayers on the basis of GFP positivity. Staining of HUVEC stimulated with 100U TNFfor 
10minutes served as a positive control for the assay. Histograms for phospho-p38MAPK staining 
of  UT-EC (UT), V and NI populations are representative of three experiments. 
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7.3 DISCUSSION 
Chemokines and certain growth factors in the extracellular milieu affect the motility of cells 
that express their cognate receptors. In this chapter, the hypothesis that the enhanced 
transmigration of KSHV-infected compared to non-infected or untreated HUVEC might be 
explained by infection-induced expression or upregulation of receptors to chemokines or growth 
factors secreted by inoculated cultures was tested.  
KSHV-inoculation increased secretion of both IL-8 and IP-10 which signal via the G-protein 
coupled C-X-C chemokine receptors CXCR1 and CXCR2 and CXCR3 respectively (Figure 7.1). 
Neither CXCR1 nor CXCR2 was detected on the surface of KSHV-infected, non-infected or 
untreated HUVEC (Figure 7.2); thus a role for IL-8 in promoting migration of KSHV-infected 
cells was not supported by this study. Blocking the activity of IP-10 during transmigration also 
did not appear to reduce KSHV-enhanced transmigration (Figure 7.4). Expression of the VEGFC 
receptor, VEGFR3, was examined but in contrast to its strong expression by lymphatic 
endothelium it was detected at very low level on the surfaces of KSHV-infected, non-infected 
and untreated HUVEC, and was not upregulated with KSHV-infection (Figure 7.5); thus 
dissuading a role for VEGFC, a factor suggested to be upregulated upon KSHV infection of 
endothelial cells (Sivakumar et al., 2008), in promoting the enhanced transmigration of KSHV-
infected HUVEC in this system. 
P38 MAPK activity was also considered for its role in cell migration as a transducer of 
growth factor signaling and the upregulation of pro-angiogenic and promigratory factor 
expression. Interestingly an increase in transmigration rate was observed for both untreated and 
CHAPTER SEVEN: Effects of KSHV-induced chemokines and growth factors on motility   
 
 
279 
 
KSHV-infected HUVEC in the presence of p38 MAPK inhibitor and the difference in percentage 
transmigration between untreated and KSHV-inoculated cultures found to be no longer 
significant (Figure 7.6). While this might suggest that p38 MAPK activity was suppressive of 
transmigration and KSHV at day-seven post-infection was inhibitory to p38 MAPK activation, 
p38 MAPK activation was not evident for any category of cell when levels of phospho-p38 
MAPK were examined (Figure 7.7). Taken together, these data suggest that p38 MAPK was also 
not a key mediator in the mechanism of KSHV-enhanced transmigration at day-seven post-
inoculation. The increased migration response in the presence of p38 inhibition might have arisen 
as a feedback effect to counteract the inhibition of a cellular pathway that when activated under 
certain conditions supports increased cell migration.  
The increase in IL-8 in the supernatants of KSHV-inoculated HUVEC was consistent with 
previous reports that KSHV infection or transfection with KSHV-vGPCR increases secretion of 
IL-8 by endothelial cells. IL-8 has angiogenic properties (Schraufstatter et al., 2003); thus it is 
likely that during KS pathogenesis, the increased release of IL-8 by KSHV-infected spindle cells 
contributes to the aberrant angiogenesis that is a hallmark of the lesions. However, it remains 
unclear how IL-8 induces this response.  
Microvascular endothelial cells are reported to express one or both of the IL-8 receptors and 
to demonstrate responses to IL-8 in proportion with their level of receptor expression (Salcedo et 
al., 2000) but it continues to be debated whether macrovascular endothelial cells, for which 
HUVEC provide a model, can bind and respond to IL-8: Li et al (2003) observed constitutive but 
low levels of IL-8 receptor on HUVEC, whereas Petzelbaur et al (1995) could not detect any IL-8 
binding to HUVEC nor any receptor expression. In vivo CXCR1 was not expressed in normal 
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skin biopsies but the spindle shaped cells in KS biopsies stained positively for CXCR1 (Masood 
et al., 2001). Hence the data in this thesis provide further support that primary HUVEC do not 
express the classical receptors for IL-8 and are therefore unlikely to be directly responsive to IL-
8. The absence of staining for either of the IL-8 receptors on infected HUVEC implies that 
KSHV infection does not impart direct responsiveness to IL-8. Further studies are needed to 
establish CXCR1 as a routine marker of KS spindle cells but if future studies validate it as a 
marker, the data in the present study suggest that KSHV-infected HUVEC may not fully 
recapitulate the properties of KS spindle cells in vivo.  
Absence of VEGFR3 upregulation on KSHV-infected HUVEC appears to be another 
example of discrepancy between the expression profile of spindle cells in KS lesions and that of 
KSHV-infected HUVEC and was a surprising observation given that KSHV infection of BEC has 
been identified to cause modulation of the BEC phenotype toward that of lymphatic endothelium 
(Carroll et al., 2004; Hong et al., 2004; Wang et al., 2004a) including induction of VEGFR3 gene 
expression. However, the vascular bed from which BEC are isolated might be an important 
determinant in the response to infection.  
Commercially available microvascular endothelial cells used in the work by Hong et al and 
Wang et al were mixed populations of blood and lymphatic endothelial cells (Hong et al., 2004; 
Wang et al., 2004a). While changes in the lymphatic component might have predominated in the 
gene expression data, microvascular blood and lymphatic cells might represent endothelial cell 
lineages with greater phenotype plasticity compared with HUVEC, rendering them more 
susceptible to a switch in phenotype under the influence of KSHV. Supportive of this hypothesis, 
characterisation of human dermal microvascular endothelial cells showed that most but not all of 
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VEGFR-3-expressing cells and a few VEGFR-3 negative cells stain for the lymphatic endothelial 
cell marker LYVE-1 (Makinen et al., 2001). Nonetheless, in their commentary Hong et al did 
report the induction of lymphatic lineage-specific genes after KSHV infection of HUVEC and the 
concurrent downregulation of several blood vascular-specific genes (Hong et al., 2004). 
Therefore, the source of KSHV, and conditions of infection and subsequent culture might be 
responsible for differences between studies. Notably, the recombinant KSHV used in the present 
study was derived from the JSC-1 cell line whereas Wang et al (2004a) and Carroll et al (2004) 
used BCBL-1 derived KSHV.  
Although VEGFR3 was not upregulated on the surface of infected HUVEC in the present 
study and was therefore not a favoured candidate for KSHV-induced enhanced transmigration, it 
is possible that infection induced activation of the receptor (expressed at low levels) thereby 
facilitating enhanced transmigration potential of KSHV-infected cells within inoculated cultures 
in the presence of cognate ligand. In this scenario, VEGFR3 might act in consort with VEGFR2 
since the motogenic stimulatory effect of VEGFC on cells of an immortalised KS cell line was 
reduced when a mutant form of VEGFC unable to bind to VEGFR2 was used (Marchio et al., 
1999).   
In KS pathogenesis, active VEGFR3 might also cooperate with VEGFR2 to promote the 
proliferation of KS cells since stimulation with a mutant form of VEGFC unable to bind to and 
activate VEGFR2 prevented KS cell proliferation (Marchio et al., 1999). Similar to the debate 
over VEGFR3 however, while studies using microvascular endothelial cells and microvascular 
blood-endothelial cells (Sivakumar et al., 2008) observed upregulation of VEGFC following 
KSHV infection and some have reported increased levels in lesions (Skobe et al., 1999; Ye et al., 
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2007), others suggest down regulation of VEGFC expression following the infection of BEC 
(Hong et al., 2004) and no substantial over expression in Kaposi’s sarcoma (Wang et al., 2004a). 
Thus it remains questionable as to whether VEGFC and VEGFR3 are present at sufficient level 
and appropriately activated in this system for VEGFC action on VEGFR3 to have a role in 
enhanced transmigration.  
IP-10 is known to be an inverse agonist of KSHV-vGPCR (Geras-Raaka et al., 1998; 
Rosenkilde et al., 1999) and IP-10 mRNA has been detected in frozen sections of non-AIDS KS 
skin biopsies (Uccini et al., 2003) but to my knowledge there are no reports of induction of IP-10 
secretion by KSHV-infected primary endothelial cells in vitro. Thus the present study provides 
the first indication of a feedback loop involving IP-10 in KSHV-infected endothelial cell cultures.  
Physiologically, IP-10 has angiostatic properties (Boshoff et al., 1997; Strieter et al., 1995) 
while constitutive signaling of vGPCR is proangiogenic (Ma et al., 2010); hence the inhibitory 
action of IP-10 at vGPCR might be expected to protect against angiogenesis in KS. Conversely 
however, Couty et al (2009) demonstrated that IP-10 acting as a chemokine induced the 
transmigration of vGPCR expressing MLEC thereby relieving an apparent suppressive effect of 
KSHV-vGPCR on endothelial cell transmigration. When IP-10 was added to both sides of the 
transwell assay, a trend toward increased transmigration of KSHV-vGPCR was also evident, 
implying IP-10 might stimulate chemokinesis of vGPCR expressing cells. The data in this thesis 
blocking IP-10 activity does not however substantiate a role for IP-10 in KSHV-enhanced 
transmigration.  
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In the present study, although vGPCR mRNA was detected at day-seven for inoculated 
cultures, reagents were not available to assess the percentage of vGPCR positive cells in the 
cultures. Since virus gene expression follows temporal changesvGPCR is a ‘lytic’ gene and 
lytic infection is low at day-sevenit is possible that the vGPCR mRNA signal was due to a 
small number of vGPCR expressing cells. Therefore, it may be that blocking IP-10 did act in our 
system to suppress the motility of vGPCR expressing cells but the number of cells was too few to 
have a significant and noticeable impact on transmigration rate at the population level. Clearly, 
therefore another factor was more important on the population level. In KS lesions, rather than 
affecting spindle cell migration, it is possible that IP-10 release is instructive in the recruitment of 
effector T-lymphocytes underlying the inflammatory phenotype of the lesions (Loetscher et al., 
1996).  
Previous reports of a role for p38 MAPK activation in cell migration have implicated the p38 
MAPK pathway in mediating growth factor, chemokine and proinflammatory cytokine induced 
cell migration. For example each of PDGF, IL-1and TGF-induced transmigration of tracheal 
smooth muscle myocytes involved p38 MAPK activation (Hedges et al., 1999), and endothelial 
cell growth factor promotion of bovine aortic endothelial cell migration in a scratch wound assay 
was p38 MAPK dependent (Denes et al., 2002). Couty et al (2009) also found phosphorylation of 
p38 MAPK occurred in vGPCR expressing MLEC concomitant with IP-10 treatment. They 
hypothesized that p38 MAPK activation might underlie IP-10-induced chemotaxis of vGPCR 
expressing MLEC.  
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Given these associations of p38 MAPK with growth factor and chemokine induced cell 
migration, the lack of observation of p38 MAPK activation in the present study following KSHV 
inoculation agrees with the additional findings in this chapter that growth factors and chemokines 
(e.g. VEGFC, IL-8 and IP-10) are unlikely mediators of KSHV-induced migration. Moreover, 
while Xie et al (2005) observed upregulation of AP-1 activity within 30minutes following KSHV 
infection and attributed this to p38 MAPK activation though studies using inhibitors and 
dominant negatives, Sadagopan et al (2007) reported p38 MAPK activation to subside beyond 
48hours. Thus the fact that baseline p38 MAPK was not elevated at day-seven is in agreement 
with p38 MAPK activity as an early response to infection but not in underlying the functional 
phenotypes of cells harbouring established latent KSHV-infection as used in the present study. 
In summary, secreted growth factors and chemokines, upregulated upon KSHV infection of 
endothelial cells, were investigated in this chapter for their roles in the enhanced migration of 
KSHV-infected primary endothelial cells. The absence of expression and upregulation of their 
receptors on the surfaces of KSHV-infected cells suggested that none of those tested was 
responsible (IL-8 via CXCR1 or CXCR2; VEGFC via VEGFR3). IP-10, an inverse agonist for 
vGPCR was also not involved and p38 MAPK activation was not evident. In view of the 
enhanced transmigration of KSHV-infected cells however, differential expression and or 
activation of key molecules involved in cell migration is expected between infected and 
uninfected cells. Candidates may be receptors or components of intracellular signaling pathways 
that regulate for example the plasticity of the cytoskeleton and assembly/disassembly of focal 
adhesions. 
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8.1 SUMMARY OF FINDINGS IN RELATION TO PREVIOUS STUDIES 
An extensive aberrant vasculature is a hallmark of KS, a multifocal malignancy caused by 
KSHV. In view of the role that cell migration plays in tumour angiogenesis, the underlying aims 
of this thesis were to determine, using in vitro methods, the impacts of KSHV infection on the 
migration of primary endothelial cells per se and on properties of endothelial cells that might 
contribute to the regulation of their motility.  
Prior to this thesis, few studies had examined the effects of infection by the whole KSHV 
virus on the behaviours of primary endothelial cells. Instead, investigations had concentrated on 
characterising the functions of individual KSHV genes through approaches such as ectopic gene 
expression. This was presumably due, at least in part, to the paucity of endothelial cells to be 
infected by the virus in vitro. Hence for the functional studies described in this thesis, it was 
necessary to first establish a robust method for infection of primary endothelial cells with KSHV. 
Primary HUVEC were the endothelial cell of choice for this work.  
KSHV concentrated from supernatants of PMA and sodium butyrate-reactivated PEL 
cells afforded less than 20% infection of primary HUVEC (Figure 3.1). In contrast, a 
recombinant variant of the virus (rKSHV.219) that was propagated in the primate Vero cell line 
and reactivated using ectopic supply of the lytic switch protein RTA together with sodium 
butyrate could be concentrated to high titre and used to infect primary HUVEC with greater than 
50% efficiency (Figures 3.4 and 3.7A). To my knowledge, the opening studies in this thesis 
provide the first rigorous characterisation of the properties of HUVEC cultures infected with this 
recombinant virus strain over a prolonged period (up to ten days). This work provides new 
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information to the field that could aid the design and interpretation of functional studies in the 
future.  
Consistent with the spindle shape of KSHV-infected cells in KS lesions, KSHV infection 
induced a change in cell shape from cobblestone to spindloid that became more pronounced with 
time post-infection (Figure 3.6).  Percent infection of inoculated cultures increased over time to 
80% latent infection by day-ten (Figure 3.7A). In contrast, following a lytic burst over the first 
2.5 days, during which an average of 15% of the culture died, the numbers of infected cells in 
which the virus entered lytic replication decreased with time: between days 6.5 and 8.5 only 1.5% 
of cells died due to lytic death (Figures 3.7B and 3.11B). Therefore, in the long-term, KSHV-
infected cultures were predominantly latently infected consistent with the nature of KSHV 
infection in KS lesions. As suggested for in vivo disease, the low background of spontaneous lytic 
replication may have contributed to the maintenance of infection of inoculated cultures (Gantt 
and Casper, 2011; Grundhoff and Ganem, 2004). 
The temporal rise in percent infection of primary HUVEC fitted with observations by 
others in cell lines (Moses et al., 1999). It had previously been hypothesised that such increases in 
percent infection over time were due to the proliferation of infected cells or horizontal spread of 
infection through the culture (Moses et al., 1999). However, the data presented in this thesis 
provide important insight that neither of these factors is the predominant cause for the time-
dependent rise in infection within cultures of primary HUVEC.  
Firstly, rather than an increase in cell numbers within inoculated cultures, monolayer 
density decreased and to an extent that was largely explained by the lytic death (Figure 3.11). 
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There was no rise in cell numbers after the initial lytic burst to suggest enhanced proliferation 
rates of infected cells. Thus the virus was not found to be transforming of primary HUVEC and 
the effects of contact inhibition of cell division appeared to be maintained even within KSHV-
infected monolayers. This recapitulates the behaviour of spindle cells isolated from KS lesions 
(Lagunoff et al., 2002). However, Ciufo et al (2011) showed that colonies of infected cells, which 
established in inoculated monolayers of primary dermal microvascular endothelial cells could be 
isolated and expanded to generate cultures in which all cells were infected and spindloid; thus it 
would be interesting to isolate infected cells from inoculated monolayers and compare the 
expansion of these cultures to that of parallel untreated control cells.  
Secondly, when cultures of KSHV-inoculated and untreated HUVEC were mixed, 
transmission of infection occurred to only 3.3% of untreated cells in contrast to 35% of non-
infected cells during a five-day period between days three and eight post-inoculation (Figures 3.8 
and 3.9B). Although a background of spontaneous lytic replication might support maintenance of 
infected cultureswhich otherwise lose the KSHV episome over serial passages if there is no 
selection or re-infection (Grundhoff and Ganem, 2004)and is in agreement with suggestions 
that ongoing lytic replication and infection of new cells is needed for tumour development, we 
postulate that a high (70-80%) infection occurs upon initial inoculation but there is a delay in 
appearance of infection in some cells compared to others due to heterogeneity in the number of 
viral particles entering cells upon inoculation: In cells where the initial loading is lower, more 
time is required before replication of the viral episome and subsequent gene expression reaches 
adequate levels for the viral and reporter genes to be expressed to levels that provide evidence of 
infection.  
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Having established a method for high level KSHV infection of primary endothelial cells, 
it was used to prepare populations of inoculated HUVEC, which inevitably included infected and 
non-infected cells, for functional studies. 
In set ups that allowed observation of cell migration in the context of confluent 
monolayers (transmigration and wound recovery assays), KSHV infection increased HUVEC 
migration (Figures 4.2, 4.3, 4.8 and 4.9). In contrast, the virus did not alter the distance migrated 
or persistence of migration of isolated cells (Figures 4.12, 4.13 and 4.14). With the aid of GFP 
fluorescence to distinguish infected and non-infected cells, it was evident that enhanced 
transmigration over a 48hour period was the result of preferential transmigration of infected cells: 
non-infected cells in inoculated cultures maintained a level of transmigration equivalent to that of 
untreated controls (Figure 4.3). Interestingly, in the wound recovery setting such differential 
behaviour between infected and non-infected HUVEC was not apparent: infected and non-
infected HUVEC presented equivalent migration rates and pathways (Figure 4.11). The reason 
for this discrepancy is not clear but might be attributed to differences in the physical constraints 
(presence or absence of a porous barrier) between the two systems.  
Cell migration occurs in response to a stimulus that may be soluble, immobilised or 
mechanical force. Subsequent to detection of the stimulus by the cell via activation of its cognate 
receptors, the cell establishes points of contact with its underlying substrate and coordinates 
changes in the organisation of its actin cytoskeleton to facilitate the generation of traction forces 
through the cell that support its forward movement (Lamalice et al., 2007). Thus 
chemotactic/chemokinetic factors, molecules of underlying substratum (basement membrane 
proteins), integrins and other proteins of focal adhesion complexes and cytoskeleton organisation 
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might all contribute to the overall migration rates of cells. In this thesis the effect of the virus on 
major candidates selected from each one of these categories was examined in an effort to identify 
the key determinants of cell migration that are regulated by the virus.  
At the level of possible chemokinetic factors the virus was found to increase IL-8, and IP-
10 secretion by HUVEC (Figure 7.1). Since transmigration of non-infected cells was less than 
that of infected (Figure 4.3) and supernatants from KSHV-inoculated cultures did not support an 
increase in the transmigration rates of previously untreated cells (Figure 4.4), it was clear that if 
a soluble factor was responsible for enhanced transmigration it would have to act only on infected 
cells through their selective upregulation or activation of cognate receptors. Neither of the IL-8 
receptors, CXCR1 or CXCR2, was induced by the virus, dissuading a migration stimulating role 
for IL-8 (Figure 7.2).   
KSHV-infection had been associated with the production of VEGFC (Carroll et al., 2004; 
Sivakumar et al., 2008) and the presence of VEGFR3 (Carroll et al., 2004; Hong et al., 2004) 
expression but no upregulation of VEGFR3 was found following KSHV infection of HUVEC 
dissuading the likelihood that action of VEGFC, possibly evolved into culture supernatants by 
KSHV infected cells was responsible (Figure 7.5). Constitutive vGPCR activity had been 
suggested to have anti-migratory effects and IP-10, acting as an inverse agonist, shown to 
enhance migration (Couty et al., 2009) but use of a neutralising antibody to block the action of 
IP-10 secreted in this system in the presence of KSHV infection did not appear to reduce the 
virus-induced enhanced transmigration (Figure 7.4).  
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Growth factors signal through p38MAPK pathways to regulate migration but induction of 
p38MAPK activation was not evident with KSHV infection (Figure 7.7) further supporting that 
selective control of cell motility was unlikely to be through the signalling of secreted growth 
factors.   
Studies in this thesis to address the impact of KSHV upon the deposition of endothelial 
basement membrane proteins (examples of insoluble, haptotactic stimuli) highlighted that the 
virus modulates basement membrane laminins. Overall the proteins of the sub-endothelial matrix 
examined in the study included the three major constituents of endothelial basement membranes: 
collagen IV, fibronectin and laminins. No change in deposition of either collagen IV or 
fibronectin was found with KSHV infection while Laminin-P1 (laminin detected by an antibody 
raised against the P1 Pepsin-resistant fragment of human placental laminin, but for which the 
precise conformation of the epitope recognised was not known) decreased three fold (Figures 5.2 
and 5.4) and laminin-4 chain increased three-fold (Figure 5.10A).  
Follow-up studies in this thesis were unable to elucidate the reasons for these changes in 
laminin deposition induced by KSHV infection. Although KSHV infection had been noted to 
increase MMP production (Meade-Tollin et al., 1999; Qian et al., 2007; Wang et al., 2004b), the 
decrease in laminin-P1 following KSHV inoculation was not prevented by culture in the presence 
of MMPs or serine proteases (Figure 5.6). In addition, exposure of untreated endothelium to 
supernatants from inoculated cultures failed to induce a reduction in deposition of laminin-P1 by 
these cultures; thus dissuading the hypothesis that a factor secreted by KSHV-infected cultures 
has laminin degrading activity (Figure 5.5). At the mRNA level, the virus was not seen to alter 
expression of any one of the main endothelial laminin chains (1, 2, 1, 2 or 1) (Figure 5.9) 
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but intracellular protein levels of laminin-4 were increased in KSHV-infected cells, suggesting 
translational regulation by the virus (Figure 5.11). While laminin  and  chains require 
dimerisation and subsequent incorporation of the  subunit in order to be secreted,  chains may 
be secreted independently (Yurchenco et al., 1997). Such enhanced -chain secretion may 
explain the rise in laminin-4 within the sub-endothelial matrix of inoculated cultures.  
The impact of these changes in laminins upon HUVEC migration was investigated in this 
thesis but using siRNA to deplete endogenous laminin-4 chain did not reduce transmigration 
rates (Figure 5.15C), neither was the closure of wounds of untreated HUVEC enhanced on 
matrix deposited by KSHV-infected cultures (Figure 5.12). Nonetheless, compensatory changes 
in deposition of other laminin chains might have been induced in the presence of laminin-4 
knockdown. Furthermore, simply reducing laminin-4 levels may not have restored a normal 
matrix organisation and the assembly process rather than the organisation of matrix fibres could 
be an important determinant of migration.  
Consistent with the changes in laminins deposited, KSHV infection was observed to 
upregulate surface expression of the laminin-binding, 6-integrin (Figure 5.17). While blocking 
the function of this integrin during transmigration assays did not prevent KSHV-enhanced 
transmigration (Figure 5.18) the observation of changes to the laminin network and its receptors 
provides a strong indication that the laminin-integrin axis may play fundamental roles in the 
pathobiology of KS. 
In addition to effects on the basement membrane proteins, KSHV infection targeted the 
actin cytoskeleton.  Previously an effect of the virus on the actin cytoskeleton had been noticed in 
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the context of initial infection, mediating virus entry and traffic to the nucleus (Greene and Gao, 
2009; Raghu et al., 2009). To my knowledge, the work in this thesis provides the first evidence 
that the virus continues to manipulate the actin cytoskeleton of endothelial cells over an extended 
period (up to seven days post-inoculation). Redistribution of the actin filaments from a network 
across the whole cytosol into stress fibres that partitioned toward the cell cortex was identified 
with infection (Figures 6.3, 6.5 and 6.6). Since the actin cytoskeleton is known to have a key 
role in facilitating cell movement through generation of traction forces, it is likely that such 
dramatic remodelling of the cytoskeleton by the virus contributed to the altered migration rates.  
Coincident with actin filament bundling and the extension of these fibres along the length 
of the cell, virus infection led to the presence of vinculin-stained focal adhesion structures at the 
tips of the cell rather than around the entire cell perimeter (Figure 6.8). Moreover, the puncti 
formed were significantly smaller and fewer in number with KSHV infection (Figure 6.9). These 
changes in focal adhesions are hypothesised to be key contributors to changes in motility. A 
reduction in focal contact size could for example reflect weaker adhesive forces and/or increased 
rates of turnover; such properties could facilitate an increase in migration rates providing that 
sufficient traction on the cell surface is still achieved.  
8.2 PERSPECTIVES AND FURTHER WORK 
Overall, the studies contained in this thesis indicate that KSHV infection can promote the 
migration of endothelial cells at least from the context of an endothelial monolayer and it is 
tempting to speculate that the increased transmigratory, penetrative behaviour of KSHV-infected 
cells is indicative of tip cell characteristics. Since there was no known chemoattractant gradient in 
the transmigration assay it raises the question of whether KSHV infection might even confer a 
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constitutive tip cell phenotype. The enhanced rates of wound recovery also indicated a potential 
for endothelial monolayers to move more rapidly when infected cells are present and this could 
also support new vessel formation.  
During the process of angiogenesis, endothelial cells migrate into the tissue stroma. The 
studies reported in this thesis examined the effect of KSHV on HUVEC motility in the absence of 
tissue matrix; thus to verify enhanced motility as an inducer of angiogenesis, further studies could 
examine the effect of the virus on the formation of ‘tube-like’ structures when the cells are either 
plated on Matrigel or when spheroids of cells are embedded into a collagen matrix: the latter 
would permit observation of 3D angiogenesis in vitro. KSHV-infected HUVEC might also be 
introduced into mice to test whether they will promote angiogenesis in vivo. However, since the 
data in this study suggested that KSHV-infection of HUVEC is not transforming, it is uncertain 
whether tumours derived from KSHV-infected HUVEC would arise in the mouse.  
The studies reported examined properties of endothelial cells through which KSHV might 
act to confer enhanced migratory potential to infected cells. The selection of secreted chemokines 
and surface receptors examined was restricted by the availability of reagents, thus within each 
class of molecule, other family members not examined might be responsible. For example 
infection might have induced the surface expression of integrins that are not typically expressed 
on endothelial cells as reported with HCMV infection of endothelial cells (Tabata et al., 2008). 
Alternatively a receptor’s expression level might not alter but its activation be enhanced. 
Observing activating post translational modifications such as phosphorylation status could thus 
be informative as to the importance of a given receptor (e.g. growth factor receptors and 
integrins).  
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Besides endothelial expressed genes, KSHV genes that direct the response could be 
examined. K15M has been linked to enhanced migration (Tsai et al., 2009) hence is an attractive 
candidate. Moreover, the suggestions that KSHV- vGPCR (Couty et al., 2009) and K5 (Mansouri 
et al., 2006) are inhibitory to migration are based upon single studies, thus it would be 
informative to verify through methods such as siRNA knockdown their roles in this system also. 
Indeed in view of the pro-angiogenic effect of vGPCR it is counterintuitive that it should have 
anti-migratory effects and K5 was shown to induce changes to the actin cytoskeleton similar to 
those reported in this study. The latency protein vFLIP has also been noted for its effects on the 
actin cytoskeleton thus might be considered too (Grossmann et al., 2006).  
The striking changes in laminin deposition with KSHV-infection warrant further 
investigation. The fact that laminin-P1 decreased whereas laminin-4 increased raises the 
question as to what effect the virus had upon laminin  and  chains. It would be interesting to 
examine by ELISA the effect of KSHV-infection on deposition of each of the endothelial 
laminin- and chains (1, 2, 1). This would help to establish whether or not the increase in 
laminin 4 is due to increased -chain secretion. Such an imbalance in chain deposition would 
likely have significant influence upon the properties of the matrix given that the  and  chains 
each contain domains that mediate the interaction of laminin with other macromolecules of the 
extracellular matrix such as proteoglycans, netrin 4, and nidogen (Hamill et al., 2009).  
Although studies in this thesis did not demonstrate a role for the altered sub-endothelial 
matrix in the phenotype of KSHV-enhanced migration, KSHV infection might have upregulated 
deposition of other laminin  chains, either constitutively or in response to laminin-4 
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knockdown, that compensated for laminin-4 when its levels were reduced toward those of 
untreated endothelium. To help provide insight into whether a ‘normal’ basement membrane was 
generated by the intervention of laminin-4 knockdown, the laminin-P1 and laminin-5 levels 
could be evaluated in consort with laminin-4 knockdown. Electron microscopy imaging might 
also provide qualitative evidence to indicate whether the matrix architecture is recovered by 
simply reducing laminin-4 expression.  
It is important to note that the regulation of laminin-4 by KSHV was not at the genetic 
level. It is likely that other proteins were regulated through a similar posttranslational mechanism 
to laminin-4 and could be mediators of the enhanced migration. Thus ascertaining the 
mechanism underlying increased laminin-4 deposition might help to identify key regulators of 
KSHV-induced endothelial cell migration. Mass spectrometry with Stable Isotype Labelling with 
Amino acids in Cell culture (SILAC) to compare the protein complements of KSHV-infected and 
untreated cells would be useful. Similar assessment of deposited sub-endothelial matrices would 
also be advantageous for gaining a fuller understanding of the changes arising in this extracellular 
substance and may help to identify further endothelial proteins that might be harnessed by the 
virus for enhancing migratory/angiogenic effects. Candidates could then be tested functionally. 
Phosphoproteome arrays could also help establish proteins whose activation states are regulated.  
Using such global protein and phosphoprotein screens would also be expected to aid 
understanding of the changes in focal adhesion size and number that were observed in this thesis 
by immunofluorescence staining for vinculin. For example, if the reduction in focal adhesion size 
was due to reduced vinculin recruitment into focal adhesions, downregulation of proteins 
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involved in vinculin recruitment might be identified or increased activity of proteins associated 
with focal adhesion turnover might be evident. Verification of any candidate proteins identified 
in this way could be made using the method of immunofluorescence staining as described in this 
thesis for vinculin. Even without large arrays, an indication of whether the decreases in focal 
adhesion size and number were due to the choice of vinculin as the marker for focal adhesions 
would be possible from staining cells with a panel of antibodies against other proteins routinely 
observed at focal adhesions such as: talin, paxillin and FAK. 
The vessels observed in KS lesions are described as ‘leaky’ suggesting that the 
endothelium might have greater porosity following KSHV infection. Possibly the degradation of 
junctional proteins catalysed by KSHV genes, such as K5, has roles in this. The alterations to the 
basement membrane might also make it more porous and contribute to this property of leakiness. 
Porosity differences could be compared for KSHV-inoculated and untreated cultures using 
optical fluorometric methods.  
Another impact of the altered basement membrane that would be interesting to pursue is 
its effect upon leukocyte recruitment to tissue since KS lesions are characterised by a large 
inflammatory infiltrate. Consistent with the concept that basement membrane might influence 
this process, we recently demonstrated that the maturation of ‘normal’ sub-endothelial matrix 
hindered neutrophil migration across cytokine stimulated endothelium (Burton et al., 2011). 
While the work by Burton et al (2011) did not demonstrate an effect of matrix maturation upon 
the extravasation of lymphocytes or monocytes, other investigators have shown that laminin-4 
deficiency impairs the recruitment of all major leukocyte subsets in response to inflammatory 
stimuli: a role for laminin-4 in aiding leukocyte penetration of the vessel wall was proposed 
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(Kenne et al., 2010; Sixt et al., 2001; Wondimu et al., 2004). Hence the increase in laminin-4 
with KSHV infection might support increased leukocyte extravasation.   
To date the precursor of the KS spindle cell has not been fully defined. Both LEC and 
BEC are infected by KSHV and infection appears to cause a shift in the phenotype of each cell 
type toward that of the other (Hansen et al., 2010; Hong et al., 2004; Wang et al., 2004a). While 
the present study supports a pro-angiogenic impact of KSHV on endothelial cells consistent with 
the angiogenic nature of KS, from observations that the gene signatures of neoplastic cells of KS 
closely resemble those of LEC, and LEC support a higher number of KSHV genomes than BEC, 
Wang et al (2004) suggested that a lymphatic origin be favoured over blood vascular. Therefore, 
it would be interesting to examine whether KSHV infection modulates the migration and 
migration-influential factors of primary LEC as well as of HUVEC.   
An expansion of the KS-like spindle cell population isolated from peripheral blood has 
been found in KS patients compared to controls and KSHV infection detected in these cells 
(Sirianni et al., 1997). These cells cultured from circulation express endothelial and macrophage 
markers (Browning et al., 1994; Sirianni et al., 1997). By their localisation into tissues they might 
contribute to the multifocal appearance of KS; however their specific origin continues to remain 
unknown. Endothelial progenitor cells, which originate in the bone marrow, are one candidate. 
Over recent years, methods to reliably isolate and culture endothelial progenitor cells from whole 
blood have been established and it would be interesting to observe the impact of KSHV infection 
on this class of endothelial cell too. 
 
CHAPTER EIGHT: General discussion   
 
 
299 
 
8.3 PHYSIOLOGICAL AND THERAPEUTIC RELEVANCE OF THIS STUDY  
This study has provided evidence that infection of endothelial cells by KSHV causes 
chronic alterations in multiple facets of endothelial cell biology, impacting properties such as 
basement membrane protein deposition, integrin profiles, chemokine secretion, wound recovery 
migration and transmigratory, ‘penetrative’ migration. Although the precise intracellular 
mechanisms by which the virus yields these effects are not known, it is likely that together they 
contribute to the development of KS lesions in vivo.  
The homology between KSHV and other herpesviruses, suggests the effects of KSHV on 
endothelial cells described in this study might be recapitulated in other cell types infected by 
other herpesviruses and contribute to the development of the diseases with which they are 
associated. Other cancer causing viruses including members of the polyomavirus, hepadnavirus, 
and papillomavirus families (Morris et al., 2008) might also utilise similar mechanisms.   
To my knowledge, changes in matrix protein deposition and matrix architecture have not 
been widely examined in the context of virus induced cancers. The alterations in the laminin and 
integrin profiles with KSHV infection of primary endothelial cells provide strong support that the 
ECM secreted by tumour-associated cells, such as endothelial cells, governs lesion formation. 
This influence of the ECM may be via effects on the adhesion and migration, proliferation and 
survival of both the secreting cell and the other cell types present in the lesions (fibroblasts, 
endothelial cells, immune cells, proliferating cells).  
Clinical trials to establish the most appropriate regimens for the treatment of KS are 
ongoing. Strategies include the use of chemotherapeutic agents, radiotherapy, Highly Active 
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Anti-Retroviral Therapy (HAART) and herpesvirus DNA synthesis inhibitors (Gantt and Casper, 
2011; Sarwar et al., 2007; Uldrick and Whitby, 2011). Both monotherapy and combination 
therapy approaches have been tried.  HAART and herpesvirus DNA synthesis inhibitors have 
also been tested prophylactically with some indication of benefit. In fact inhibitors of herpesvirus 
DNA synthesis, when given as a monotherapy, appear more effective for preventative medicine 
than as an active therapy (Gantt and Casper, 2011).   
HAART, a combination of nucleoside reverse transcriptase inhibitors with a non-
nucleoside reverse transcriptase inhibitor or protease inhibitor, was first introduced based on the 
association of HIV-infection with increased risk of KS (AIDS-KS). Immune reconstitution is 
central to the clinical benefit of HAART; however, there is some indication that the protease 
inhibitors might target KS development in a mechanism independent of effects on HIV 
replication and restoration of the immune system, thereby having a therapeutic effect even in a 
non-HIV setting (Gantt and Casper, 2011).  
The use of HAART has greatly reduced incidence of AIDS-KS in developed countries 
when given either alone to treat early stage AIDS-KS or in combination with chemotherapeutic 
agents to treat advanced AIDS-KS (Sarwar et al., 2007). Such positive results with HAART in 
western countries mean that the current clinical burden of KS is primarily in the developing 
world, where HAART is not only too expensive but non-HIV-associated endemic-KS is 
prevalent. Sadly, due to this divide between resource wealthy and resource poor countries, in 
terms of the pressure placed by KS on healthcare resources, the development of new drugs to 
treat KS has received minimal investment by pharmaceutical industries. Since current KSHV-
targeting drugs/strategies available are often ineffective, novel therapies are needed in order to 
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successfully treat or prevent non-AIDS-KS, which is a cause of high morbidity and mortality in 
parts of Africa. Treatments which target KSHV and/or its mechanism of induced tumourigenesis 
may be of benefit, possibly also affording reduced side effects compared to traditional 
chemotherapeutic approaches. The design of such drugs requires greater understanding of the 
mechanisms underlying KS pathogenesis.  
While the present study has not identified a viral or host cell gene that might be targeted 
therapeutically, it has described functional effects of KSHV infection on endothelial cell biology 
(migration, laminins, actin cytoskeleton, focal adhesions, chemokines), which may be targeted or 
for which the viral genes responsible might now be pursued. If future studies show other viruses 
to be inducers of similar responses, such novel therapies might have application in the treatment 
of a range of diseases besides KS.  
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% Transmigration 
by microscopy 
Number of                          
KSHV-EC/100cells 
% GFP positive 
cells by flow 
cytometry 
Number of                              
GFP+ve/100 cells 
Number of                            
GFP-ve/100 cells 
% Transmigration 
by microscopy and 
flow cytometry 
combined 
 
Expt UT-EC 
KSHV-
EC 
Top Bottom Top Bottom Top Bottom Top Bottom V NI 
48
 h
r 
A 36.54 44.83 55.17 44.83 46.94 62.49 25.90 28.02 29.27 16.82 51.97 36.49 
B 36.86 52.11 47.89 52.11 60.80 84.80 29.12 44.19 18.77 7.92 60.28 29.67 
C 33.34 41.91 58.09 41.91 82.96 89.80 48.18 37.64 9.90 4.28 43.86 30.16 
D 39.96 47.78 52.22 47.78 62.97 73.06 32.88 34.91 19.34 12.87 51.50 39.97 
Table 9.1: Determination of the percentage transmigration of KSHV-infected (V) and non-infected (NI) HUVEC by 
calculation from the results of parallel 48hour transmigration assays with microscopic and flow cytometry readout. 
KSHV-inoculated (KSHV-EC) and untreated (UT-EC) HUVEC were seeded into 8m-pore transwell chambers on day-seven 
post-inoculation and the percentage transmigration after 48hours examined by microscopy. The number of KSHV-EC in every 
100 cells that were on each side of the filter was calculated. The percentage of GFP positive cells in KSHV-EC cultures 
removed from the top and bottom surfaces of parallel 8m-pore transwell chamber filters at 48hours was quantified by flow 
cytometry. By multiplying together the number of KSHV-EC/100 cells (as determined by microscopy) and the proportion that 
were GFP positive or negative, the numbers of GFP positive (KSHV-infected (V)) and GFP negative (non-infected (NI)) cells 
on each side of the filter were calculated and the percentage transmigration determined for each of V and NI. 
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